MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.01.01.1AH|P|2.5.1|PID|||2UeC-B.01.01^^^AIRA-TEST^MR||Clay^Doreen^Undine^^^^L|Otoe^Adila|20131216|F||2106-3^White^HL70005|279 Noble Ave^^Whitmore Lake^MI^48189^USA^P||^PRN^PH^^^734^5094026|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Otoe^Adila^^^^^L|MTH^Mother^HL70063|279 Noble Ave^^Whitmore Lake^MI^48189^USA^P|^PRN^PH^^^734^5094026|ORC|RE||E92Z7018.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.01.02.1AH|P|2.5.1|PID|||2UeC-B.01.02^^^AIRA-TEST^MR||Multnomah^Elyse^A^^^^L|Upton^Edina|20131203|M||2106-3^White^HL70005|318 Egland Ln^^Grand Rapids^MI^49546^USA^P||^PRN^PH^^^616^6876341|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Multnomah^Edina^^^^^L|MTH^Mother^HL70063|318 Egland Ln^^Grand Rapids^MI^49546^USA^P|^PRN^PH^^^616^6876341|ORC|RE||A01M7019.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.01.03.1Bc|P|2.5.1|PID|||2UeC-B.01.03^^^AIRA-TEST^MR||Wexford^Xylon^G^^^^L|McErlaine^Mertice|20131210|U||1002-5^American Indian or Alaska Native^HL70005|294 Clermont St^^Auburn Hills^MI^48321^USA^P||^PRN^PH^^^248^4013761|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Wexford^Mertice^^^^^L|MTH^Mother^HL70063|294 Clermont St^^Auburn Hills^MI^48321^USA^P|^PRN^PH^^^248^4013761|ORC|RE||I86L7020.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.02.01.1Bc|P|2.5.1|PID|||2UeC-B.02.01^^^AIRA-TEST^MR||Morris^Sarkis^Ademaro^^^^L|Cumberland^Whitney|20131201|M||1002-5^American Indian or Alaskan Native^HL70005|192 Alcona Ln^^Belleville^MI^48112^USA^P||^PRN^PH^^^734^7530381|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Morris^Whitney^^^^^L|MTH^Mother^HL70063|192 Alcona Ln^^Belleville^MI^48112^USA^P|^PRN^PH^^^734^7530381|ORC|RE||C66Z7021.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.02.02.1Bc|P|2.5.1|PID|||2UeC-B.02.02^^^AIRA-TEST^MR||Pushmataha^Aldred^Verrell^^^^L|Hughes^Maiya|20131203|M||2028-9^Asian^HL70005|397 Worth Ave^^Lake Orion^MI^48361^USA^P||^PRN^PH^^^248^3159081|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Knott^Maiya^^^^^L|MTH^Mother^HL70063|397 Worth Ave^^Lake Orion^MI^48361^USA^P|^PRN^PH^^^248^3159081|ORC|RE||E48A7022.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.02.03.1Bc|P|2.5.1|PID|||2UeC-B.02.03^^^AIRA-TEST^MR||Swift^Henleigh^Tallis^^^^L|Centre^Myfanwy|20131204|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|229 Lyon Cir^^Charlevoix^MI^49720^USA^P||^PRN^PH^^^231^3638668|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Swift^Myfanwy^^^^^L|MTH^Mother^HL70063|229 Lyon Cir^^Charlevoix^MI^49720^USA^P|^PRN^PH^^^231^3638668|ORC|RE||F40C7023.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.02.04.1Bs|P|2.5.1|PID|||2UeC-B.02.04^^^AIRA-TEST^MR||Polk^Audrey^Madhu^^^^L|Sherman^Alankrita|20131130|F||2054-5^Black or African-American^HL70005|69 Pedersen Pl^^Sylvan Beach^MI^49463^USA^P||^PRN^PH^^^231^7505440|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Galveston^Alankrita^^^^^L|MTH^Mother^HL70063|69 Pedersen Pl^^Sylvan Beach^MI^49463^USA^P|^PRN^PH^^^231^7505440|ORC|RE||N46Z7024.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.02.05.1Bs|P|2.5.1|PID|||2UeC-B.02.05^^^AIRA-TEST^MR||Dahl^Sherman^Miklos^^^^L|Wolfe^Kitty|20131207|M||2106-3^White^HL70005|219 Franklin St^^Tawas City^MI^48763^USA^P||^PRN^PH^^^989^8854844|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Dahl^Kitty^^^^^L|MTH^Mother^HL70063|219 Franklin St^^Tawas City^MI^48763^USA^P|^PRN^PH^^^989^8854844|ORC|RE||B71G7025.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.02.06.1Bs|P|2.5.1|PID|||2UeC-B.02.06^^^AIRA-TEST^MR||Edmonson^Zigmund^Upendra^^^^L|Brot^Corbin|20131129|M||2131-1^Other Race^HL70005|58 Washington Cir^^Dearborn^MI^48121^USA^P||^PRN^PH^^^313^8213074|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Power^Corbin^^^^^L|MTH^Mother^HL70063|58 Washington Cir^^Dearborn^MI^48121^USA^P|^PRN^PH^^^313^8213074|ORC|RE||Q84T7026.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.02.07.1BH|P|2.5.1|PID|||2UeC-B.02.07^^^AIRA-TEST^MR||Cowle^Newlyn^G^^^^L|Borden^Rhoda|20131207|M||^Unknown/undetermined^HL70005|382 Madison Cir^^Burnips^MI^49314^USA^P||^PRN^PH^^^616^9038408|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Cowle^Rhoda^^^^^L|MTH^Mother^HL70063|382 Madison Cir^^Burnips^MI^49314^USA^P|^PRN^PH^^^616^9038408|ORC|RE||O78G7027.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.02.08.1BH|P|2.5.1|PID|||2UeC-B.02.08^^^AIRA-TEST^MR||Gallatin^Roman^M^^^^L|Ellis^Alodia|20131207|M||I^American Indian or Alaskan Native^HL70005|323 Wilsson Ave^^Armada^MI^48005^USA^P||^PRN^PH^^^586^9826204|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Gallatin^Alodia^^^^^L|MTH^Mother^HL70063|323 Wilsson Ave^^Armada^MI^48005^USA^P|^PRN^PH^^^586^9826204|ORC|RE||O37N7028.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.02.09.1BH|P|2.5.1|PID|||2UeC-B.02.09^^^AIRA-TEST^MR||Midland^Yusuf^Tewdwr^^^^L|Pulaski^Cinnabar|20131217|M||A^Asian or Pacific Islander^HL70005|264 Kinney Pl^^Lansing^MI^48908^USA^P||^PRN^PH^^^517^7524342|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Sutherns^Cinnabar^^^^^L|MTH^Mother^HL70063|264 Kinney Pl^^Lansing^MI^48908^USA^P|^PRN^PH^^^517^7524342|ORC|RE||S67Y7029.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.02.10.1BX|P|2.5.1|PID|||2UeC-B.02.10^^^AIRA-TEST^MR||Stephens^Canute^^^^^L|Fitzpatrick^Binty|20131222|M||B^Black or African-American^HL70005|341 Willacy Ln^^Coleman^MI^48618^USA^P||^PRN^PH^^^989^6721768|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Stephens^Binty^^^^^L|MTH^Mother^HL70063|341 Willacy Ln^^Coleman^MI^48618^USA^P|^PRN^PH^^^989^6721768|ORC|RE||I79V7030.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.02.11.1BX|P|2.5.1|PID|||2UeC-B.02.11^^^AIRA-TEST^MR||Patricio^Jagger^Gannon^^^^L|Kartwold^Carmel|20131119|M||W^White^HL70005|256 Marshall St^^Sand Lake^MI^49343^USA^P||^PRN^PH^^^616^4707601|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Patricio^Carmel^^^^^L|MTH^Mother^HL70063|256 Marshall St^^Sand Lake^MI^49343^USA^P|^PRN^PH^^^616^4707601|ORC|RE||C19W7031.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.02.12.1BX|P|2.5.1|PID|||2UeC-B.02.12^^^AIRA-TEST^MR||LaRue^Kehinde^Lenis^^^^L|Kearney^Alda|20131211|F||O^Other Race^HL70005|378 Cameron Ave^^Byron Township^MI^49315^USA^P||^PRN^PH^^^616^4087055|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|LaRue^Alda^^^^^L|MTH^Mother^HL70063|378 Cameron Ave^^Byron Township^MI^49315^USA^P|^PRN^PH^^^616^4087055|ORC|RE||I83R7032.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.02.13.1Cd|P|2.5.1|PID|||2UeC-B.02.13^^^AIRA-TEST^MR||Jackson^Abhi^Nambur^^^^L|Baraga^Revelation|20131120|M||U^Unknown/undetermined^HL70005|339 Farstan Ave^^Grass Lake^MI^49240^USA^P||^PRN^PH^^^517^9481528|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Jackson^Revelation^^^^^L|MTH^Mother^HL70063|339 Farstan Ave^^Grass Lake^MI^49240^USA^P|^PRN^PH^^^517^9481528|ORC|RE||X45B7033.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.03.01.1Cs|P|2.5.1|PID|||2UeC-B.03.01^^^AIRA-TEST^MR||Monroe^Lobsang^Valter^^^^L|Franklin^Kaya|20131204|M||1511-5^Taos^HL70005|162 Saint Clair Ln^^Baraga^MI^49908^USA^P||^PRN^PH^^^906^4639414|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Monroe^Kaya^^^^^L|MTH^Mother^HL70063|162 Saint Clair Ln^^Baraga^MI^49908^USA^P|^PRN^PH^^^906^4639414|ORC|RE||C63J7034.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.04.01.1Cs|P|2.5.1|PID|||2UeC-B.04.01^^^AIRA-TEST^MR||Parasari^Charu^Io^^^^L|Parasari^Ashlyn|20131126|F||2106-3^White^HL70005|287 Los Angeles St^^Detroit^MI^48231^USA^P||^PRN^PH^^^313^2919058|||||||||2135-2^Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Uvalde^Ashlyn^^^^^L|MTH^Mother^HL70063|287 Los Angeles St^^Detroit^MI^48231^USA^P|^PRN^PH^^^313^2919058|ORC|RE||X43V7035.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.04.02.1Cs|P|2.5.1|PID|||2UeC-B.04.02^^^AIRA-TEST^MR||Browne^Israel^^^^^L|Sharples^Anamika|20131205|M||2106-3^White^HL70005|227 Pike Ln^^Eckerman^MI^49728^USA^P||^PRN^PH^^^906^7819593|||||||||2186-5^not Hispanic or Latino^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Browne^Anamika^^^^^L|MTH^Mother^HL70063|227 Pike Ln^^Eckerman^MI^49728^USA^P|^PRN^PH^^^906^7819593|ORC|RE||O16M7036.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.04.03.1CI|P|2.5.1|PID|||2UeC-B.04.03^^^AIRA-TEST^MR||Morrow^Annora^Leola^^^^L|Mahoney^Kiden|20131209|F||1002-5^American Indian or Alaska Native^HL70005|290 Wold Ln^^Prescott^MI^48756^USA^P||^PRN^PH^^^989^5211742|||||||||^Unknown^CDCREC|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Morrow^Kiden^^^^^L|MTH^Mother^HL70063|290 Wold Ln^^Prescott^MI^48756^USA^P|^PRN^PH^^^989^5211742|ORC|RE||D84U7037.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.04.04.1CI|P|2.5.1|PID|||2UeC-B.04.04^^^AIRA-TEST^MR||Daly^Allan^M^^^^L|Story^Jazmine|20131202|M||1002-5^American Indian or Alaska Native^HL70005|73 Jackson Pl^^Riga^MI^49276^USA^P||^PRN^PH^^^517^6076443|||||||||2135-2^Hispanic or Latino^HL70189|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Story^Jazmine^^^^^L|MTH^Mother^HL70063|73 Jackson Pl^^Riga^MI^49276^USA^P|^PRN^PH^^^517^6076443|ORC|RE||I73U7038.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.04.05.1CI|P|2.5.1|PID|||2UeC-B.04.05^^^AIRA-TEST^MR||Graves^Jimena^G^^^^L|Buckles^Ryann|20131208|F||2106-3^White^HL70005|16 Burleson Pl^^Lansing^MI^48917^USA^P||^PRN^PH^^^517^8271831|||||||||2186-5^not Hispanic or Latino^HL70189|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Buckles^Ryann^^^^^L|MTH^Mother^HL70063|16 Burleson Pl^^Lansing^MI^48917^USA^P|^PRN^PH^^^517^8271831|ORC|RE||R51Y7039.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.04.06.1CI|P|2.5.1|PID|||2UeC-B.04.06^^^AIRA-TEST^MR||Marsh^Aviv^Vaughn^^^^L|Harris^Joakima|20131130|M||2106-3^White^HL70005|21 Clarke Ave^^Grosse Pointe^MI^48224^USA^P||^PRN^PH^^^313^2739893|||||||||^Unknown^HL70189|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Harris^Joakima^^^^^L|MTH^Mother^HL70063|21 Clarke Ave^^Grosse Pointe^MI^48224^USA^P|^PRN^PH^^^313^2739893|ORC|RE||H66J7040.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.04.07.1CX|P|2.5.1|PID|||2UeC-B.04.07^^^AIRA-TEST^MR||Tama^Wilton^Everett^^^^L|Saginaw^Esmeralda|20131205|M||2054-5^Black or African-American^HL70005|153 Linn Cir^^Mayville^MI^48744^USA^P||^PRN^PH^^^989^7285271|||||||||H^Hispanic or Latino^HL70189|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Tama^Esmeralda^^^^^L|MTH^Mother^HL70063|153 Linn Cir^^Mayville^MI^48744^USA^P|^PRN^PH^^^989^7285271|ORC|RE||C54S7041.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.04.08.1CX|P|2.5.1|PID|||2UeC-B.04.08^^^AIRA-TEST^MR||Caldwell^Prassana^^^^^L|Colorado^Adeline|20131201|M||1002-5^American Indian or Alaska Native^HL70005|137 Franklin Ln^^Horton^MI^49246^USA^P||^PRN^PH^^^517^5651620|||||||||N^not Hispanic or Latino^HL70189|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Larson^Adeline^^^^^L|MTH^Mother^HL70063|137 Franklin Ln^^Horton^MI^49246^USA^P|^PRN^PH^^^517^5651620|ORC|RE||Y84J7042.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.04.09.1CX|P|2.5.1|PID|||2UeC-B.04.09^^^AIRA-TEST^MR||Olsen^Canace^L^^^^L|Mono^Chyou|20131201|F||1002-5^American Indian or Alaska Native^HL70005|187 Josephine Ln^^Ann Arbor^MI^48113^USA^P||^PRN^PH^^^734^5487433|||||||||U^Unknown^HL70189|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Mono^Chyou^^^^^L|MTH^Mother^HL70063|187 Josephine Ln^^Ann Arbor^MI^48113^USA^P|^PRN^PH^^^734^5487433|ORC|RE||Z69F7043.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.05.01.1Dd|P|2.5.1|PID|||2UeC-B.05.01^^^AIRA-TEST^MR||Caldwell^Mikayla^S^^^^L|Jackson^Minelli|20131214|F||2106-3^White^HL70005|196 Monroe Pl^^Detroit^MI^48220^USA^P||^PRN^PH^^^248^2141951|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Caldwell^Minelli^^^^^L|MTH^Mother^HL70063|196 Monroe Pl^^Detroit^MI^48220^USA^P|^PRN^PH^^^248^2141951|ORC|RE||N44W7044.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^New immunization record^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.05.02.1Dd|P|2.5.1|PID|||2UeC-B.05.02^^^AIRA-TEST^MR||Northampton^Kyran^S^^^^L||20041204|M|ORC|RE||X27V7045.3^AIRA|RXA|0|1|20151129||62^HPV^CVX|999|||01^Historical information - source unspecified^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.05.03.1Dd|P|2.5.1|PID|||2UeC-B.05.03^^^AIRA-TEST^MR||Adams^Kenley^Amita^^^^L||20041130|F|ORC|RE||Z26Z7046.3^AIRA|RXA|0|1|20151205||83^Hep A^CVX|999|||02^Historical information - from other provider^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.05.04.1Dd|P|2.5.1|PID|||2UeC-B.05.04^^^AIRA-TEST^MR||Olson^Burton^Roddie^^^^L||20041203|M|ORC|RE||D27Q7047.3^AIRA|RXA|0|1|20151206||83^Hep A^CVX|999|||03^Historical information - from parent's written record^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.05.05.1Dd|P|2.5.1|PID|||2UeC-B.05.05^^^AIRA-TEST^MR||San Joaquin^Anil^Davy^^^^L||20041122|M|ORC|RE||N75D7048.3^AIRA|RXA|0|1|20151203||115^Tdap^CVX|999|||04^Historical information - from parent's recall^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.05.06.1Dd|P|2.5.1|PID|||2UeC-B.05.06^^^AIRA-TEST^MR||Clinton^Theora^Sudevi^^^^L||20041119|F|ORC|RE||N71I7049.3^AIRA|RXA|0|1|20151129||118^HPV^CVX|999|||05^Historical information - from other registry^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.05.07.1Dd|P|2.5.1|PID|||2UeC-B.05.07^^^AIRA-TEST^MR||Butler^Menteith^Mekhi^^^^L||20041207|M|ORC|RE||Q90U7050.3^AIRA|RXA|0|1|20151210||62^HPV^CVX|999|||06^Historical information - from birth certificate^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.05.08.1Dd|P|2.5.1|PID|||2UeC-B.05.08^^^AIRA-TEST^MR||Warren^Dail^A^^^^L||20041210|M|ORC|RE||L38N7051.3^AIRA|RXA|0|1|20151211||115^Tdap^CVX|999|||07^Historical information - from school record^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.05.09.1Dd|P|2.5.1|PID|||2UeC-B.05.09^^^AIRA-TEST^MR||Preble^Klarissa^Galya^^^^L||20041213|F|ORC|RE||I29K7052.3^AIRA|RXA|0|1|20151205||83^Hep A^CVX|999|||08^Historical information - from public agency^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.06.01.1Dd|P|2.5.1|PID|||2UeC-B.06.01^^^AIRA-TEST^MR||Tobin^Sinjon^S^^^^L|Lake^Seiriol|20131126|M||2106-3^White^HL70005|239 Rogers Cir^^GR^MI^49519^USA^P||^PRN^PH^^^616^5685500|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Lake^Seiriol^^^^^L|MTH^Mother^HL70063|239 Rogers Cir^^GR^MI^49519^USA^P|^PRN^PH^^^616^5685500|ORC|RE||V29V7053.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.06.02.1Dt|P|2.5.1|PID|||2UeC-B.06.02^^^AIRA-TEST^MR||Henry^Burt^Marston^^^^L|Mills^Altair|20131208|M||2054-5^Black or African-American^HL70005|225 Charlevoix St^^State of Mich Dept Treasury^MI^48930^USA^P||^PRN^PH^^^517^7820122|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Mills^Altair^^^^^L|MTH^Mother^HL70063|225 Charlevoix St^^State of Mich Dept Treasury^MI^48930^USA^P|^PRN^PH^^^517^7820122|ORC|RE||D55I7054.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible-Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.06.03.1DI|P|2.5.1|PID|||2UeC-B.06.03^^^AIRA-TEST^MR||Rodriguez^Harper^Chiamaka^^^^L|Muscatine^Mignon|20131201|M||2106-3^White^HL70005|384 Pawnee St^^Westland^MI^48184^USA^P||^PRN^PH^^^734^3547884|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Rodriguez^Mignon^^^^^L|MTH^Mother^HL70063|384 Pawnee St^^Westland^MI^48184^USA^P|^PRN^PH^^^734^3547884|ORC|RE||P29U7055.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible- Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.06.04.1DI|P|2.5.1|PID|||2UeC-B.06.04^^^AIRA-TEST^MR||Dawes^Rach^Eternity^^^^L|Bannock^Hina|20131122|F||2106-3^White^HL70005|277 Letcher Pl^^Lansing^MI^48913^USA^P||^PRN^PH^^^517^8725291|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Dawes^Hina^^^^^L|MTH^Mother^HL70063|277 Letcher Pl^^Lansing^MI^48913^USA^P|^PRN^PH^^^517^8725291|ORC|RE||Y93R7056.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible- American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.06.05.1DI|P|2.5.1|PID|||2UeC-B.06.05^^^AIRA-TEST^MR||Woods^Philomena^^^^^L|Humboldt^Harlow|20131201|F||2106-3^White^HL70005|348 Pittsburg Ave^^Lawrence^MI^49064^USA^P||^PRN^PH^^^269^7333864|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Jackson^Harlow^^^^^L|MTH^Mother^HL70063|348 Pittsburg Ave^^Lawrence^MI^49064^USA^P|^PRN^PH^^^269^7333864|ORC|RE||J55O7057.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible-Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.06.06.1DY|P|2.5.1|PID|||2UeC-B.06.06^^^AIRA-TEST^MR||Pend Oreille^Geert^Vougay^^^^L|Wotherspoon^Marinel|20131130|M||1002-5^American Indian or Alaska Native^HL70005|308 Osceola Ave^^Royal Oak^MI^48068^USA^P||^PRN^PH^^^248^4671741|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Delta^Marinel^^^^^L|MTH^Mother^HL70063|308 Osceola Ave^^Royal Oak^MI^48068^USA^P|^PRN^PH^^^248^4671741|ORC|RE||O73W7058.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V07^Local-specific eligibility^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.01.1DY|P|2.5.1|PID|||2UeC-B.07.01^^^AIRA-TEST^MR||Clay^Bo-Bae^Kesare^^^^L||20041127|F||2054-5^Black or African-American^HL70005|280 Pocahontas Pl^^Lansing^MI^48909^USA^P||^PRN^PH^^^517^5058773|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||B47A7059.2^AIRA|RXA|0|1|20151128||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|409498004^Anthrax (disorder)^SCT||||||F|ORC|RE||B47A7059.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||115^Tdap^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U5706DN||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.02.1DY|P|2.5.1|PID|||2UeC-B.07.02^^^AIRA-TEST^MR||Jefferson^Tran^Beck^^^^L||20041129|M||2054-5^Black or African-American^HL70005|369 Grayson St^^Rochester Hls^MI^48306^USA^P||^PRN^PH^^^248^6121602|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||P39H7060.2^AIRA|RXA|0|1|20151211||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|397428000^Diphtheria (disorder)^SCT||||||F|ORC|RE||P39H7060.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||83^Hep A^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L0214MX||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|85^Hepatitis A^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20111025||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.03.1Ee|P|2.5.1|PID|||2UeC-B.07.03^^^AIRA-TEST^MR||Barrett^Carlo^N^^^^L||20041128|M||1002-5^American Indian or Alaska Native^HL70005|112 Kohlmeister Ave^^Chippewa Temp Correction Fac^MI^49785^USA^P||^PRN^PH^^^906^8719701|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||U32V7061.2^AIRA|RXA|0|1|20151127||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|76902006^Tetanus (disorder)^SCT||||||F|ORC|RE||U32V7061.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||115^Tdap^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||E3441NS||PMC^sanofi pasteur^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.04.1Ee|P|2.5.1|PID|||2UeC-B.07.04^^^AIRA-TEST^MR||Lowe^Aurelia^Eileen^^^^L||20041121|F||2106-3^White^HL70005|162 Grays Pl^^Ubly^MI^48475^USA^P||^PRN^PH^^^989^5880594|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||U01D7062.2^AIRA|RXA|0|1|20151127||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|27836007^Pertussis (disorder)^SCT||||||F|ORC|RE||U01D7062.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||83^Hep A^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z9162JF||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|85^Hepatitis A^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20111025||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.05.1Ee|P|2.5.1|PID|||2UeC-B.07.05^^^AIRA-TEST^MR||O'Neill^Phuong^Stafford^^^^L||20041118|M||2106-3^White^HL70005|163 King Ln^^Kewadin^MI^49648^USA^P||^PRN^PH^^^231^5692107|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||A54N7063.2^AIRA|RXA|0|1|20151128||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|40468003^Viral hepatitis, type A (disorder)^SCT||||||F|ORC|RE||A54N7063.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||62^HPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||I2083FW||MSD^Merck and Co^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|137^HPV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120222||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.06.1Et|P|2.5.1|PID|||2UeC-B.07.06^^^AIRA-TEST^MR||Fayette^Durdanius^Vavrin^^^^L||20041206|M||2106-3^White^HL70005|182 Delaware St^^Bloomfield^MI^48301^USA^P||^PRN^PH^^^248^9628504|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||S75C7064.2^AIRA|RXA|0|1|20151211||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|66071002^Type B viral hepatitis (disorder)^SCT||||||F|ORC|RE||S75C7064.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||83^Hep A^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G2789NM||MSD^Merck and Co^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|85^Hepatitis A^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20111025||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.07.1Et|P|2.5.1|PID|||2UeC-B.07.07^^^AIRA-TEST^MR||Boyd^Ketan^Bosworth^^^^L||20041215|M||2106-3^White^HL70005|218 Howard Ln^^Rankin^MI^48473^USA^P||^PRN^PH^^^810^8512497|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||F35R7065.2^AIRA|RXA|0|1|20151209||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|91428005^Haemophilus influenzae infection (disorder)^SCT||||||F|ORC|RE||F35R7065.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||115^Tdap^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U5706DN||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.08.1Et|P|2.5.1|PID|||2UeC-B.07.08^^^AIRA-TEST^MR||Mitchell^Loorea^Cristina^^^^L||20041122|F||2106-3^White^HL70005|301 Fremstad Ln^^Canadian Lake^MI^49346^USA^P||^PRN^PH^^^231^2077081|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||B77S7066.2^AIRA|RXA|0|1|20151127||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|240532009^Human papilloma virus infection (disorder)^SCT||||||F|ORC|RE||B77S7066.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||62^HPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||I2083FW||MSD^Merck and Co^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|137^HPV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120222||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.09.1Et|P|2.5.1|PID|||2UeC-B.07.09^^^AIRA-TEST^MR||Barrett^Fala^^^^^L||20041123|F||2106-3^White^HL70005|310 Adams Ln^^Northville^MI^48167^USA^P||^PRN^PH^^^248^5044448|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||F10P7067.2^AIRA|RXA|0|1|20151130||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|6142004^Influenza (disorder)^SCT||||||F|ORC|RE||F10P7067.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||118^HPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N1113LK||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|137^HPV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120222||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.10.1EJ|P|2.5.1|PID|||2UeC-B.07.10^^^AIRA-TEST^MR||Krog^Joss^P^^^^L||20041212|M||2106-3^White^HL70005|110 Sabine Ave^^Trenary^MI^49891^USA^P||^PRN^PH^^^906^7391760|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||W32P7068.2^AIRA|RXA|0|1|20151209||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|52947006^Japanese encephalitis virus disease (disorder)^SCT||||||F|ORC|RE||W32P7068.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||83^Hep A^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z9162JF||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|85^Hepatitis A^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20111025||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.11.1EJ|P|2.5.1|PID|||2UeC-B.07.11^^^AIRA-TEST^MR||Medina^Aijah^^^^^L||20041123|F||2106-3^White^HL70005|298 Huron Ln^^Gladstone^MI^49837^USA^P||^PRN^PH^^^906^9453896|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||Z72Q7069.2^AIRA|RXA|0|1|20151130||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|14189004^Measles (disorder)^SCT||||||F|ORC|RE||Z72Q7069.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||115^Tdap^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||B4969SU||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.12.1EJ|P|2.5.1|PID|||2UeC-B.07.12^^^AIRA-TEST^MR||Cherokee^Aubert^Yobachi^^^^L||20041118|M||2054-5^Black or African-American^HL70005|259 Geauga St^^Hillman^MI^49746^USA^P||^PRN^PH^^^989^8808229|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||B05F7070.2^AIRA|RXA|0|1|20151128||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|36989005^Mumps (disorder)^SCT||||||F|ORC|RE||B05F7070.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||115^Tdap^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||B5324WU||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.13.1EJ|P|2.5.1|PID|||2UeC-B.07.13^^^AIRA-TEST^MR||Jensen^Blaine^Vilma^^^^L||20041127|F||2028-9^Asian^HL70005|99 Chope St^^Harrison Township^MI^48045^USA^P||^PRN^PH^^^586^4331483|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||H46A7071.2^AIRA|RXA|0|1|20151210||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|36653000^Rubella (disorder)^SCT||||||F|ORC|RE||H46A7071.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||115^Tdap^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||B4969SU||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.14.1EY|P|2.5.1|PID|||2UeC-B.07.14^^^AIRA-TEST^MR||Union^Imperia^Lylah^^^^L||20041210|F||2106-3^White^HL70005|104 Jensen St^^Hghtn Lk Heights^MI^48630^USA^P||^PRN^PH^^^989^8020897|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||R22F7072.2^AIRA|RXA|0|1|20151203||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|23511006^Meningococcal infectious disease (disorder)^SCT||||||F|ORC|RE||R22F7072.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||115^Tdap^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q1871CB||PMC^sanofi pasteur^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.15.1Fe|P|2.5.1|PID|||2UeC-B.07.15^^^AIRA-TEST^MR||Brot^Rumer^T^^^^L||20041213|F||2131-1^Other Race^HL70005|32 Vistanst Ln^^New Buffalo^MI^49117^USA^P||^PRN^PH^^^269^4110434|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||F05U7073.2^AIRA|RXA|0|1|20151211||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|16814004^Pneumococcal infectious disease (disorder)^SCT||||||F|ORC|RE||F05U7073.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||115^Tdap^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||F7478FB||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.16.1Fe|P|2.5.1|PID|||2UeC-B.07.16^^^AIRA-TEST^MR||Cannavin^Kyrena^V^^^^L||20041202|F||2106-3^White^HL70005|323 Williams Ln^^Lewiston^MI^49756^USA^P||^PRN^PH^^^989^3119331|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||Z41V7074.2^AIRA|RXA|0|1|20151205||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|398102009^Acute poliomyelitis (disorder)^SCT||||||F|ORC|RE||Z41V7074.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||115^Tdap^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||F7478FB||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.17.1Fe|P|2.5.1|PID|||2UeC-B.07.17^^^AIRA-TEST^MR||Preble^Aquamarine^Sara^^^^L||20041118|F||2106-3^White^HL70005|164 Keith Pl^^Iron Mountain^MI^49801^USA^P||^PRN^PH^^^906^9911412|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||N46A7075.2^AIRA|RXA|0|1|20151129||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|14168008^Rabies (disorder)^SCT||||||F|ORC|RE||N46A7075.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||115^Tdap^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||A4200AS||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.18.1Fu|P|2.5.1|PID|||2UeC-B.07.18^^^AIRA-TEST^MR||Iversen^Marie^Susila^^^^L||20041205|F||1002-5^American Indian or Alaska Native^HL70005|361 Oates Cir^^Detroit^MI^48278^USA^P||^PRN^PH^^^313^8735522|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||Y98V7076.2^AIRA|RXA|0|1|20151203||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|18624000^Disease due to Rotavirus (disorder)^SCT||||||F|ORC|RE||Y98V7076.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||118^HPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z3245NJ||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|137^HPV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120222||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.19.1Fu|P|2.5.1|PID|||2UeC-B.07.19^^^AIRA-TEST^MR||Kent^Jobina^M^^^^L||20041125|F||1002-5^American Indian or Alaska Native^HL70005|354 Figgens Pl^^Corunna^MI^48817^USA^P||^PRN^PH^^^989^8806953|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||X52L7077.2^AIRA|RXA|0|1|20151206||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|4834000^Typhoid fever (disorder)^SCT||||||F|ORC|RE||X52L7077.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||115^Tdap^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q1871CB||PMC^sanofi pasteur^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.20.1Fu|P|2.5.1|PID|||2UeC-B.07.20^^^AIRA-TEST^MR||Lacey^Loxley^B^^^^L||20041216|M||2054-5^Black or African-American^HL70005|72 Gogebic Pl^^Northville Tw^MI^48167^USA^P||^PRN^PH^^^248^8471375|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||M05S7078.2^AIRA|RXA|0|1|20151211||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|111852003^Vaccinia (disorder)^SCT||||||F|ORC|RE||M05S7078.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||115^Tdap^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||E3441NS||PMC^sanofi pasteur^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.21.1Fu|P|2.5.1|PID|||2UeC-B.07.21^^^AIRA-TEST^MR||Sacramento^Anika^^^^^L||20041117|F||2054-5^Black or African-American^HL70005|276 Oldham St^^Allouez^MI^49805^USA^P||^PRN^PH^^^906^7102970|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||K88T7079.2^AIRA|RXA|0|1|20151128||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|38907003^Varicella (disorder)^SCT||||||F|ORC|RE||K88T7079.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||118^HPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||C7865YE||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|137^HPV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120222||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.22.1FJ|P|2.5.1|PID|||2UeC-B.07.22^^^AIRA-TEST^MR||Reilly^Joseph^K^^^^L||20041215|M||2106-3^White^HL70005|152 Gray Ave^^Lima Township^MI^48118^USA^P||^PRN^PH^^^734^8153404|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||F81G7080.2^AIRA|RXA|0|1|20151209||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|16541001^Yellow fever (disorder)^SCT||||||F|ORC|RE||F81G7080.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||62^HPV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||M2976AT||MSD^Merck and Co^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|137^HPV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120222||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.07.23.1FJ|P|2.5.1|PID|||2UeC-B.07.23^^^AIRA-TEST^MR||Reeves^Zane^Leila^^^^L||20041123|F||2131-1^Other Race^HL70005|101 Jessen Cir^^Saint Clair Shrs^MI^48081^USA^P||^PRN^PH^^^586^2460629|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||E85P7081.2^AIRA|RXA|0|1|20151128||998^No vaccine administered^CVX|999|||||||||||||||A|OBX|1|CE|59784-9^Disease with presumed immunity^LN|1|271511000^Hepatitis B immune (finding)^SCT||||||F|ORC|RE||E85P7081.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||115^Tdap^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||B5324WU||SKB^GlaxoSmithKline^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|115^Tdap^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120124||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.08.01.1FJ|P|2.5.1|PID|||2UeC-B.08.01^^^AIRA-TEST^MR||Washington^Juan^Thurstan^^^^L|Van Wert^Eberta|20131122|M||2106-3^White^HL70005|282 Murray Ave^^Orion Township^MI^48359^USA^P||^PRN^PH^^^248^2714605|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204140816-0700|20171204|NK1|1|Washington^Eberta^^^^^L|MTH^Mother^HL70063|282 Murray Ave^^Orion Township^MI^48359^USA^P|^PRN^PH^^^248^2714605|ORC|RE||D65Y7082.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.08.02.1FZ|P|2.5.1|PID|||2UeC-B.08.02^^^AIRA-TEST^MR||Allegheny^Ciannait^Peridot^^^^L|Ronning^Eleora|20131208|F||2054-5^Black or African-American^HL70005|6 Robinson St^^Marine City^MI^48039^USA^P||^PRN^PH^^^810^8557678|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||I|20171204140816-0700|20171204|NK1|1|Ronning^Eleora^^^^^L|MTH^Mother^HL70063|6 Robinson St^^Marine City^MI^48039^USA^P|^PRN^PH^^^810^8557678|ORC|RE||D25X7083.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.08.03.1FZ|P|2.5.1|PID|||2UeC-B.08.03^^^AIRA-TEST^MR||Mohave^Acton^Vairaja^^^^L|Maricopa^Marny|20131206|M||2054-5^Black or African-American^HL70005|397 Grant Ave^^Iron River^MI^49935^USA^P||^PRN^PH^^^906^6050391|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||L|20171204140816-0700|20171204|NK1|1|Mohave^Marny^^^^^L|MTH^Mother^HL70063|397 Grant Ave^^Iron River^MI^49935^USA^P|^PRN^PH^^^906^6050391|ORC|RE||K09W7084.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.08.04.1FZ|P|2.5.1|PID|||2UeC-B.08.04^^^AIRA-TEST^MR||Love^Allan^Leontes^^^^L|Gibbons^Crystal|20131211|M||2106-3^White^HL70005|261 Knight Ave^^Madison Heights^MI^48071^USA^P||^PRN^PH^^^248^3223919|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||M|20171204140816-0700|20171204|NK1|1|Leslie^Crystal^^^^^L|MTH^Mother^HL70063|261 Knight Ave^^Madison Heights^MI^48071^USA^P|^PRN^PH^^^248^3223919|ORC|RE||Z90I7085.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.08.05.1Gf|P|2.5.1|PID|||2UeC-B.08.05^^^AIRA-TEST^MR||Byrne^Joanna^Jacinta^^^^L|Allen^Alyson|20131204|F||2131-1^Other Race^HL70005|59 Cheboygan Ave^^Traverse City^MI^49686^USA^P||^PRN^PH^^^231^8861927|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||P|20171204140816-0700|20171204|NK1|1|Byrne^Alyson^^^^^L|MTH^Mother^HL70063|59 Cheboygan Ave^^Traverse City^MI^49686^USA^P|^PRN^PH^^^231^8861927|ORC|RE||J61O7086.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.08.06.1Gf|P|2.5.1|PID|||2UeC-B.08.06^^^AIRA-TEST^MR||Blanco^Szabolcs^K^^^^L|Lyon^Ultreia|20131128|M||2054-5^Black or African-American^HL70005|301 LaRue Ln^^Pearl Beach^MI^48001^USA^P||^PRN^PH^^^810^5020862|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||U|20171204140816-0700|20171204|NK1|1|Blanco^Ultreia^^^^^L|MTH^Mother^HL70063|301 LaRue Ln^^Pearl Beach^MI^48001^USA^P|^PRN^PH^^^810^5020862|ORC|RE||X87C7087.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.09.01.1Gf|P|2.5.1|PID|||2UeC-B.09.01^^^AIRA-TEST^MR||Marlin^Yona^^^^^L||20131204|F||2106-3^White^HL70005|280 Calhoun St^^Westwood^MI^49006^USA^P||^PRN^PH^^^269^3348894|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||W85Y7088.2^AIRA|RXA|0|1|20150703||21^Varicella^CVX|999||||||||||||00^Parental decision^NIP002||RE|A|ORC|RE||W85Y7088.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.09.02.1Gu|P|2.5.1|PID|||2UeC-B.09.02^^^AIRA-TEST^MR||Limestone^Deepika^Bette^^^^L||20131211|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|64 Monroe Cir^^Bingham Farms^MI^48025^USA^P||^PRN^PH^^^248^9261821|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||Y63I7089.2^AIRA|RXA|0|1|20150709||94^MMRV^CVX|999||||||||||||01^Religious exemption^NIP002||RE|A|ORC|RE||Y63I7089.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.09.03.1Gu|P|2.5.1|PID|||2UeC-B.09.03^^^AIRA-TEST^MR||Mitchell^Bogart^^^^^L||20131130|M||2054-5^Black or African-American^HL70005|113 Spencer Ln^^Chase Bank^MI^48277^USA^P||^PRN^PH^^^313^7873437|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||B75T7090.2^AIRA|RXA|0|1|20150702||94^MMRV^CVX|999||||||||||||02^Other^NIP002||RE|A|ORC|RE||B75T7090.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.09.04.1GK|P|2.5.1|PID|||2UeC-B.09.04^^^AIRA-TEST^MR||Columbia^Kichi^Cheri^^^^L||20131128|F||2106-3^White^HL70005|51 Waldo Pl^^Germfask^MI^49836^USA^P||^PRN^PH^^^906^4199479|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||Y83T7091.2^AIRA|RXA|0|1|20150627||03^MMR^CVX|999||||||||||||03^Patient decision^NIP002||RE|A|ORC|RE||Y83T7091.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.01.1GK|P|2.5.1|PID|||2UeC-B.10.01^^^AIRA-TEST^MR||Jessamine^Alexis^L^^^^L|Kartwold^Ginny|20131207|F||1002-5^American Indian or Alaska Native^HL70005|348 Pedersen Ave^^West Bloomfield^MI^48323^USA^P||^PRN^PH^^^248^6275146|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Jessamine^Ginny^^^^^L|BRO^Brother^HL70063|348 Pedersen Ave^^West Bloomfield^MI^48323^USA^P|^PRN^PH^^^248^6275146|ORC|RE||L07K7092.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.02.1GK|P|2.5.1|PID|||2UeC-B.10.02^^^AIRA-TEST^MR||Gibbons^Snowden^King^^^^L|Apache^Yehudi|20131208|M||2106-3^White^HL70005|48 Mason Cir^^Elsie^MI^48831^USA^P||^PRN^PH^^^989^9093706|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Roberts^Yehudi^^^^^L|CGV^Care Giver^HL70063|48 Mason Cir^^Elsie^MI^48831^USA^P|^PRN^PH^^^989^9093706|ORC|RE||M48K7093.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.03.1GZ|P|2.5.1|PID|||2UeC-B.10.03^^^AIRA-TEST^MR||Fremming^Clay^T^^^^L|Fremming^Nike|20131123|M||2106-3^White^HL70005|293 Malheur Pl^^Wyoming^MI^49508^USA^P||^PRN^PH^^^616^8697136|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|McClain^Nike^^^^^L|CHD^Child^HL70063|293 Malheur Pl^^Wyoming^MI^49508^USA^P|^PRN^PH^^^616^8697136|ORC|RE||D79D7094.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.04.1GZ|P|2.5.1|PID|||2UeC-B.10.04^^^AIRA-TEST^MR||Johnson^Sasha^Tryne^^^^L|Roger Mills^Mayuko|20131129|F||2106-3^White^HL70005|168 King St^^Grand Rapids^MI^49528^USA^P||^PRN^PH^^^616^7476769|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Roger Mills^Mayuko^^^^^L|FCH^Foster Child^HL70063|168 King St^^Grand Rapids^MI^49528^USA^P|^PRN^PH^^^616^7476769|ORC|RE||T73A7095.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.05.1GZ|P|2.5.1|PID|||2UeC-B.10.05^^^AIRA-TEST^MR||Grant^Zachariah^K^^^^L|Allegan^Ayita|20131201|M||2106-3^White^HL70005|360 Payette Cir^^Reading^MI^49274^USA^P||^PRN^PH^^^517^8305582|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Grant^Ayita^^^^^L|FTH^Father^HL70063|360 Payette Cir^^Reading^MI^49274^USA^P|^PRN^PH^^^517^8305582|ORC|RE||P81J7096.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.06.1GZ|P|2.5.1|PID|||2UeC-B.10.06^^^AIRA-TEST^MR||Wharton^Carel^R^^^^L|Gelfry^Sierra|20131210|M||2106-3^White^HL70005|50 Ogemaw Pl^^Middleville^MI^49333^USA^P||^PRN^PH^^^269^9102845|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Gelfry^Sierra^^^^^L|GRD^Guardian^HL70063|50 Ogemaw Pl^^Middleville^MI^49333^USA^P|^PRN^PH^^^269^9102845|ORC|RE||V73E7097.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.07.1Hf|P|2.5.1|PID|||2UeC-B.10.07^^^AIRA-TEST^MR||Dallas^Manus^Tranio^^^^L|Allegan^Anstice|20131202|M||2028-9^Asian^HL70005|112 Nowata Ln^^Richville^MI^48758^USA^P||^PRN^PH^^^989^5949316|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Dallas^Anstice^^^^^L|GRP^Grand Parent^HL70063|112 Nowata Ln^^Richville^MI^48758^USA^P|^PRN^PH^^^989^5949316|ORC|RE||L10T7098.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.08.1Hf|P|2.5.1|PID|||2UeC-B.10.08^^^AIRA-TEST^MR||Dimmit^Columba^R^^^^L|Trigg^Kathryn|20131212|M||2106-3^White^HL70005|155 Chambers Pl^^Delphi West^MI^48555^USA^P||^PRN^PH^^^810^9840684|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Trigg^Kathryn^^^^^L|MTH^Mother^HL70063|155 Chambers Pl^^Delphi West^MI^48555^USA^P|^PRN^PH^^^810^9840684|ORC|RE||B73Y7099.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.09.1Hf|P|2.5.1|PID|||2UeC-B.10.09^^^AIRA-TEST^MR||Ferry^Sagara^D^^^^L|Ferry^Zita|20131128|F||2106-3^White^HL70005|85 Moore Pl^^Idlewild^MI^49642^USA^P||^PRN^PH^^^231^9382263|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Logan^Zita^^^^^L|OTH^Other^HL70063|85 Moore Pl^^Idlewild^MI^49642^USA^P|^PRN^PH^^^231^9382263|ORC|RE||Z06Y7100.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.10.1Hv|P|2.5.1|PID|||2UeC-B.10.10^^^AIRA-TEST^MR||Jackson^Taksa^J^^^^L|Adams^Campbell|20131207|M||2106-3^White^HL70005|299 Ryan Ln^^Clifford^MI^48727^USA^P||^PRN^PH^^^989^8084763|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Jackson^Campbell^^^^^L|PAR^Parent^HL70063|299 Ryan Ln^^Clifford^MI^48727^USA^P|^PRN^PH^^^989^8084763|ORC|RE||A36N7101.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.11.1Hv|P|2.5.1|PID|||2UeC-B.10.11^^^AIRA-TEST^MR||Malone^Maddie^^^^^L|Swift^Madilynn|20131126|F||2106-3^White^HL70005|262 Tillamook Pl^^Comerica Incorporated^MI^48264^USA^P||^PRN^PH^^^313^8624621|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Malone^Madilynn^^^^^L|SCH^Step Child^HL70063|262 Tillamook Pl^^Comerica Incorporated^MI^48264^USA^P|^PRN^PH^^^313^8624621|ORC|RE||O19V7102.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.12.1Hv|P|2.5.1|PID|||2UeC-B.10.12^^^AIRA-TEST^MR||Lyon^Primel^Hont^^^^L|Haskell^Placida|20131127|M||2106-3^White^HL70005|338 O'Brien Cir^^Pellston^MI^49769^USA^P||^PRN^PH^^^616^3005111|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Lyon^Placida^^^^^L|SEL^Self^HL70063|338 O'Brien Cir^^Pellston^MI^49769^USA^P|^PRN^PH^^^616^3005111|ORC|RE||N60R7103.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.13.1HK|P|2.5.1|PID|||2UeC-B.10.13^^^AIRA-TEST^MR||Julin^Brilynn^Priya^^^^L|Gogebic^Avel|20131121|F||2106-3^White^HL70005|73 Delaware St^^Watersmeet^MI^49969^USA^P||^PRN^PH^^^906^2388546|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Julin^Avel^^^^^L|SIB^Sibling^HL70063|73 Delaware St^^Watersmeet^MI^49969^USA^P|^PRN^PH^^^906^2388546|ORC|RE||B47S7104.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.14.1HK|P|2.5.1|PID|||2UeC-B.10.14^^^AIRA-TEST^MR||Ball^Tem^Eton^^^^L|Wallin^Elke|20131126|M||2106-3^White^HL70005|226 Green Cir^^Holland^MI^49423^USA^P||^PRN^PH^^^616^9471637|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Wallin^Elke^^^^^L|SIS^Sister^HL70063|226 Green Cir^^Holland^MI^49423^USA^P|^PRN^PH^^^616^9471637|ORC|RE||R31F7105.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.10.15.1HK|P|2.5.1|PID|||2UeC-B.10.15^^^AIRA-TEST^MR||McClean^Ora^^^^^L|Duncan^Ivy|20131207|M||1002-5^American Indian or Alaska Native^HL70005|80 Creghan Cir^^Kentwood^MI^49508^USA^P||^PRN^PH^^^616^8240953|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Vance^Ivy^^^^^L|SPO^Spouse^HL70063|80 Creghan Cir^^Kentwood^MI^49508^USA^P|^PRN^PH^^^616^8240953|ORC|RE||D03L7106.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.01.1HK|P|2.5.1|PID|||2UeC-B.11.01^^^AIRA-TEST^MR||Jefferson^Natalya^Sundeep^^^^L||20170922|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|29 Reagan Pl^^Lake Orion^MI^48359^USA^P||^PRN^PH^^^248^9231774|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||P49L7107.3^AIRA|RXA|0|1|20171201||28^DT (pediatric)^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.02.1I0|P|2.5.1|PID|||2UeC-B.11.02^^^AIRA-TEST^MR||Parasari^Aniya^Galiena^^^^L||20170918|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|348 Alexander Cir^^Arcadia^MI^49613^USA^P||^PRN^PH^^^231^8664176|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||W40D7108.3^AIRA|RXA|0|1|20171124||20^DTaP^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.03.1I0|P|2.5.1|PID|||2UeC-B.11.03^^^AIRA-TEST^MR||Robinson^Yachne^K^^^^L||20170927|F||1002-5^American Indian or Alaska Native^HL70005|381 Rains Pl^^Hesperia^MI^49421^USA^P||^PRN^PH^^^231^5352118|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||P06E7109.3^AIRA|RXA|0|1|20171130||110^DTaP-Hep B-IPV^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.04.1I0|P|2.5.1|PID|||2UeC-B.11.04^^^AIRA-TEST^MR||Fleming^Ezra^Giuseppe^^^^L||20171003|M||2028-9^Asian^HL70005|131 Kimble Ln^^Brownstown Township^MI^48183^USA^P||^PRN^PH^^^734^8714933|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||W29H7110.3^AIRA|RXA|0|1|20171204||120^DTaP-Hib-IPV^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.05.1I0|P|2.5.1|PID|||2UeC-B.11.05^^^AIRA-TEST^MR||Taylor^Lisa^Pierah^^^^L||20170923|F||2106-3^White^HL70005|185 Lie Pl^^Sterling Heights^MI^48314^USA^P||^PRN^PH^^^586^9811623|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||W24Z7111.3^AIRA|RXA|0|1|20171125||106^DTaP, 5 pertussis antigens^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.06.1I0|P|2.5.1|PID|||2UeC-B.11.06^^^AIRA-TEST^MR||Sioux^Terry^F^^^^L||20170920|M||2054-5^Black or African-American^HL70005|163 Armstrong Cir^^Yankee Springs^MI^49333^USA^P||^PRN^PH^^^269^6314297|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||H63W7112.3^AIRA|RXA|0|1|20171121||83^Hep A, ped/adol, 2 dose^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.07.1I0|P|2.5.1|PID|||2UeC-B.11.07^^^AIRA-TEST^MR||King^Anderson^Eric^^^^L||20170930|M||2054-5^Black or African-American^HL70005|124 Major Pl^^East China Township^MI^48054^USA^P||^PRN^PH^^^810^4203129|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||S21A7113.3^AIRA|RXA|0|1|20171204||08^Hep B, adolescent or pediatric^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.08.1Ig|P|2.5.1|PID|||2UeC-B.11.08^^^AIRA-TEST^MR||Dodge^Tane^P^^^^L||20170926|M||2054-5^Black or African-American^HL70005|275 Lee Cir^^Battle Creek^MI^49015^USA^P||^PRN^PH^^^269^7084459|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||E10M7114.3^AIRA|RXA|0|1|20171129||49^Hib (PRP-OMP)^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.09.1Ig|P|2.5.1|PID|||2UeC-B.11.09^^^AIRA-TEST^MR||Summresgill^Eden^Marisa^^^^L||20171002|F||2106-3^White^HL70005|35 Carter Pl^^Paradise^MI^49768^USA^P||^PRN^PH^^^906^3138433|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||S47U7115.3^AIRA|RXA|0|1|20171204||48^Hib (PRP-T)^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.10.1Ig|P|2.5.1|PID|||2UeC-B.11.10^^^AIRA-TEST^MR||Eriksson^Zelpha^Valletta^^^^L||20170925|F||2028-9^Asian^HL70005|181 O Neill Ave^^Adrian^MI^49221^USA^P||^PRN^PH^^^517^5686320|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||F30Q7116.3^AIRA|RXA|0|1|20171125||51^Hib-Hep B^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.11.1Ig|P|2.5.1|PID|||2UeC-B.11.11^^^AIRA-TEST^MR||Mohave^Jayla^^^^^L||20170921|F||2106-3^White^HL70005|266 Montour Cir^^Detroit^MI^48216^USA^P||^PRN^PH^^^313^9558035|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||S40N7117.3^AIRA|RXA|0|1|20171130||10^IPV^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.12.1Ig|P|2.5.1|PID|||2UeC-B.11.12^^^AIRA-TEST^MR||Louisa^Maurice^J^^^^L||20170921|M||2106-3^White^HL70005|372 Winterman Ave^^GR^MI^49523^USA^P||^PRN^PH^^^616^6138439|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||S07P7118.3^AIRA|RXA|0|1|20171123||133^Pneumococcal conjugate PCV 13^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.13.1Ig|P|2.5.1|PID|||2UeC-B.11.13^^^AIRA-TEST^MR||Clay^Kalpanath^Dunham^^^^L||20170925|M||1002-5^American Indian or Alaska Native^HL70005|84 Saunders Ln^^Oakville^MI^48160^USA^P||^PRN^PH^^^734^7124354|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||G20B7119.3^AIRA|RXA|0|1|20171129||33^pneumococcal polysaccharide PPV23^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.14.1Ig|P|2.5.1|PID|||2UeC-B.11.14^^^AIRA-TEST^MR||Waters^Seirian^Aiyana^^^^L||20170919|F||1002-5^American Indian or Alaska Native^HL70005|110 Swift St^^Ypsilanti^MI^48197^USA^P||^PRN^PH^^^734^7940013|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||P83M7120.3^AIRA|RXA|0|1|20171123||40^rabies, intradermal injection^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.15.1Ig|P|2.5.1|PID|||2UeC-B.11.15^^^AIRA-TEST^MR||Alcona^Nioka^Brad^^^^L||20170923|M||2106-3^White^HL70005|139 Rogers Cir^^Hesperia^MI^49421^USA^P||^PRN^PH^^^231^6402117|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||K12A7121.3^AIRA|RXA|0|1|20171129||18^rabies, intramuscular injection^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.16.1Ig|P|2.5.1|PID|||2UeC-B.11.16^^^AIRA-TEST^MR||Holmes^Yaritza^N^^^^L||20170923|F||2028-9^Asian^HL70005|10 Pacific Ave^^Franklin^MI^48025^USA^P||^PRN^PH^^^248^6255665|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||W16P7122.3^AIRA|RXA|0|1|20171130||34^RIG^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.17.1Iv|P|2.5.1|PID|||2UeC-B.11.17^^^AIRA-TEST^MR||Biela^Gabriella^Majesta^^^^L||20170930|F||2106-3^White^HL70005|375 Burt Pl^^Ida^MI^48140^USA^P||^PRN^PH^^^734^9781919|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||H17Q7123.3^AIRA|RXA|0|1|20171203||119^rotavirus, monovalent^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.18.1Iv|P|2.5.1|PID|||2UeC-B.11.18^^^AIRA-TEST^MR||Orange^Danielle^Aubine^^^^L||20170920|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|180 Barker St^^Jackson^MI^49204^USA^P||^PRN^PH^^^517^6722588|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||G40V7124.3^AIRA|RXA|0|1|20171123||116^rotavirus, pentavalent^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.11.19.1Iv|P|2.5.1|PID|||2UeC-B.11.19^^^AIRA-TEST^MR||Morrill^Pedr^^^^^L||20170929|M||2106-3^White^HL70005|239 Grayson Ave^^Galien^MI^49113^USA^P||^PRN^PH^^^269^8416273|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||I29E7125.3^AIRA|RXA|0|1|20171201||75^vaccinia (smallpox)^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.01.1Iv|P|2.5.1|PID|||2UeC-B.12.01^^^AIRA-TEST^MR||Lilley^Goronwy^Xanti^^^^L||20151119|M||2106-3^White^HL70005|382 Crumbaker Cir^^Princeton^MI^49841^USA^P||^PRN^PH^^^906^3779247|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||O38K7126.3^AIRA|RXA|0|1|20171123||10^IPV^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.02.1Iv|P|2.5.1|PID|||2UeC-B.12.02^^^AIRA-TEST^MR||Grant^Mignonette^Ursula^^^^L||20151123|F||2106-3^White^HL70005|341 Atwell Ln^^Comstock^MI^49041^USA^P||^PRN^PH^^^269^4084143|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||O45A7127.3^AIRA|RXA|0|1|20171201||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.03.1Iv|P|2.5.1|PID|||2UeC-B.12.03^^^AIRA-TEST^MR||Erath^Kelly^S^^^^L||20151203|M||2054-5^Black or African-American^HL70005|334 Jolsen Pl^^Bloomfield Hills^MI^48304^USA^P||^PRN^PH^^^248^3229177|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||F52A7128.3^AIRA|RXA|0|1|20171204||08^Hep B, adolescent or pediatric^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.04.1Iv|P|2.5.1|PID|||2UeC-B.12.04^^^AIRA-TEST^MR||McClung^Keshia^Amandeep^^^^L||20151130|F||2131-1^Other Race^HL70005|258 Kossuth Pl^^Business Reply Mail^MI^49502^USA^P||^PRN^PH^^^616^3918202|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||U23B7129.3^AIRA|RXA|0|1|20171204||134^Japanese Encephalitis IM^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.05.1Iv|P|2.5.1|PID|||2UeC-B.12.05^^^AIRA-TEST^MR||Tobiassen^Machiko^^^^^L||20151129|F||2106-3^White^HL70005|36 Brazoria Ln^^Mi Department of Revenue^MI^48956^USA^P||^PRN^PH^^^517^4745775|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||V21B7130.3^AIRA|RXA|0|1|20171204||39^Japanese encephalitis SC^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.06.1Iv|P|2.5.1|PID|||2UeC-B.12.06^^^AIRA-TEST^MR||Creek^Wendi^Renuka^^^^L||20151119|F||2131-1^Other Race^HL70005|46 Greene Ave^^Grand Rapids^MI^49530^USA^P||^PRN^PH^^^616^5076126|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||N36I7131.3^AIRA|RXA|0|1|20171123||148^Meningococcal C/Y-HIB PRP^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.07.1Iv|P|2.5.1|PID|||2UeC-B.12.07^^^AIRA-TEST^MR||Marsh^Janina^^^^^L||20151203|F||2054-5^Black or African-American^HL70005|259 Jackson Cir^^Almont Township^MI^48003^USA^P||^PRN^PH^^^810^3483222|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||H14N7132.3^AIRA|RXA|0|1|20171204||136^Meningococcal MCV4O^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.08.1Iv|P|2.5.1|PID|||2UeC-B.12.08^^^AIRA-TEST^MR||Lewis^Kai^Nadir^^^^L||20151203|M||2054-5^Black or African-American^HL70005|354 Lincoln Pl^^Detroit^MI^48202^USA^P||^PRN^PH^^^313^3727731|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||E08E7133.3^AIRA|RXA|0|1|20171204||114^meningococcal MCV4P^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.09.1Iv|P|2.5.1|PID|||2UeC-B.12.09^^^AIRA-TEST^MR||Midland^Gage^Gayle^^^^L||20151203|M||2106-3^White^HL70005|245 Lee St^^Vulcan^MI^49852^USA^P||^PRN^PH^^^906^9777873|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||X09Z7134.3^AIRA|RXA|0|1|20171204||32^meningococcal MPSV4^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.10.1Iv|P|2.5.1|PID|||2UeC-B.12.10^^^AIRA-TEST^MR||Lake^Isaac^Amund^^^^L||20151122|M||2106-3^White^HL70005|152 Cusack Ln^^Berrien Center^MI^49102^USA^P||^PRN^PH^^^269^7155223|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||I49L7135.3^AIRA|RXA|0|1|20171201||03^MMR^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.11.1IL|P|2.5.1|PID|||2UeC-B.12.11^^^AIRA-TEST^MR||Lueatos^Bela^P^^^^L||20151122|M||2054-5^Black or African-American^HL70005|138 Lokken Ln^^Wolverine Lake^MI^48390^USA^P||^PRN^PH^^^248^6381125|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||K03E7136.3^AIRA|RXA|0|1|20171123||94^MMRV^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.12.1IL|P|2.5.1|PID|||2UeC-B.12.12^^^AIRA-TEST^MR||Lucas^Amaro^Varad^^^^L||20151130|M||2106-3^White^HL70005|163 Lubbock Cir^^Bruce Township^MI^48065^USA^P||^PRN^PH^^^586^4892850|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||Z55M7137.3^AIRA|RXA|0|1|20171204||41^typhoid, parenteral^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.13.1IL|P|2.5.1|PID|||2UeC-B.12.13^^^AIRA-TEST^MR||Iversen^Argenta^^^^^L||20151120|F||2054-5^Black or African-American^HL70005|191 Montgomery St^^Springfield Township^MI^48350^USA^P||^PRN^PH^^^248^6655076|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||B30V7138.3^AIRA|RXA|0|1|20171125||53^typhoid, parenteral, AKD (U.S. military)^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.14.1IL|P|2.5.1|PID|||2UeC-B.12.14^^^AIRA-TEST^MR||Snyder^Brencis^E^^^^L||20151126|M||2106-3^White^HL70005|302 Black Hawk Cir^^Kinde^MI^48445^USA^P||^PRN^PH^^^989^9921355|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||P12G7139.3^AIRA|RXA|0|1|20171204||101^typhoid, ViCPs^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.15.1IL|P|2.5.1|PID|||2UeC-B.12.15^^^AIRA-TEST^MR||Kane^Marla^Hulda^^^^L||20151130|F||1002-5^American Indian or Alaska Native^HL70005|41 Borthroyd St^^Elk Rapids^MI^49629^USA^P||^PRN^PH^^^231^9541068|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||M73I7140.3^AIRA|RXA|0|1|20171203||21^varicella^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.12.16.1IL|P|2.5.1|PID|||2UeC-B.12.16^^^AIRA-TEST^MR||Daviess^Lawley^Rastus^^^^L||20151126|M||2106-3^White^HL70005|61 Ball Ave^^Clinton Township^MI^48038^USA^P||^PRN^PH^^^586^7650753|||||||||2186-5^not Hispanic or Latino^HL70005|ORC|RE||X74V7141.3^AIRA|RXA|0|1|20171126||37^yellow fever^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.13.01.1IL|P|2.5.1|PID|||2UeC-B.13.01^^^AIRA-TEST^MR||Gibbons^Donna^Wyuna^^^^L||20131204|F||2054-5^Black or African-American^HL70005|62 Hardin Ln^^Detroit^MI^48214^USA^P||^PRN^PH^^^313^5125980|||||||||2135-2^Hispanic or Latino^HL70005|ORC|RE||T50L7142.3^AIRA|RXA|0|1|20171204||130^DTaP-IPV^CVX|999|||01^Historical^NIP001||||||||||||A|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.01.1IL|P|2.5.1|PID|||2UeC-B.19.01^^^AIRA-TEST^MR||Harding^Reed^Philostrate^^^^L|Evans^Ariana|20131202|M||2106-3^White^HL70005|161 Sivertsen Cir^^Grayling^MI^49738^USA^P||^PRN^PH^^^989^7191217|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Jefferson^Ariana^^^^^L|MTH^Mother^HL70063|161 Sivertsen Cir^^Grayling^MI^49738^USA^P|^PRN^PH^^^989^7191217|ORC|RE||P34S7143.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|C28161^Intramuscular^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.02.1J0|P|2.5.1|PID|||2UeC-B.19.02^^^AIRA-TEST^MR||Lawrence^Yooralla^Chantel^^^^L|Spokane^Padmini|20131207|F||2054-5^Black or African-American^HL70005|254 Santiago Ave^^Lodi Township^MI^48103^USA^P||^PRN^PH^^^734^2185484|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Spokane^Padmini^^^^^L|MTH^Mother^HL70063|254 Santiago Ave^^Lodi Township^MI^48103^USA^P|^PRN^PH^^^734^2185484|ORC|RE||M15H7144.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|C38238^Intradermal^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.03.1J0|P|2.5.1|PID|||2UeC-B.19.03^^^AIRA-TEST^MR||Winnebago^Jarel^Thurstan^^^^L|Lacey^Kambo|20131208|M||2106-3^White^HL70005|213 Hammar Ave^^Boyne City^MI^49712^USA^P||^PRN^PH^^^231^4672948|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Winnebago^Kambo^^^^^L|MTH^Mother^HL70063|213 Hammar Ave^^Boyne City^MI^49712^USA^P|^PRN^PH^^^231^4672948|ORC|RE||Q53G7145.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|C38276^Intravenous^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.04.1J0|P|2.5.1|PID|||2UeC-B.19.04^^^AIRA-TEST^MR||Furnas^Atulya^S^^^^L|Johnson^Elsa|20131203|M||2106-3^White^HL70005|304 Jefferson Pl^^Bad Axe^MI^48413^USA^P||^PRN^PH^^^989^6867568|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Furnas^Elsa^^^^^L|MTH^Mother^HL70063|304 Jefferson Pl^^Bad Axe^MI^48413^USA^P|^PRN^PH^^^989^6867568|ORC|RE||A12L7146.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|C38284^Nasal^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.05.1J0|P|2.5.1|PID|||2UeC-B.19.05^^^AIRA-TEST^MR||Greene^Jolene^Saumya^^^^L|Caldwell^Mayra|20131202|F||2054-5^Black or African-American^HL70005|169 Lowndes St^^Highland Park^MI^48203^USA^P||^PRN^PH^^^313^9684015|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Greene^Mayra^^^^^L|MTH^Mother^HL70063|169 Lowndes St^^Highland Park^MI^48203^USA^P|^PRN^PH^^^313^9684015|ORC|RE||H68F7147.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|C38288^Oral^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.06.1Jg|P|2.5.1|PID|||2UeC-B.19.06^^^AIRA-TEST^MR||Anderson^Wylie^Hadar^^^^L|Hill^Sanaa|20131129|M||2106-3^White^HL70005|155 Richland Ave^^Lucky Losers^MI^48916^USA^P||^PRN^PH^^^517^8943514|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Anderson^Sanaa^^^^^L|MTH^Mother^HL70063|155 Richland Ave^^Lucky Losers^MI^48916^USA^P|^PRN^PH^^^517^8943514|ORC|RE||M99E7148.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|C38299^Subcutaneous^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.07.1Jg|P|2.5.1|PID|||2UeC-B.19.07^^^AIRA-TEST^MR||York^Gregg^Z^^^^L|Todd^Lucetta|20131212|M||2106-3^White^HL70005|309 Pickaway Cir^^Riley^MI^48041^USA^P||^PRN^PH^^^810^5358873|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|York^Lucetta^^^^^L|MTH^Mother^HL70063|309 Pickaway Cir^^Riley^MI^48041^USA^P|^PRN^PH^^^810^5358873|ORC|RE||O03J7149.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|C38305^Transdermal^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.08.1Jg|P|2.5.1|PID|||2UeC-B.19.08^^^AIRA-TEST^MR||Ofvermark^Rayner^Weylin^^^^L|Olssen^Erianthe|20131206|M||2106-3^White^HL70005|38 Dodge Ln^^Concord^MI^49237^USA^P||^PRN^PH^^^517^2063933|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Ofvermark^Erianthe^^^^^L|MTH^Mother^HL70063|38 Dodge Ln^^Concord^MI^49237^USA^P|^PRN^PH^^^517^2063933|ORC|RE||G41T7150.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|C38676^Percutaneous^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.09.1Jw|P|2.5.1|PID|||2UeC-B.19.09^^^AIRA-TEST^MR||Nelson^Darri^Ngaire^^^^L|Henry^Onyx|20131123|F||2106-3^White^HL70005|351 Navajo Pl^^Scio^MI^48130^USA^P||^PRN^PH^^^734^9230065|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Henry^Onyx^^^^^L|MTH^Mother^HL70063|351 Navajo Pl^^Scio^MI^48130^USA^P|^PRN^PH^^^734^9230065|ORC|RE||C44X7151.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|ID^Intradermal^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.10.1Jw|P|2.5.1|PID|||2UeC-B.19.10^^^AIRA-TEST^MR||Wise^Jett^N^^^^L|Powell^Taylar|20131123|M||2106-3^White^HL70005|362 Bourbon St^^Lake Leelanau^MI^49653^USA^P||^PRN^PH^^^231^3583528|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Wise^Taylar^^^^^L|MTH^Mother^HL70063|362 Bourbon St^^Lake Leelanau^MI^49653^USA^P|^PRN^PH^^^231^3583528|ORC|RE||V26F7152.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|IM^Intramuscular^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.11.1Jw|P|2.5.1|PID|||2UeC-B.19.11^^^AIRA-TEST^MR||Yuba^Sapphire^^^^^L|Bredberg^Risako|20131205|F||2106-3^White^HL70005|294 Josephine Ave^^Pleasant Ridge^MI^48069^USA^P||^PRN^PH^^^248^3050022|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Thomas^Risako^^^^^L|MTH^Mother^HL70063|294 Josephine Ave^^Pleasant Ridge^MI^48069^USA^P|^PRN^PH^^^248^3050022|ORC|RE||N19Z7153.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|IN^Intranasal^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.12.1JL|P|2.5.1|PID|||2UeC-B.19.12^^^AIRA-TEST^MR||Coke^Kolina^Meckenzie^^^^L|Madison^Usha|20131124|F||2131-1^Other Race^HL70005|388 Bohne Ave^^Unionville^MI^48767^USA^P||^PRN^PH^^^989^5001092|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Oxford^Usha^^^^^L|MTH^Mother^HL70063|388 Bohne Ave^^Unionville^MI^48767^USA^P|^PRN^PH^^^989^5001092|ORC|RE||B30D7154.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|IV^Intravenous^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.13.1JL|P|2.5.1|PID|||2UeC-B.19.13^^^AIRA-TEST^MR||Montague^Brent^V^^^^L|Whitley^Willa|20131215|M||2106-3^White^HL70005|303 Van Zandt Ln^^Interlochen^MI^49643^USA^P||^PRN^PH^^^231^4390267|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|River^Willa^^^^^L|MTH^Mother^HL70063|303 Van Zandt Ln^^Interlochen^MI^49643^USA^P|^PRN^PH^^^231^4390267|ORC|RE||T11C7155.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|NS^Nasal^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.14.1K1|P|2.5.1|PID|||2UeC-B.19.14^^^AIRA-TEST^MR||Crowe^Keshav^I^^^^L|Eaton^Fadila|20131218|M||1002-5^American Indian or Alaska Native^HL70005|135 Meaghan Cir^^Bloomfield Township^MI^48302^USA^P||^PRN^PH^^^248^2670860|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Crowe^Fadila^^^^^L|MTH^Mother^HL70063|135 Meaghan Cir^^Bloomfield Township^MI^48302^USA^P|^PRN^PH^^^248^2670860|ORC|RE||D35S7156.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|OTH^Other/Miscellaneous^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.15.1K1|P|2.5.1|PID|||2UeC-B.19.15^^^AIRA-TEST^MR||Cannavin^Tuncer^A^^^^L|Powell^Kylee|20131129|M||2106-3^White^HL70005|224 Greeley Pl^^Dearborn^MI^48128^USA^P||^PRN^PH^^^313^2105015|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Cannavin^Kylee^^^^^L|MTH^Mother^HL70063|224 Greeley Pl^^Dearborn^MI^48128^USA^P|^PRN^PH^^^313^2105015|ORC|RE||Z09M7157.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|PO^Oral^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.16.1Kh|P|2.5.1|PID|||2UeC-B.19.16^^^AIRA-TEST^MR||Indiana^Gala^^^^^L|Wallowa^Yasmin|20131201|F||2054-5^Black or African-American^HL70005|390 Gem Ln^^South Manitou^MI^49654^USA^P||^PRN^PH^^^231^4258924|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Indiana^Yasmin^^^^^L|MTH^Mother^HL70063|390 Gem Ln^^South Manitou^MI^49654^USA^P|^PRN^PH^^^231^4258924|ORC|RE||B56X7158.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^Subcutaneous^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.19.17.1Kh|P|2.5.1|PID|||2UeC-B.19.17^^^AIRA-TEST^MR||Hudspeth^Avery^Holofernes^^^^L|Buchanan^Aurkene|20131214|M||2131-1^Other Race^HL70005|228 McCurtain St^^Sumpter Township^MI^48111^USA^P||^PRN^PH^^^734^2635713|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Hudspeth^Aurkene^^^^^L|MTH^Mother^HL70063|228 McCurtain St^^Sumpter Township^MI^48111^USA^P|^PRN^PH^^^734^2635713|ORC|RE||O13R7159.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|TD^Transdermal^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.01.1Kh|P|2.5.1|PID|||2UeC-B.20.01^^^AIRA-TEST^MR||Webster^Shalin^Jarrod^^^^L|Lackawanna^Jenna|20131214|M||1002-5^American Indian or Alaska Native^HL70005|305 Sequoyah Ln^^Scio^MI^48130^USA^P||^PRN^PH^^^734^3702776|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Webster^Jenna^^^^^L|MTH^Mother^HL70063|305 Sequoyah Ln^^Scio^MI^48130^USA^P|^PRN^PH^^^734^3702776|ORC|RE||I60I7160.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^Left Upper Arm^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.02.1Kw|P|2.5.1|PID|||2UeC-B.20.02^^^AIRA-TEST^MR||Merwik^Trisha^J^^^^L|Ainslie^Priscilla|20131124|F||2106-3^White^HL70005|23 Polk Pl^^Waterford^MI^48327^USA^P||^PRN^PH^^^248^5267127|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Merwik^Priscilla^^^^^L|MTH^Mother^HL70063|23 Polk Pl^^Waterford^MI^48327^USA^P|^PRN^PH^^^248^5267127|ORC|RE||B89L7161.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LD^Left Deltoid^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.03.1Kw|P|2.5.1|PID|||2UeC-B.20.03^^^AIRA-TEST^MR||Shelby^Theobald^Aric^^^^L|Sac^Berry|20131209|M||1002-5^American Indian or Alaska Native^HL70005|183 Lincoln Pl^^Kenockee^MI^48006^USA^P||^PRN^PH^^^810^3349622|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Sac^Berry^^^^^L|MTH^Mother^HL70063|183 Lincoln Pl^^Kenockee^MI^48006^USA^P|^PRN^PH^^^810^3349622|ORC|RE||E57T7162.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LG^Left Gluteous Medius^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.04.1Kw|P|2.5.1|PID|||2UeC-B.20.04^^^AIRA-TEST^MR||Ontonagon^Ziazan^Karly^^^^L|Hefford^Ursala|20131201|F||2106-3^White^HL70005|74 Grady St^^Imlay City^MI^48444^USA^P||^PRN^PH^^^810^5900238|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Ontonagon^Ursala^^^^^L|MTH^Mother^HL70063|74 Grady St^^Imlay City^MI^48444^USA^P|^PRN^PH^^^810^5900238|ORC|RE||A98G7163.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LLFA^Left Lower Forearm^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.05.1KM|P|2.5.1|PID|||2UeC-B.20.05^^^AIRA-TEST^MR||Hood River^Mete^^^^^L|Montague^Carmel|20131206|M||2054-5^Black or African-American^HL70005|54 Hendle Cir^^Saint Joseph^MI^49085^USA^P||^PRN^PH^^^269^7608242|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Hood River^Carmel^^^^^L|MTH^Mother^HL70063|54 Hendle Cir^^Saint Joseph^MI^49085^USA^P|^PRN^PH^^^269^7608242|ORC|RE||Q92R7164.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LT^Left Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.06.1KM|P|2.5.1|PID|||2UeC-B.20.06^^^AIRA-TEST^MR||Menifee^Sherry^N^^^^L|Menifee^Kevina|20131220|F||2106-3^White^HL70005|350 Upshur St^^Manchester^MI^48158^USA^P||^PRN^PH^^^734^3420173|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Browne^Kevina^^^^^L|MTH^Mother^HL70063|350 Upshur St^^Manchester^MI^48158^USA^P|^PRN^PH^^^734^3420173|ORC|RE||X10B7165.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LVL^Left Vastus Lateralis^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.07.1KM|P|2.5.1|PID|||2UeC-B.20.07^^^AIRA-TEST^MR||Boyle^Brinley^Phoolan^^^^L|Upshur^Belinda|20131127|F||2054-5^Black or African-American^HL70005|159 Guadalupe St^^Detroit^MI^48279^USA^P||^PRN^PH^^^313^6456140|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Boyle^Belinda^^^^^L|MTH^Mother^HL70063|159 Guadalupe St^^Detroit^MI^48279^USA^P|^PRN^PH^^^313^6456140|ORC|RE||Z64W7166.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^Right Upper Arm^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.08.1L1|P|2.5.1|PID|||2UeC-B.20.08^^^AIRA-TEST^MR||Lampasas^Tessa^Bly^^^^L|Fox^Odera|20131212|F||2106-3^White^HL70005|273 San Bernardino Ln^^Munger^MI^48747^USA^P||^PRN^PH^^^989^2828363|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Lampasas^Odera^^^^^L|MTH^Mother^HL70063|273 San Bernardino Ln^^Munger^MI^48747^USA^P|^PRN^PH^^^989^2828363|ORC|RE||E50F7167.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RD^Right Deltoid^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.09.1L1|P|2.5.1|PID|||2UeC-B.20.09^^^AIRA-TEST^MR||Davis^Jan^A^^^^L|Burt^Meda|20131214|M||2054-5^Black or African-American^HL70005|394 Hunt St^^Rudyard^MI^49780^USA^P||^PRN^PH^^^906^6611521|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Burt^Meda^^^^^L|MTH^Mother^HL70063|394 Hunt St^^Rudyard^MI^49780^USA^P|^PRN^PH^^^906^6611521|ORC|RE||S91E7168.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RG^Right Gluteous Medius^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.10.1L1|P|2.5.1|PID|||2UeC-B.20.10^^^AIRA-TEST^MR||Reeves^Mena^Blake^^^^L|Arenac^Aquaria|20131219|F||2054-5^Black or African-American^HL70005|53 Cooper St^^Sand Lake^MI^49343^USA^P||^PRN^PH^^^616^9127044|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Arenac^Aquaria^^^^^L|MTH^Mother^HL70063|53 Cooper St^^Sand Lake^MI^49343^USA^P|^PRN^PH^^^616^9127044|ORC|RE||I42R7169.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RLFA^Right Lower Forearm^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.11.1L1|P|2.5.1|PID|||2UeC-B.20.11^^^AIRA-TEST^MR||Madison^Steffi^A^^^^L|Reeves^Zelda|20131115|F||2054-5^Black or African-American^HL70005|147 Duncan St^^Kalamazoo^MI^49001^USA^P||^PRN^PH^^^269^3440383|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Madison^Zelda^^^^^L|MTH^Mother^HL70063|147 Duncan St^^Kalamazoo^MI^49001^USA^P|^PRN^PH^^^269^3440383|ORC|RE||T26Z7170.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RT^Right Thigh^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.12.1Lh|P|2.5.1|PID|||2UeC-B.20.12^^^AIRA-TEST^MR||Castro^Elsa^Rachna^^^^L|Westport^Ayesha|20131129|F||2106-3^White^HL70005|389 Baraga Ln^^White Lake^MI^48383^USA^P||^PRN^PH^^^248^3464556|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Castro^Ayesha^^^^^L|MTH^Mother^HL70063|389 Baraga Ln^^White Lake^MI^48383^USA^P|^PRN^PH^^^248^3464556|ORC|RE||G07W7171.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RVL^Right Vastus Lateralis^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.13.1Lh|P|2.5.1|PID|||2UeC-B.20.13^^^AIRA-TEST^MR||Coryell^Ingmar^T^^^^L|MontmorencyMuskegon^Rihana|20131222|M||1002-5^American Indian or Alaska Native^HL70005|385 Grady Cir^^Tawas City^MI^48763^USA^P||^PRN^PH^^^989^5285580|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Coryell^Rihana^^^^^L|MTH^Mother^HL70063|385 Grady Cir^^Tawas City^MI^48763^USA^P|^PRN^PH^^^989^5285580|ORC|RE||E07H7172.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|BN^Bilateral Nares^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.14.1Lh|P|2.5.1|PID|||2UeC-B.20.14^^^AIRA-TEST^MR||Cusack^Delilah^Ashlynn^^^^L|Sykes^Jaida|20131208|F||2106-3^White^HL70005|194 Bear Lake Cir^^Mecosta^MI^49332^USA^P||^PRN^PH^^^231^9901682|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Cusack^Jaida^^^^^L|MTH^Mother^HL70063|194 Bear Lake Cir^^Mecosta^MI^49332^USA^P|^PRN^PH^^^231^9901682|ORC|RE||C57V7173.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^Left Arm^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.15.1Lx|P|2.5.1|PID|||2UeC-B.20.15^^^AIRA-TEST^MR||Leonard^Pepper^^^^^L|Sarpy^Sylvia|20131205|F||2106-3^White^HL70005|77 Parmer Cir^^Comerica Incorporated^MI^48264^USA^P||^PRN^PH^^^313^7467739|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Rusk^Sylvia^^^^^L|MTH^Mother^HL70063|77 Parmer Cir^^Comerica Incorporated^MI^48264^USA^P|^PRN^PH^^^313^7467739|ORC|RE||Z34V7174.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|MO^Mouth^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.16.1Lx|P|2.5.1|PID|||2UeC-B.20.16^^^AIRA-TEST^MR||Mala^Naveen^Somerled^^^^L|Bracken^Maliha|20131202|M||2106-3^White^HL70005|86 Greene Pl^^Dafter^MI^49724^USA^P||^PRN^PH^^^906^6364448|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Mala^Maliha^^^^^L|MTH^Mother^HL70063|86 Greene Pl^^Dafter^MI^49724^USA^P|^PRN^PH^^^906^6364448|ORC|RE||C77K7175.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LN^Left Nares^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.20.17.1Lx|P|2.5.1|PID|||2UeC-B.20.17^^^AIRA-TEST^MR||Madera^Rokus^Nihar^^^^L|Harrison^Felcia|20131205|M||2054-5^Black or African-American^HL70005|356 Columbia Cir^^Stalwart^MI^49736^USA^P||^PRN^PH^^^906^2487561|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Adams^Felcia^^^^^L|MTH^Mother^HL70063|356 Columbia Cir^^Stalwart^MI^49736^USA^P|^PRN^PH^^^906^2487561|ORC|RE||H50C7176.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RN^Right Nares^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.21.01.1LM|P|2.5.1|PID|||2UeC-B.21.01^^^AIRA-TEST^MR||Simpson^Lavache^Lawton^^^^L|Knox^Adalyn|20131120|M||1002-5^American Indian or Alaska Native^HL70005|42 Apache Ln^^Norton Shores^MI^49444^USA^P~PID-11.1^PID-11.2^PID-11.3^PID-11.4^PID-11.5^^B||^PRN^PH^^^231^7934619|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Santa Clara^Adalyn^^^^^L|MTH^Mother^HL70063|42 Apache Ln^^Norton Shores^MI^49444^USA^P|^PRN^PH^^^231^7934619|ORC|RE||T23Y7177.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.21.02.1LM|P|2.5.1|PID|||2UeC-B.21.02^^^AIRA-TEST^MR||Madison^Ramona^^^^^L|Estill^Shruti|20131204|F||2106-3^White^HL70005|253 Lucas Ln^^GR^MI^49546^USA^P~PID-11.1^PID-11.2^PID-11.3^PID-11.4^PID-11.5^^BA||^PRN^PH^^^616^5299015|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Estill^Shruti^^^^^L|MTH^Mother^HL70063|253 Lucas Ln^^GR^MI^49546^USA^P|^PRN^PH^^^616^5299015|ORC|RE||L31O7178.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.21.03.1Mi|P|2.5.1|PID|||2UeC-B.21.03^^^AIRA-TEST^MR||Bracken^Marot^P^^^^L|Thorne^Ghada|20131206|M||2131-1^Other Race^HL70005|5 Guadalupe Ave^^Brownstwn Township^MI^48183^USA^P~PID-11.1^PID-11.2^PID-11.3^PID-11.4^PID-11.5^^BDL||^PRN^PH^^^734^2210360|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Grendal^Ghada^^^^^L|MTH^Mother^HL70063|5 Guadalupe Ave^^Brownstwn Township^MI^48183^USA^P|^PRN^PH^^^734^2210360|ORC|RE||C79R7179.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.21.04.1Mi|P|2.5.1|PID|||2UeC-B.21.04^^^AIRA-TEST^MR||Harrison^Carsten^Reese^^^^L|Oak^Kayleen|20131203|M||2054-5^Black or African-American^HL70005|345 Texas Ln^^Northwest^MI^48531^USA^P~PID-11.1^PID-11.2^PID-11.3^PID-11.4^PID-11.5^^BR||^PRN^PH^^^810^7066820|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Oak^Kayleen^^^^^L|MTH^Mother^HL70063|345 Texas Ln^^Northwest^MI^48531^USA^P|^PRN^PH^^^810^7066820|ORC|RE||Z53B7180.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.21.05.1Mi|P|2.5.1|PID|||2UeC-B.21.05^^^AIRA-TEST^MR||Mathiesen^Merivale^H^^^^L|Mathiesen^Aubrey|20131207|F||2106-3^White^HL70005|218 Henry Ave^^Garden City^MI^48136^USA^P~PID-11.1^PID-11.2^PID-11.3^PID-11.4^PID-11.5^^C||^PRN^PH^^^734^5741382|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Kaufman^Aubrey^^^^^L|MTH^Mother^HL70063|218 Henry Ave^^Garden City^MI^48136^USA^P|^PRN^PH^^^734^5741382|ORC|RE||J55P7181.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.21.06.1Mi|P|2.5.1|PID|||2UeC-B.21.06^^^AIRA-TEST^MR||Monroe^Davina^Tansy^^^^L|Blair^Choden|20131203|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|385 Texas Pl^^Dimondale^MI^48821^USA^P~PID-11.1^PID-11.2^PID-11.3^PID-11.4^PID-11.5^^F||^PRN^PH^^^517^2197395|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Monroe^Choden^^^^^L|MTH^Mother^HL70063|385 Texas Pl^^Dimondale^MI^48821^USA^P|^PRN^PH^^^517^2197395|ORC|RE||W29H7182.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.21.07.1Mx|P|2.5.1|PID|||2UeC-B.21.07^^^AIRA-TEST^MR||Byrne^Borgny^Marly^^^^L|McLean^Christal|20131130|F||2106-3^White^HL70005|116 Buffalo St^^Lakeland^MI^48143^USA^P~PID-11.1^PID-11.2^PID-11.3^PID-11.4^PID-11.5^^H||^PRN^PH^^^810^5736675|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|McLean^Christal^^^^^L|MTH^Mother^HL70063|116 Buffalo St^^Lakeland^MI^48143^USA^P|^PRN^PH^^^810^5736675|ORC|RE||F86X7183.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.21.08.1Mx|P|2.5.1|PID|||2UeC-B.21.08^^^AIRA-TEST^MR||Lynch^Ada^O^^^^L|Bingham^Onida|20131120|F||2054-5^Black or African-American^HL70005|10 Bend St^^Dexter^MI^48130^USA^P~PID-11.1^PID-11.2^PID-11.3^PID-11.4^PID-11.5^^L||^PRN^PH^^^734^5438634|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Lynch^Onida^^^^^L|MTH^Mother^HL70063|10 Bend St^^Dexter^MI^48130^USA^P|^PRN^PH^^^734^5438634|ORC|RE||J49J7184.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.21.09.1Mx|P|2.5.1|PID|||2UeC-B.21.09^^^AIRA-TEST^MR||Darke^Tigerlily^Ryba^^^^L|Shelby^Ceinwen|20131207|F||2028-9^Asian^HL70005|271 Hardin Ln^^Brant^MI^48614^USA^P~PID-11.1^PID-11.2^PID-11.3^PID-11.4^PID-11.5^^M||^PRN^PH^^^989^5264135|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Darke^Ceinwen^^^^^L|MTH^Mother^HL70063|271 Hardin Ln^^Brant^MI^48614^USA^P|^PRN^PH^^^989^5264135|ORC|RE||O66Q7185.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.21.10.1MN|P|2.5.1|PID|||2UeC-B.21.10^^^AIRA-TEST^MR||Shappe^Bron^Yasu^^^^L|Allegan^Filippa|20131201|F||2106-3^White^HL70005|158 Stephens Ave^^Grosse Pointe Park^MI^48236^USA^P~PID-11.1^PID-11.2^PID-11.3^PID-11.4^PID-11.5^^N||^PRN^PH^^^313^6768776|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Shappe^Filippa^^^^^L|MTH^Mother^HL70063|158 Stephens Ave^^Grosse Pointe Park^MI^48236^USA^P|^PRN^PH^^^313^6768776|ORC|RE||K65N7186.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.21.11.1MN|P|2.5.1|PID|||2UeC-B.21.11^^^AIRA-TEST^MR||Poweshiek^Kaley^Kylah^^^^L|Colfax^Sirikit|20131210|F||2054-5^Black or African-American^HL70005|232 Pesken Pl^^Lowell^MI^49331^USA^P~PID-11.1^PID-11.2^PID-11.3^PID-11.4^PID-11.5^^O||^PRN^PH^^^616^6529190|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Poweshiek^Sirikit^^^^^L|MTH^Mother^HL70063|232 Pesken Pl^^Lowell^MI^49331^USA^P|^PRN^PH^^^616^6529190|ORC|RE||U31A7187.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.21.12.1N2|P|2.5.1|PID|||2UeC-B.21.12^^^AIRA-TEST^MR||Curry^Phillip^S^^^^L|Krog^Noni|20131208|M||2106-3^White^HL70005|387 Canyon St^^Cutlerville^MI^49508^USA^P~PID-11.1^PID-11.2^PID-11.3^PID-11.4^PID-11.5^^P||^PRN^PH^^^616^2811430|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Curry^Noni^^^^^L|MTH^Mother^HL70063|387 Canyon St^^Cutlerville^MI^49508^USA^P|^PRN^PH^^^616^2811430|ORC|RE||J85X7188.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.21.13.1N2|P|2.5.1|PID|||2UeC-B.21.13^^^AIRA-TEST^MR||Audubon^Octavia^Sibel^^^^L|Kern^Dristi|20131204|F||2028-9^Asian^HL70005|243 Creaser Ave^^Kincheloe^MI^49785^USA^P~PID-11.1^PID-11.2^PID-11.3^PID-11.4^PID-11.5^^RH||^PRN^PH^^^906^4580637|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Kern^Dristi^^^^^L|MTH^Mother^HL70063|243 Creaser Ave^^Kincheloe^MI^49785^USA^P|^PRN^PH^^^906^4580637|ORC|RE||A61X7189.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.22.01.1N2|P|2.5.1|PID|||2UeC-B.22.01^^^AIRA-TEST^MR||Fulton^Amber^Gloria^^^^L~Jaxon^Yuur^^^^^A|Yuur^Talon|20131202|F||2106-3^White^HL70005|50 Columbia Pl^^Houghton Lake Heights^MI^48630^USA^P||^PRN^PH^^^989^7444023|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Yuur^Talon^^^^^L|MTH^Mother^HL70063|50 Columbia Pl^^Houghton Lake Heights^MI^48630^USA^P|^PRN^PH^^^989^7444023|ORC|RE||D91Q7190.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.22.02.1N2|P|2.5.1|PID|||2UeC-B.22.02^^^AIRA-TEST^MR||Monaghan^Beacher^Edmund^^^^L~Magee^Painter^^^^^L|Letcher^Carly|20131126|M||1002-5^American Indian or Alaska Native^HL70005|259 Wilsson Ave^^Oakland^MI^48306^USA^P||^PRN^PH^^^248^9358461|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Monaghan^Carly^^^^^L|MTH^Mother^HL70063|259 Wilsson Ave^^Oakland^MI^48306^USA^P|^PRN^PH^^^248^9358461|ORC|RE||Y62O7191.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.22.03.1Ni|P|2.5.1|PID|||2UeC-B.22.03^^^AIRA-TEST^MR||Lenawee^Erith^A^^^^L~Massimo^Pima^^^^^D|Lenawee^Shobhna|20131206|M||2106-3^White^HL70005|22 Alexanderson Ave^^Brownstown Township^MI^48193^USA^P||^PRN^PH^^^734^6191828|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Pima^Shobhna^^^^^L|MTH^Mother^HL70063|22 Alexanderson Ave^^Brownstown Township^MI^48193^USA^P|^PRN^PH^^^734^6191828|ORC|RE||V24X7192.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.22.04.1Ni|P|2.5.1|PID|||2UeC-B.22.04^^^AIRA-TEST^MR||Donley^Ibrahim^Lincoln^^^^L~Armon^Smith^^^^^M|Donley^Burilda|20131203|M||2106-3^White^HL70005|293 Douglas Cir^^Bloomfield^MI^48302^USA^P||^PRN^PH^^^248^9621245|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Smith^Burilda^^^^^L|MTH^Mother^HL70063|293 Douglas Cir^^Bloomfield^MI^48302^USA^P|^PRN^PH^^^248^9621245|ORC|RE||J01Z7193.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.22.05.1Ni|P|2.5.1|PID|||2UeC-B.22.05^^^AIRA-TEST^MR||Hall^Fielding^A^^^^L~Christopher^Klamath^^^^^C|Klamath^Terena|20131219|M||2054-5^Black or African-American^HL70005|173 Reeves Cir^^Wells^MI^49894^USA^P||^PRN^PH^^^906^9272685|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Hall^Terena^^^^^L|MTH^Mother^HL70063|173 Reeves Cir^^Wells^MI^49894^USA^P|^PRN^PH^^^906^9272685|ORC|RE||M09N7194.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.22.06.1Ny|P|2.5.1|PID|||2UeC-B.22.06^^^AIRA-TEST^MR||Manistee^Lawrence^Yehuda^^^^L~Zebulun^Lowndes^^^^^B|Lowndes^Vivienne|20131206|M||2028-9^Asian^HL70005|264 Lawrence Ave^^Clayton^MI^49235^USA^P||^PRN^PH^^^517^5741680|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Monon^Vivienne^^^^^L|MTH^Mother^HL70063|264 Lawrence Ave^^Clayton^MI^49235^USA^P|^PRN^PH^^^517^5741680|ORC|RE||P99P7195.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.22.07.1Ny|P|2.5.1|PID|||2UeC-B.22.07^^^AIRA-TEST^MR||Larsen^Joab^^^^^L~Trevor^Culp^^^^^P|Oldham^Abella|20131121|M||1002-5^American Indian or Alaska Native^HL70005|84 Green Ave^^Buckley^MI^49620^USA^P||^PRN^PH^^^231^6728692|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Culp^Abella^^^^^L|MTH^Mother^HL70063|84 Green Ave^^Buckley^MI^49620^USA^P|^PRN^PH^^^231^6728692|ORC|RE||A46O7196.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.22.08.1Ny|P|2.5.1|PID|||2UeC-B.22.08^^^AIRA-TEST^MR||Roach^Kulvir^^^^^L~Timothy^Lycoming^^^^^U|Galveston^Adabelle|20131201|M||2028-9^Asian^HL70005|225 Silseth Ave^^Three Oaks^MI^49128^USA^P||^PRN^PH^^^269^9316665|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Roach^Adabelle^^^^^L|MTH^Mother^HL70063|225 Silseth Ave^^Three Oaks^MI^49128^USA^P|^PRN^PH^^^269^9316665|ORC|RE||C65I7197.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.23.01.1NN|P|2.5.1|PID|||2UeC-B.23.01^^^AIRA-TEST^MR||Cedar^Kay^Cathleen^^^^L|Cedar^Niradhara|20131201|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|106 Baraga Ave^^Manitou Beach^MI^49253^USA^P||^ASN^PH^^^517^5873298|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Washington^Niradhara^^^^^L|MTH^Mother^HL70063|106 Baraga Ave^^Manitou Beach^MI^49253^USA^P|^PRN^PH^^^517^5873298|ORC|RE||T51S7198.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.23.02.1NN|P|2.5.1|PID|||2UeC-B.23.02^^^AIRA-TEST^MR||Toale^Brander^U^^^^L|Gage^Peggie|20131130|M||2054-5^Black or African-American^HL70005|71 Pendleton Ln^^Willow^MI^48164^USA^P||^PRN^PH^^^734^3619372~^BPN^BP|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Morrey^Peggie^^^^^L|MTH^Mother^HL70063|71 Pendleton Ln^^Willow^MI^48164^USA^P|^PRN^PH^^^734^3619372|ORC|RE||W67T7199.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.23.03.1NN|P|2.5.1|PID|||2UeC-B.23.03^^^AIRA-TEST^MR||Power^Eric^S^^^^L|Banner^Ishi|20131129|M||2054-5^Black or African-American^HL70005|258 Bend Ln^^Gladstone^MI^49837^USA^P||^EMR^PH^^^906^8562424|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Power^Ishi^^^^^L|MTH^Mother^HL70063|258 Bend Ln^^Gladstone^MI^49837^USA^P|^PRN^PH^^^906^8562424|ORC|RE||Z21D7200.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.23.04.1NN|P|2.5.1|PID|||2UeC-B.23.04^^^AIRA-TEST^MR||Alameda^Vikas^Anders^^^^L|Cheboygan^Caralee|20131209|M||2106-3^White^HL70005|295 Weil Ln^^Kalamazoo^MI^49019^USA^P||^PRN^PH^^^269^2208451~^NET^X.400^caralee.alameda@madeupemailaddress.com|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Alameda^Caralee^^^^^L|MTH^Mother^HL70063|295 Weil Ln^^Kalamazoo^MI^49019^USA^P|^PRN^PH^^^269^2208451|ORC|RE||G55Y7201.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.23.05.1O3|P|2.5.1|PID|||2UeC-B.23.05^^^AIRA-TEST^MR||Simpson^Rudi^Ambler^^^^L|San Diego^Tarsha|20131123|M||2106-3^White^HL70005|30 Canadian Pl^^Stephenson^MI^49887^USA^P||^ORN^PH^^^906^5236942|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Simpson^Tarsha^^^^^L|MTH^Mother^HL70063|30 Canadian Pl^^Stephenson^MI^49887^USA^P|^PRN^PH^^^906^5236942|ORC|RE||F85T7202.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.23.06.1O3|P|2.5.1|PID|||2UeC-B.23.06^^^AIRA-TEST^MR||Culp^Anieli^Davy^^^^L|Wharton^Fabrianne|20131212|M||1002-5^American Indian or Alaska Native^HL70005|358 Jakobsen Ln^^Grand Rapids^MI^49534^USA^P||^PRN^PH^^^616^9780189|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Lindstrom^Fabrianne^^^^^L|MTH^Mother^HL70063|358 Jakobsen Ln^^Grand Rapids^MI^49534^USA^P|^PRN^PH^^^616^9780189|ORC|RE||C94P7203.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.23.07.1Oj|P|2.5.1|PID|||2UeC-B.23.07^^^AIRA-TEST^MR||Cowlitz^Bode^Bobbie^^^^L|Jefferson^Evangeline|20131205|M||2054-5^Black or African-American^HL70005|376 Green Ln^^Leslie^MI^49251^USA^P||^VHN^PH^^^517^3106823|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Cowlitz^Evangeline^^^^^L|MTH^Mother^HL70063|376 Green Ln^^Leslie^MI^49251^USA^P|^PRN^PH^^^517^3106823|ORC|RE||J04H7204.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.23.08.1Oj|P|2.5.1|PID|||2UeC-B.23.08^^^AIRA-TEST^MR||Dauphin^Christmas^Mamta^^^^L|Fox^Zerlina|20131130|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|352 Cannavin St^^Bloomingdale^MI^49026^USA^P||^WPN^PH^^^269^8527929|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Dauphin^Zerlina^^^^^L|MTH^Mother^HL70063|352 Cannavin St^^Bloomingdale^MI^49026^USA^P|^PRN^PH^^^269^8527929|ORC|RE||N39H7205.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.24.01.1Oj|P|2.5.1|PID|||2UeC-B.24.01^^^AIRA-TEST^MR||Polk^Seanna^Sadie^^^^L|McIntosh^Brit|20131204|F||2131-1^Other Race^HL70005|267 Waller Pl^^Norway^MI^49870^USA^P||^PRN^PH^^^906^3942149~^BPN^BP|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Polk^Brit^^^^^L|MTH^Mother^HL70063|267 Waller Pl^^Norway^MI^49870^USA^P|^PRN^PH^^^906^3942149|ORC|RE||S65J7206.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.24.02.1Oy|P|2.5.1|PID|||2UeC-B.24.02^^^AIRA-TEST^MR||Mercer^Azariah^W^^^^L|Olsson^Marsha|20131205|F||2106-3^White^HL70005|147 Gustafson Ave^^Berrien Springs^MI^49103^USA^P||^PRN^CP^^^269^4253566|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Mercer^Marsha^^^^^L|MTH^Mother^HL70063|147 Gustafson Ave^^Berrien Springs^MI^49103^USA^P|^PRN^PH^^^269^4253566|ORC|RE||X15S7207.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.24.03.1Oy|P|2.5.1|PID|||2UeC-B.24.03^^^AIRA-TEST^MR||Hillsdale^Rune^Kieran^^^^L|Durbin^Soraya|20131203|M||2054-5^Black or African-American^HL70005|107 Asotin Ln^^Eben Jct^MI^49825^USA^P||^PRN^FX^^^906^6682169|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Casey^Soraya^^^^^L|MTH^Mother^HL70063|107 Asotin Ln^^Eben Jct^MI^49825^USA^P|^PRN^PH^^^906^6682169|ORC|RE||A80P7208.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.24.04.1Oy|P|2.5.1|PID|||2UeC-B.24.04^^^AIRA-TEST^MR||O Neill^Brian^Mekhi^^^^L|Latah^Emerson|20131211|M||2028-9^Asian^HL70005|351 Montgomery Ln^^Grand Rapids^MI^49512^USA^P||^PRN^PH^^^616^9728116~^NET^Internet^http://openimmunizationsoftware.net/|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|O Neill^Emerson^^^^^L|MTH^Mother^HL70063|351 Montgomery Ln^^Grand Rapids^MI^49512^USA^P|^PRN^PH^^^616^9728116|ORC|RE||X29O7209.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.24.05.1Oy|P|2.5.1|PID|||2UeC-B.24.05^^^AIRA-TEST^MR||Clermont^Amitabh^Jacy^^^^L|Erickson^Zola|20131128|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|332 Clinton Ln^^Jackson National Life Ins Co^MI^48951^USA^P||^PRN^MD^^^517^7872950|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Clermont^Zola^^^^^L|MTH^Mother^HL70063|332 Clinton Ln^^Jackson National Life Ins Co^MI^48951^USA^P|^PRN^PH^^^517^7872950|ORC|RE||P82C7210.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.24.06.1OO|P|2.5.1|PID|||2UeC-B.24.06^^^AIRA-TEST^MR||Willacy^Lilianna^J^^^^L|Carroll^Summer|20131211|F||2106-3^White^HL70005|336 Richardson Ave^^Sylvan Township^MI^48118^USA^P||^PRN^PH^^^734^5422357|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Willacy^Summer^^^^^L|MTH^Mother^HL70063|336 Richardson Ave^^Sylvan Township^MI^48118^USA^P|^PRN^PH^^^734^5422357|ORC|RE||E84J7211.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.24.07.1OO|P|2.5.1|PID|||2UeC-B.24.07^^^AIRA-TEST^MR||Leelanau^Azul^C^^^^L|Richland^Tamora|20131121|F||1002-5^American Indian or Alaska Native^HL70005|259 Alexanderson Cir^^Reese^MI^48757^USA^P||^PRN^TDD^^^989^8814036|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Richland^Tamora^^^^^L|MTH^Mother^HL70063|259 Alexanderson Cir^^Reese^MI^48757^USA^P|^PRN^PH^^^989^8814036|ORC|RE||R91P7212.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140816-0700||VXU^V04^VXU_V04|2UeC-B.24.08.1OO|P|2.5.1|PID|||2UeC-B.24.08^^^AIRA-TEST^MR||La Salle^Keaton^Sydenham^^^^L|Frio^Natane|20131129|M||2106-3^White^HL70005|4 Lyon Ave^^Grayling^MI^49738^USA^P||^PRN^TTY^^^989^6827425|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Spencer^Natane^^^^^L|MTH^Mother^HL70063|4 Lyon Ave^^Grayling^MI^49738^USA^P|^PRN^PH^^^989^6827425|ORC|RE||M87K7213.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.24.09.1P3|P|2.5.1|PID|||2UeC-B.24.09^^^AIRA-TEST^MR||Pushmataha^Joselyn^Noemi^^^^L|Mercer^Alda|20131215|F||2054-5^Black or African-American^HL70005|275 Magri Pl^^Sparta^MI^49345^USA^P||^PRN^PH^^^616^7285317~^NET^X.400^alda.pushmataha@madeupemailaddress.com|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Pushmataha^Alda^^^^^L|MTH^Mother^HL70063|275 Magri Pl^^Sparta^MI^49345^USA^P|^PRN^PH^^^616^7285317|ORC|RE||O89E7214.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.01.1P3|P|2.5.1|PID|||2UeC-B.25.01^^^AIRA-TEST^MR~S74Y7215^^^OIS^AN||Floyd^Adelinda^J^^^^L|Pierce^Jinx|20131209|F||2028-9^Asian^HL70005|58 Stephens Cir^^Covington^MI^49919^USA^P||^PRN^PH^^^906^8874600|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Rowan^Jinx^^^^^L|MTH^Mother^HL70063|58 Stephens Cir^^Covington^MI^49919^USA^P|^PRN^PH^^^906^8874600|ORC|RE||S74Y7215.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.02.1P3|P|2.5.1|PID|||2UeC-B.25.02^^^AIRA-TEST^MR~D09T7216^^^OIS^ANC||Page^Cade^Suprabha^^^^L|Antelope^Noora|20131211|F||2131-1^Other Race^HL70005|233 Jonson Pl^^Htn Lk Hghts^MI^48630^USA^P||^PRN^PH^^^989^3892068|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Antelope^Noora^^^^^L|MTH^Mother^HL70063|233 Jonson Pl^^Htn Lk Hghts^MI^48630^USA^P|^PRN^PH^^^989^3892068|ORC|RE||D09T7216.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.03.1Pj|P|2.5.1|PID|||2UeC-B.25.03^^^AIRA-TEST^MR~T85S7217^^^OIS^AND||Morris^Fortescue^Caleb^^^^L|Pend Oreille^Manilla|20131203|M||2106-3^White^HL70005|96 Latimer St^^Flint^MI^48555^USA^P||^PRN^PH^^^810^3272111|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Llano^Manilla^^^^^L|MTH^Mother^HL70063|96 Latimer St^^Flint^MI^48555^USA^P|^PRN^PH^^^810^3272111|ORC|RE||T85S7217.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.04.1Pj|P|2.5.1|PID|||2UeC-B.25.04^^^AIRA-TEST^MR~Q85P7218^^^OIS^APRN||Montgomery^Averie^Saryu^^^^L|Alpine^Clara|20131215|F||2106-3^White^HL70005|312 Gagle Cir^^Lexington^MI^48450^USA^P||^PRN^PH^^^810^3438844|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Aroostook^Clara^^^^^L|MTH^Mother^HL70063|312 Gagle Cir^^Lexington^MI^48450^USA^P|^PRN^PH^^^810^3438844|ORC|RE||Q85P7218.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.05.1Pj|P|2.5.1|PID|||2UeC-B.25.05^^^AIRA-TEST^MR~C92D7219^^^OIS^AM||Bagley^Vesna^Lailah^^^^L|Guadalupe^Alena|20131126|F||2054-5^Black or African-American^HL70005|46 Martin Ln^^Wyandotte^MI^48192^USA^P||^PRN^PH^^^734^7438371|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Bagley^Alena^^^^^L|MTH^Mother^HL70063|46 Martin Ln^^Wyandotte^MI^48192^USA^P|^PRN^PH^^^734^7438371|ORC|RE||C92D7219.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.06.1Pz|P|2.5.1|PID|||2UeC-B.25.06^^^AIRA-TEST^MR~M84Y7220^^^OIS^ANON||Cottle^Daisy^A^^^^L|Humboldt^Lenis|20131207|F||2054-5^Black or African-American^HL70005|336 Olsson Ave^^State Farm Ins^MI^49069^USA^P||^PRN^PH^^^269^3894471|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Humboldt^Lenis^^^^^L|MTH^Mother^HL70063|336 Olsson Ave^^State Farm Ins^MI^49069^USA^P|^PRN^PH^^^269^3894471|ORC|RE||M84Y7220.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.07.1Pz|P|2.5.1|PID|||2UeC-B.25.07^^^AIRA-TEST^MR~B41W7221^^^OIS^BA||Graves^Dugald^N^^^^L|Haagen^Melissa|20131222|M||2106-3^White^HL70005|297 Inyo Cir^^Croton^MI^49337^USA^P||^PRN^PH^^^231^3334312|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Graves^Melissa^^^^^L|MTH^Mother^HL70063|297 Inyo Cir^^Croton^MI^49337^USA^P|^PRN^PH^^^231^3334312|ORC|RE||B41W7221.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.08.1Pz|P|2.5.1|PID|||2UeC-B.25.08^^^AIRA-TEST^MR~Y40U7222^^^OIS^BC||Buchanan^Hope^E^^^^L|Lundgren^Olivia|20131208|F||2106-3^White^HL70005|245 Okfuskee Cir^^Novi^MI^48375^USA^P||^PRN^PH^^^248^2104973|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Buchanan^Olivia^^^^^L|MTH^Mother^HL70063|245 Okfuskee Cir^^Novi^MI^48375^USA^P|^PRN^PH^^^248^2104973|ORC|RE||Y40U7222.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.09.1PO|P|2.5.1|PID|||2UeC-B.25.09^^^AIRA-TEST^MR~N55Y7223^^^OIS^BR||Preble^Marmion^Sage^^^^L|Okanogan^Aleena|20131206|M||2106-3^White^HL70005|198 Refugio Pl^^Canton^MI^48188^USA^P||^PRN^PH^^^734^3899695|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Preble^Aleena^^^^^L|MTH^Mother^HL70063|198 Refugio Pl^^Canton^MI^48188^USA^P|^PRN^PH^^^734^3899695|ORC|RE||N55Y7223.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.10.1PO|P|2.5.1|PID|||2UeC-B.25.10^^^AIRA-TEST^MR~W15S7224^^^OIS^BRN||Dallas^Cho^R^^^^L|Dallas^Seraphina|20131129|F||2106-3^White^HL70005|201 Hogg St^^Podunk^MI^48158^USA^P||^PRN^PH^^^734^9543146|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Erie^Seraphina^^^^^L|MTH^Mother^HL70063|201 Hogg St^^Podunk^MI^48158^USA^P|^PRN^PH^^^734^9543146|ORC|RE||W15S7224.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.11.1PO|P|2.5.1|PID|||2UeC-B.25.11^^^AIRA-TEST^MR~U25W7225^^^OIS^CC||Merced^Yan^Shay^^^^L|Erickson^Kimberley|20131129|M||2106-3^White^HL70005|336 Clark Ln^^Manistique^MI^49854^USA^P||^PRN^PH^^^906^7953827|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Hygens^Kimberley^^^^^L|MTH^Mother^HL70063|336 Clark Ln^^Manistique^MI^49854^USA^P|^PRN^PH^^^906^7953827|ORC|RE||U25W7225.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.12.1Q4|P|2.5.1|PID|||2UeC-B.25.12^^^AIRA-TEST^MR~X78Q7226^^^OIS^CY||Harrison^Nisi^Wilbur^^^^L|Smith^Mckenna|20131206|M||1002-5^American Indian or Alaska Native^HL70005|317 Sherman Ln^^Midland^MI^48670^USA^P||^PRN^PH^^^989^6769785|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Nelson^Mckenna^^^^^L|MTH^Mother^HL70063|317 Sherman Ln^^Midland^MI^48670^USA^P|^PRN^PH^^^989^6769785|ORC|RE||X78Q7226.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.13.1Q4|P|2.5.1|PID|||2UeC-B.25.13^^^AIRA-TEST^MR~D25S7227^^^OIS^DDS||Kjerulf^Carrigan^Win^^^^L|Ashtabula^Avice|20131209|F||2106-3^White^HL70005|386 Mala Cir^^Oxford^MI^48370^USA^P||^PRN^PH^^^248^4790136|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Kjerulf^Avice^^^^^L|MTH^Mother^HL70063|386 Mala Cir^^Oxford^MI^48370^USA^P|^PRN^PH^^^248^4790136|ORC|RE||D25S7227.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.14.1Qk|P|2.5.1|PID|||2UeC-B.25.14^^^AIRA-TEST^MR~F75L7228^^^OIS^DI||Hall^Ainhoa^Manya^^^^L|King^Audrey|20131130|F||2131-1^Other Race^HL70005|233 Ida Pl^^Fulton^MI^49052^USA^P||^PRN^PH^^^269^8598953|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Hall^Audrey^^^^^L|MTH^Mother^HL70063|233 Ida Pl^^Fulton^MI^49052^USA^P|^PRN^PH^^^269^8598953|ORC|RE||F75L7228.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.15.1Qk|P|2.5.1|PID|||2UeC-B.25.15^^^AIRA-TEST^MR~G20H7229^^^OIS^DS||Camas^Hernando^Joshua^^^^L|Washington^Jaylyn|20131201|M||2106-3^White^HL70005|89 Jerome Pl^^Fort Gratiot Township^MI^48059^USA^P||^PRN^PH^^^810^5561825|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Camas^Jaylyn^^^^^L|MTH^Mother^HL70063|89 Jerome Pl^^Fort Gratiot Township^MI^48059^USA^P|^PRN^PH^^^810^5561825|ORC|RE||G20H7229.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.16.1Qz|P|2.5.1|PID|||2UeC-B.25.16^^^AIRA-TEST^MR~K90H7230^^^OIS^DN||Mason^Dennis^Lawrance^^^^L|Maverick^Leslie|20131214|M||2106-3^White^HL70005|148 Ofvermark Pl^^Levering^MI^49755^USA^P||^PRN^PH^^^616^6968871|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Haskell^Leslie^^^^^L|MTH^Mother^HL70063|148 Ofvermark Pl^^Levering^MI^49755^USA^P|^PRN^PH^^^616^6968871|ORC|RE||K90H7230.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.17.1Qz|P|2.5.1|PID|||2UeC-B.25.17^^^AIRA-TEST^MR~X06S7231^^^OIS^DR||Lowe^Jane^Roma^^^^L|Coos^Cristiona|20131128|F||2106-3^White^HL70005|253 Sarpy Ln^^Curran^MI^48728^USA^P||^PRN^PH^^^989^8956706|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Coos^Cristiona^^^^^L|MTH^Mother^HL70063|253 Sarpy Ln^^Curran^MI^48728^USA^P|^PRN^PH^^^989^8956706|ORC|RE||X06S7231.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.18.1Qz|P|2.5.1|PID|||2UeC-B.25.18^^^AIRA-TEST^MR~U07U7232^^^OIS^DL||San Francisco^Gala^Qadira^^^^L|Quinla^Runa|20131205|F||2106-3^White^HL70005|174 Osceola Ave^^Middleville^MI^49333^USA^P||^PRN^PH^^^269^6043534|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Lee^Runa^^^^^L|MTH^Mother^HL70063|174 Osceola Ave^^Middleville^MI^49333^USA^P|^PRN^PH^^^269^6043534|ORC|RE||U07U7232.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.19.1QP|P|2.5.1|PID|||2UeC-B.25.19^^^AIRA-TEST^MR~X61L7233^^^OIS^DEA||Tulare^Bond^Bo^^^^L|Bastrop^Orelia|20131129|M||2028-9^Asian^HL70005|134 Monroe Ave^^Detroit^MI^48227^USA^P||^PRN^PH^^^313^3378370|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Tulare^Orelia^^^^^L|MTH^Mother^HL70063|134 Monroe Ave^^Detroit^MI^48227^USA^P|^PRN^PH^^^313^3378370|ORC|RE||X61L7233.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.20.1QP|P|2.5.1|PID|||2UeC-B.25.20^^^AIRA-TEST^MR~H50P7234^^^OIS^DFN||Washington^Madhav^Mander^^^^L|Washington^Flo|20131129|M||2106-3^White^HL70005|77 Venango Ave^^Moran^MI^49760^USA^P||^PRN^PH^^^906^8698313|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Beecher^Flo^^^^^L|MTH^Mother^HL70063|77 Venango Ave^^Moran^MI^49760^USA^P|^PRN^PH^^^906^8698313|ORC|RE||H50P7234.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.21.1QP|P|2.5.1|PID|||2UeC-B.25.21^^^AIRA-TEST^MR~O02H7235^^^OIS^EI||Harrison^Akello^K^^^^L|Salter^Josie|20131207|M||2054-5^Black or African-American^HL70005|305 Buckles Cir^^Jenison^MI^49428^USA^P||^PRN^PH^^^616^3008640|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Salter^Josie^^^^^L|MTH^Mother^HL70063|305 Buckles Cir^^Jenison^MI^49428^USA^P|^PRN^PH^^^616^3008640|ORC|RE||O02H7235.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.22.1QP|P|2.5.1|PID|||2UeC-B.25.22^^^AIRA-TEST^MR~C85W7236^^^OIS^EN||Morrell^Dartagnan^Arkin^^^^L|Nolan^Marisol|20131207|M||2106-3^White^HL70005|160 Dawes St^^Tower^MI^49792^USA^P||^PRN^PH^^^989^2622574|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Morrell^Marisol^^^^^L|MTH^Mother^HL70063|160 Dawes St^^Tower^MI^49792^USA^P|^PRN^PH^^^989^2622574|ORC|RE||C85W7236.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.23.1R4|P|2.5.1|PID|||2UeC-B.25.23^^^AIRA-TEST^MR~M24W7237^^^OIS^FI||Defiance^Pedrog^M^^^^L|Franklin^Apara|20131201|M||1002-5^American Indian or Alaska Native^HL70005|240 Stevens Pl^^Corunna^MI^48817^USA^P||^PRN^PH^^^989^4123270|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Franklin^Apara^^^^^L|MTH^Mother^HL70063|240 Stevens Pl^^Corunna^MI^48817^USA^P|^PRN^PH^^^989^4123270|ORC|RE||M24W7237.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.24.1R4|P|2.5.1|PID|||2UeC-B.25.24^^^AIRA-TEST^MR~H35R7238^^^OIS^GL||Major^Ayush^^^^^L|Green^Rawnie|20131211|M||2131-1^Other Race^HL70005|352 Bourbon Pl^^Au Train^MI^49806^USA^P||^PRN^PH^^^906^8248439|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Major^Rawnie^^^^^L|MTH^Mother^HL70063|352 Bourbon Pl^^Au Train^MI^49806^USA^P|^PRN^PH^^^906^8248439|ORC|RE||H35R7238.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.25.1R4|P|2.5.1|PID|||2UeC-B.25.25^^^AIRA-TEST^MR~G94C7239^^^OIS^GN||San Luis Obispo^Chelsia^Sammy^^^^L|Van Wert^Brie|20131220|F||2106-3^White^HL70005|325 Lincoln Ln^^Saint Helen^MI^48656^USA^P||^PRN^PH^^^989^5814630|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|San Luis Obispo^Brie^^^^^L|MTH^Mother^HL70063|325 Lincoln Ln^^Saint Helen^MI^48656^USA^P|^PRN^PH^^^989^5814630|ORC|RE||G94C7239.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.26.1Rk|P|2.5.1|PID|||2UeC-B.25.26^^^AIRA-TEST^MR~G27A7240^^^OIS^GI||San Mateo^Caine^Colin^^^^L|Benton^Jaquenetta|20131128|M||2106-3^White^HL70005|368 Peters Pl^^Rochester Hls^MI^48307^USA^P||^PRN^PH^^^248^3355756|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Delaware^Jaquenetta^^^^^L|MTH^Mother^HL70063|368 Peters Pl^^Rochester Hls^MI^48307^USA^P|^PRN^PH^^^248^3355756|ORC|RE||G27A7240.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.27.1Rk|P|2.5.1|PID|||2UeC-B.25.27^^^AIRA-TEST^MR~N48P7241^^^OIS^HC||Jefferson^Heidi^Naomi^^^^L|Lake^Addyson|20131128|F||1002-5^American Indian or Alaska Native^HL70005|355 Ottawa Ln^^Bentley^MI^48613^USA^P||^PRN^PH^^^989^3011737|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Lake^Addyson^^^^^L|MTH^Mother^HL70063|355 Ottawa Ln^^Bentley^MI^48613^USA^P|^PRN^PH^^^989^3011737|ORC|RE||N48P7241.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.28.1Rk|P|2.5.1|PID|||2UeC-B.25.28^^^AIRA-TEST^MR~W20T7242^^^OIS^IND||LaRue^Deiene^Z^^^^L|Stonewall^Prasert|20131126|F||2054-5^Black or African-American^HL70005|63 Preble Cir^^Grand Rapids^MI^49555^USA^P||^PRN^PH^^^616^9069894|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|LaRue^Prasert^^^^^L|MTH^Mother^HL70063|63 Preble Cir^^Grand Rapids^MI^49555^USA^P|^PRN^PH^^^616^9069894|ORC|RE||W20T7242.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.29.1RA|P|2.5.1|PID|||2UeC-B.25.29^^^AIRA-TEST^MR~E03D7243^^^OIS^JHN||Trumbull^Valborg^Harper^^^^L|Garfield^Nona|20131220|F||2106-3^White^HL70005|123 Orange Pl^^Point Aux Pin^MI^49775^USA^P||^PRN^PH^^^231^6359838|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Garfield^Nona^^^^^L|MTH^Mother^HL70063|123 Orange Pl^^Point Aux Pin^MI^49775^USA^P|^PRN^PH^^^231^6359838|ORC|RE||E03D7243.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.30.1RA|P|2.5.1|PID|||2UeC-B.25.30^^^AIRA-TEST^MR~J31Q7244^^^OIS^LI||Werstad^Riddhi^M^^^^L|Fayette^Molly|20131204|F||2106-3^White^HL70005|46 Casey St^^Lowell^MI^49331^USA^P||^PRN^PH^^^616^6121435|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Elliott^Molly^^^^^L|MTH^Mother^HL70063|46 Casey St^^Lowell^MI^49331^USA^P|^PRN^PH^^^616^6121435|ORC|RE||J31Q7244.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.31.1RA|P|2.5.1|PID|||2UeC-B.25.31^^^AIRA-TEST^MR~L15C7245^^^OIS^LN||La Paz^Usko^Ahmed^^^^L|Northampton^Nilgan|20131129|M||2106-3^White^HL70005|376 Campbell Cir^^Kincheloe^MI^49788^USA^P||^PRN^PH^^^906^5572737|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|La Paz^Nilgan^^^^^L|MTH^Mother^HL70063|376 Campbell Cir^^Kincheloe^MI^49788^USA^P|^PRN^PH^^^906^5572737|ORC|RE||L15C7245.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.32.1RP|P|2.5.1|PID|||2UeC-B.25.32^^^AIRA-TEST^MR~L04P7246^^^OIS^PE||Scott^Stesha^Gebriele^^^^L|Coal^Petunia|20131128|F||2106-3^White^HL70005|275 Williams Cir^^Algonac^MI^48001^USA^P||^PRN^PH^^^810^4877206|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Scott^Petunia^^^^^L|MTH^Mother^HL70063|275 Williams Cir^^Algonac^MI^48001^USA^P|^PRN^PH^^^810^4877206|ORC|RE||L04P7246.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.33.1RP|P|2.5.1|PID|||2UeC-B.25.33^^^AIRA-TEST^MR~I53O7247^^^OIS^LR||Thornley^Androcles^Kerwin^^^^L|Lueatos^Andreana|20131220|M||2106-3^White^HL70005|296 Love St^^Old Mission^MI^49673^USA^P||^PRN^PH^^^231^9886536|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Thornley^Andreana^^^^^L|MTH^Mother^HL70063|296 Love St^^Old Mission^MI^49673^USA^P|^PRN^PH^^^231^9886536|ORC|RE||I53O7247.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.34.1RP|P|2.5.1|PID|||2UeC-B.25.34^^^AIRA-TEST^MR~X48O7248^^^OIS^MS||Brennan^Rex^Durant^^^^L|Leonard^Sharay|20131203|M||2106-3^White^HL70005|10 McErlaine Ave^^Us Army Tank-Auto Command^MI^48397^USA^P||^PRN^PH^^^586^4600844|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Brennan^Sharay^^^^^L|MTH^Mother^HL70063|10 McErlaine Ave^^Us Army Tank-Auto Command^MI^48397^USA^P|^PRN^PH^^^586^4600844|ORC|RE||X48O7248.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.35.1S5|P|2.5.1|PID|||2UeC-B.25.35^^^AIRA-TEST^MR~L88P7249^^^OIS^MD||York^Xavier^Achyuta^^^^L|Clallam^Ahnada|20131124|M||2106-3^White^HL70005|375 Santa Cruz Cir^^Traverse City^MI^49684^USA^P||^PRN^PH^^^231^6417750|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|York^Ahnada^^^^^L|MTH^Mother^HL70063|375 Santa Cruz Cir^^Traverse City^MI^49684^USA^P|^PRN^PH^^^231^6417750|ORC|RE||L88P7249.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.36.1S5|P|2.5.1|PID|||2UeC-B.25.36^^^AIRA-TEST^MR~K12T7250^^^OIS^UPIN||Cameron^Tolena^Titania^^^^L|San Francisco^Boa|20131129|F||2106-3^White^HL70005|172 Cimarron St^^Riverdale^MI^48877^USA^P||^PRN^PH^^^989^6279332|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Cameron^Boa^^^^^L|MTH^Mother^HL70063|172 Cimarron St^^Riverdale^MI^48877^USA^P|^PRN^PH^^^989^6279332|ORC|RE||K12T7250.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.37.1S5|P|2.5.1|PID|||2UeC-B.25.37^^^AIRA-TEST^MR~X10H7251^^^OIS^MB||Dickinson^Audun^Adelle^^^^L|Turvo^Tola|20131206|F||2106-3^White^HL70005|159 Ottawa Ln^^Casnovia^MI^49318^USA^P||^PRN^PH^^^231^2149980|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Dickinson^Tola^^^^^L|MTH^Mother^HL70063|159 Ottawa Ln^^Casnovia^MI^49318^USA^P|^PRN^PH^^^231^2149980|ORC|RE||X10H7251.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.38.1Sl|P|2.5.1|PID|||2UeC-B.25.38^^^AIRA-TEST^MR~C54M7252^^^OIS^MCN||Crosbie^Dalton^^^^^L|Lake^Alina|20131126|M||2106-3^White^HL70005|298 Lyastrom St^^Watersmeet^MI^49969^USA^P||^PRN^PH^^^906^3606867|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Lake^Alina^^^^^L|MTH^Mother^HL70063|298 Lyastrom St^^Watersmeet^MI^49969^USA^P|^PRN^PH^^^906^3606867|ORC|RE||C54M7252.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.39.1Sl|P|2.5.1|PID|||2UeC-B.25.39^^^AIRA-TEST^MR~Z32I7253^^^OIS^MI||Bredberg^Andrew^Japhet^^^^L|Dill^Cai|20131215|M||1002-5^American Indian or Alaska Native^HL70005|210 Wayrynen Ln^^Hghtn Lk Heights^MI^48630^USA^P||^PRN^PH^^^989^7345164|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Dill^Cai^^^^^L|MTH^Mother^HL70063|210 Wayrynen Ln^^Hghtn Lk Heights^MI^48630^USA^P|^PRN^PH^^^989^7345164|ORC|RE||Z32I7253.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.40.1Sl|P|2.5.1|PID|||2UeC-B.25.40^^^AIRA-TEST^MR~X88R7254^^^OIS^NE||Power^Maiya^Yasmeen^^^^L|Callahan^Melantha|20131130|F||2106-3^White^HL70005|192 Wardle Ln^^Saginaw^MI^48603^USA^P||^PRN^PH^^^989^7898881|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Power^Melantha^^^^^L|MTH^Mother^HL70063|192 Wardle Ln^^Saginaw^MI^48603^USA^P|^PRN^PH^^^989^7898881|ORC|RE||X88R7254.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.41.1SA|P|2.5.1|PID|||2UeC-B.25.41^^^AIRA-TEST^MR~D22E7255^^^OIS^NH||Meade^Renfred^^^^^L|Watmough^Yogita|20131214|M||2106-3^White^HL70005|237 Putnam Ave^^Fairgrove^MI^48733^USA^P||^PRN^PH^^^989^9697157|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Meade^Yogita^^^^^L|MTH^Mother^HL70063|237 Putnam Ave^^Fairgrove^MI^48733^USA^P|^PRN^PH^^^989^9697157|ORC|RE||D22E7255.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.42.1SA|P|2.5.1|PID|||2UeC-B.25.42^^^AIRA-TEST^MR~I14V7256^^^OIS^NII||Manistee^Buena^Rula^^^^L|Kolar^Beckie|20131206|F||2106-3^White^HL70005|44 San Benito Cir^^Muskegon^MI^49444^USA^P||^PRN^PH^^^231^5624935|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Kolar^Beckie^^^^^L|MTH^Mother^HL70063|44 San Benito Cir^^Muskegon^MI^49444^USA^P|^PRN^PH^^^231^5624935|ORC|RE||I14V7256.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.43.1SA|P|2.5.1|PID|||2UeC-B.25.43^^^AIRA-TEST^MR~X18Y7257^^^OIS^NIIP||Murphy^Mardian^Chatillon^^^^L|Manistee^Jocelyn|20131126|M||2106-3^White^HL70005|193 Thorsen St^^Mecosta^MI^49332^USA^P||^PRN^PH^^^231^9762839|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Clark^Jocelyn^^^^^L|MTH^Mother^HL70063|193 Thorsen St^^Mecosta^MI^49332^USA^P|^PRN^PH^^^231^9762839|ORC|RE||X18Y7257.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.44.1SQ|P|2.5.1|PID|||2UeC-B.25.44^^^AIRA-TEST^MR~E72R7258^^^OIS^NNMEX||Washington^Aleksandra^V^^^^L|Sierra^Tyanne|20131210|F||1002-5^American Indian or Alaska Native^HL70005|12 Janson Ave^^Hancock^MI^49930^USA^P||^PRN^PH^^^906^3614764|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Sierra^Tyanne^^^^^L|MTH^Mother^HL70063|12 Janson Ave^^Hancock^MI^49930^USA^P|^PRN^PH^^^906^3614764|ORC|RE||E72R7258.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.45.1SQ|P|2.5.1|PID|||2UeC-B.25.45^^^AIRA-TEST^MR~P41W7259^^^OIS^NNCAN||Hockley^Arely^^^^^L|Mason^Armynel|20131123|F||2106-3^White^HL70005|247 Newberry Ln^^Genoa Township^MI^48116^USA^P||^PRN^PH^^^810^8989332|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Hockley^Armynel^^^^^L|MTH^Mother^HL70063|247 Newberry Ln^^Genoa Township^MI^48116^USA^P|^PRN^PH^^^810^8989332|ORC|RE||P41W7259.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.46.1T5|P|2.5.1|PID|||2UeC-B.25.46^^^AIRA-TEST^MR~B85N7260^^^OIS^NPI||Pocahontas^Mahendra^Joo-Chan^^^^L|Milam^Israt|20131203|M||2106-3^White^HL70005|213 Galveston Cir^^Calumet^MI^49942^USA^P||^PRN^PH^^^906^5516767|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Pocahontas^Israt^^^^^L|MTH^Mother^HL70063|213 Galveston Cir^^Calumet^MI^49942^USA^P|^PRN^PH^^^906^5516767|ORC|RE||B85N7260.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.47.1T5|P|2.5.1|PID|||2UeC-B.25.47^^^AIRA-TEST^MR~W78H7261^^^OIS^NI||Terrell^Aetos^LeBeau^^^^L|Todd^Tiffany|20131121|M||2054-5^Black or African-American^HL70005|376 Campbell Cir^^Loch Alpine^MI^48103^USA^P||^PRN^PH^^^734^4253602|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Terrell^Tiffany^^^^^L|MTH^Mother^HL70063|376 Campbell Cir^^Loch Alpine^MI^48103^USA^P|^PRN^PH^^^734^4253602|ORC|RE||W78H7261.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.48.1T5|P|2.5.1|PID|||2UeC-B.25.48^^^AIRA-TEST^MR~M99Y7262^^^OIS^NP||Holt^Arlette^A^^^^L|Lucas^Candra|20131201|F||2106-3^White^HL70005|292 Amador Cir^^Cohoctah^MI^48816^USA^P||^PRN^PH^^^517^8591013|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Holt^Candra^^^^^L|MTH^Mother^HL70063|292 Amador Cir^^Cohoctah^MI^48816^USA^P|^PRN^PH^^^517^8591013|ORC|RE||M99Y7262.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.49.1Tl|P|2.5.1|PID|||2UeC-B.25.49^^^AIRA-TEST^MR~N68H7263^^^OIS^OD||Gabrielsen^Hansi^Octavius^^^^L|Greeley^Avis|20131209|M||2028-9^Asian^HL70005|284 Calhoun Pl^^Flint^MI^48531^USA^P||^PRN^PH^^^810^5967005|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Gabrielsen^Avis^^^^^L|MTH^Mother^HL70063|284 Calhoun Pl^^Flint^MI^48531^USA^P|^PRN^PH^^^810^5967005|ORC|RE||N68H7263.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.50.1Tl|P|2.5.1|PID|||2UeC-B.25.50^^^AIRA-TEST^MR~N18J7264^^^OIS^XX||Canadian^Elie^M^^^^L|Shiawassee^Erzsebet|20131209|F||2028-9^Asian^HL70005|34 Clallam Ave^^GR^MI^49507^USA^P||^PRN^PH^^^616^3249964|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Canadian^Erzsebet^^^^^L|MTH^Mother^HL70063|34 Clallam Ave^^GR^MI^49507^USA^P|^PRN^PH^^^616^3249964|ORC|RE||N18J7264.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.51.1Tl|P|2.5.1|PID|||2UeC-B.25.51^^^AIRA-TEST^MR~Y60N7265^^^OIS^DO||Davis^Lillianna^S^^^^L|Amador^Kayna|20131210|F||2106-3^White^HL70005|122 Cornelinson Pl^^Mc Bain^MI^49657^USA^P||^PRN^PH^^^231^4222881|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Davis^Kayna^^^^^L|MTH^Mother^HL70063|122 Cornelinson Pl^^Mc Bain^MI^49657^USA^P|^PRN^PH^^^231^4222881|ORC|RE||Y60N7265.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.52.1Tl|P|2.5.1|PID|||2UeC-B.25.52^^^AIRA-TEST^MR~E82V7266^^^OIS^PPN||Cowlitz^Haylie^X^^^^L|Bingham^Terri|20131214|F||2106-3^White^HL70005|74 Marshall Pl^^GR^MI^49518^USA^P||^PRN^PH^^^616^3503029|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Bingham^Terri^^^^^L|MTH^Mother^HL70063|74 Marshall Pl^^GR^MI^49518^USA^P|^PRN^PH^^^616^3503029|ORC|RE||E82V7266.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.53.1TB|P|2.5.1|PID|||2UeC-B.25.53^^^AIRA-TEST^MR~W11G7267^^^OIS^PT||Hood^Clara^A^^^^L|Hood^Kelley|20131205|F||2106-3^White^HL70005|69 Kay Pl^^Treetops Village^MI^49735^USA^P||^PRN^PH^^^989^9085826|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Livingston^Kelley^^^^^L|MTH^Mother^HL70063|69 Kay Pl^^Treetops Village^MI^49735^USA^P|^PRN^PH^^^989^9085826|ORC|RE||W11G7267.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.54.1TB|P|2.5.1|PID|||2UeC-B.25.54^^^AIRA-TEST^MR~J49N7268^^^OIS^PI||Ainslie^Tonya^Lona^^^^L|Murray^Jamari|20131206|F||2106-3^White^HL70005|382 Ellis Ave^^Mattawan^MI^49071^USA^P||^PRN^PH^^^269^2169298|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Ainslie^Jamari^^^^^L|MTH^Mother^HL70063|382 Ellis Ave^^Mattawan^MI^49071^USA^P|^PRN^PH^^^269^2169298|ORC|RE||J49N7268.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.55.1TB|P|2.5.1|PID|||2UeC-B.25.55^^^AIRA-TEST^MR~94599760538^^^OIS^MA||Martinson^Kalle^Lulu^^^^L|Juniata^Pyrena|20131218|F||1002-5^American Indian or Alaska Native^HL70005|251 Howard Ln^^Benton Harbor^MI^49023^USA^P||^PRN^PH^^^269^2218013|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Martinson^Pyrena^^^^^L|MTH^Mother^HL70063|251 Howard Ln^^Benton Harbor^MI^49023^USA^P|^PRN^PH^^^269^2218013|ORC|RE||F83Y7269.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.56.1TQ|P|2.5.1|PID|||2UeC-B.25.56^^^AIRA-TEST^MR~I49H7270^^^OIS^MC||Washington^Candie^K^^^^L|Ross^Mariana|20131206|F||2106-3^White^HL70005|15 Wagoner Ln^^Sharon Hollow^MI^48158^USA^P||^PRN^PH^^^734^5314156|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Washington^Mariana^^^^^L|MTH^Mother^HL70063|15 Wagoner Ln^^Sharon Hollow^MI^48158^USA^P|^PRN^PH^^^734^5314156|ORC|RE||I49H7270.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.57.1TQ|P|2.5.1|PID|||2UeC-B.25.57^^^AIRA-TEST^MR~K01W7271^^^OIS^PCN||Bell^Kalpana^D^^^^L|Nordstrom^Aissa|20131117|F||2054-5^Black or African-American^HL70005|299 Stonewall St^^Bham^MI^48012^USA^P||^PRN^PH^^^248^4520414|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Ennis^Aissa^^^^^L|MTH^Mother^HL70063|299 Stonewall St^^Bham^MI^48012^USA^P|^PRN^PH^^^248^4520414|ORC|RE||K01W7271.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.58.1TQ|P|2.5.1|PID|||2UeC-B.25.58^^^AIRA-TEST^MR~X17F7272^^^OIS^PEN||Shaw^Pelton^Menenius^^^^L|Fox^Evelin|20131206|M||2106-3^White^HL70005|63 Tulare St^^Detroit^MI^48228^USA^P||^PRN^PH^^^313^9847836|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Shaw^Evelin^^^^^L|MTH^Mother^HL70063|63 Tulare St^^Detroit^MI^48228^USA^P|^PRN^PH^^^313^9847836|ORC|RE||X17F7272.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.59.1U6|P|2.5.1|PID|||2UeC-B.25.59^^^AIRA-TEST^MR~V71D7273^^^OIS^PRC||Livingston^Aretha^E^^^^L|Livingston^Roseanne|20131126|F||1002-5^American Indian or Alaska Native^HL70005|3 Hutchinson Ave^^Amway Corp^MI^49355^USA^P||^PRN^PH^^^616^8704229|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Andersen^Roseanne^^^^^L|MTH^Mother^HL70063|3 Hutchinson Ave^^Amway Corp^MI^49355^USA^P|^PRN^PH^^^616^8704229|ORC|RE||V71D7273.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.60.1U6|P|2.5.1|PID|||2UeC-B.25.60^^^AIRA-TEST^MR~U51O7274^^^OIS^PN||Montgomery^Edison^^^^^L|Harrison^Lindall|20131204|M||2131-1^Other Race^HL70005|157 Douglas Ln^^Big Bay^MI^49808^USA^P||^PRN^PH^^^906^2149163|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Montgomery^Lindall^^^^^L|MTH^Mother^HL70063|157 Douglas Ln^^Big Bay^MI^49808^USA^P|^PRN^PH^^^906^2149163|ORC|RE||U51O7274.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.61.1U6|P|2.5.1|PID|||2UeC-B.25.61^^^AIRA-TEST^MR~Q74D7275^^^OIS^RPH||Lycoming^Maru^^^^^L|Andrews^Rieko|20131125|F||2054-5^Black or African-American^HL70005|311 Sherman Cir^^Bloomfield Hills^MI^48304^USA^P||^PRN^PH^^^248^9890039|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|McDonald^Rieko^^^^^L|MTH^Mother^HL70063|311 Sherman Cir^^Bloomfield Hills^MI^48304^USA^P|^PRN^PH^^^248^9890039|ORC|RE||Q74D7275.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.62.1U6|P|2.5.1|PID|||2UeC-B.25.62^^^AIRA-TEST^MR~Z56A7276^^^OIS^PA||Glorinn^Candy^Rachna^^^^L|Hutchinson^Jonina|20131207|F||2054-5^Black or African-American^HL70005|333 O Day Pl^^Detroit^MI^48277^USA^P||^PRN^PH^^^313^5413676|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Glorinn^Jonina^^^^^L|MTH^Mother^HL70063|333 O Day Pl^^Detroit^MI^48277^USA^P|^PRN^PH^^^313^5413676|ORC|RE||Z56A7276.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.63.1Um|P|2.5.1|PID|||2UeC-B.25.63^^^AIRA-TEST^MR~J32K7277^^^OIS^DPM||Patricio^Louis^Marley^^^^L|Latimer^Hildegard|20131210|M||2054-5^Black or African-American^HL70005|295 Garza Ave^^Dow Chemical USA^MI^48674^USA^P||^PRN^PH^^^989^5427990|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Patricio^Hildegard^^^^^L|MTH^Mother^HL70063|295 Garza Ave^^Dow Chemical USA^MI^48674^USA^P|^PRN^PH^^^989^5427990|ORC|RE||J32K7277.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.64.1Um|P|2.5.1|PID|||2UeC-B.25.64^^^AIRA-TEST^MR~J36P7278^^^OIS^MCD||Mathiesen^Paris^Bethel^^^^L|Borden^Ines|20131201|F||2106-3^White^HL70005|45 Culp St^^Allendale^MI^49401^USA^P||^PRN^PH^^^616^2612566|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Borden^Ines^^^^^L|MTH^Mother^HL70063|45 Culp St^^Allendale^MI^49401^USA^P|^PRN^PH^^^616^2612566|ORC|RE||J36P7278.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.65.1Um|P|2.5.1|PID|||2UeC-B.25.65^^^AIRA-TEST^MR~I18M7279^^^OIS^MCR||Union^Autolucus^^^^^L|McIntosh^Faiza|20131130|M||2106-3^White^HL70005|191 Major Ave^^Camp Grayling^MI^49739^USA^P||^PRN^PH^^^989^6234016|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Union^Faiza^^^^^L|MTH^Mother^HL70063|191 Major Ave^^Camp Grayling^MI^49739^USA^P|^PRN^PH^^^989^6234016|ORC|RE||I18M7279.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.66.1UB|P|2.5.1|PID|||2UeC-B.25.66^^^AIRA-TEST^MR~G71N7280^^^OIS^PRN||Green^Sydelle^Gilen^^^^L|Hall^Ita|20131202|F||2106-3^White^HL70005|90 Bagley St^^Kentwood Brch^MI^49528^USA^P||^PRN^PH^^^616^3553254|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Green^Ita^^^^^L|MTH^Mother^HL70063|90 Bagley St^^Kentwood Brch^MI^49528^USA^P|^PRN^PH^^^616^3553254|ORC|RE||G71N7280.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.67.1UB|P|2.5.1|PID|||2UeC-B.25.67^^^AIRA-TEST^MR~N12P7281^^^OIS^QA||Shackelford^Mladen^Alvah^^^^L|Bryan^Gabriela|20131208|M||2054-5^Black or African-American^HL70005|352 Lincoln St^^Hadley^MI^48440^USA^P||^PRN^PH^^^810^4824432|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Shackelford^Gabriela^^^^^L|MTH^Mother^HL70063|352 Lincoln St^^Hadley^MI^48440^USA^P|^PRN^PH^^^810^4824432|ORC|RE||N12P7281.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.68.1UB|P|2.5.1|PID|||2UeC-B.25.68^^^AIRA-TEST^MR~S13H7282^^^OIS^RR||Mackey^Vaishali^^^^^L|Walcott^Mallory|20131125|F||2054-5^Black or African-American^HL70005|229 Thiemer St^^Lakeland^MI^48143^USA^P||^PRN^PH^^^810^6728457|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Mackey^Mallory^^^^^L|MTH^Mother^HL70063|229 Thiemer St^^Lakeland^MI^48143^USA^P|^PRN^PH^^^810^6728457|ORC|RE||S13H7282.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.69.1UR|P|2.5.1|PID|||2UeC-B.25.69^^^AIRA-TEST^MR~K69J7283^^^OIS^RRI||Mohave^Cayla^^^^^L|Swindells^Habika|20131127|F||2054-5^Black or African-American^HL70005|96 Adsgaard Cir^^Kingsford^MI^49802^USA^P||^PRN^PH^^^906^6639984|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Swindells^Habika^^^^^L|MTH^Mother^HL70063|96 Adsgaard Cir^^Kingsford^MI^49802^USA^P|^PRN^PH^^^906^6639984|ORC|RE||K69J7283.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.70.1UR|P|2.5.1|PID|||2UeC-B.25.70^^^AIRA-TEST^MR~S36C7284^^^OIS^RN||Crosby^Cecania^E^^^^L|Olsson^Manasi|20131201|F||2106-3^White^HL70005|235 Erie Cir^^North Port^MI^49670^USA^P||^PRN^PH^^^231^4269306|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Crosby^Manasi^^^^^L|MTH^Mother^HL70063|235 Erie Cir^^North Port^MI^49670^USA^P|^PRN^PH^^^231^4269306|ORC|RE||S36C7284.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.71.1UR|P|2.5.1|PID|||2UeC-B.25.71^^^AIRA-TEST^MR~O43Y7285^^^OIS^RI||Brazoria^Carleton^J^^^^L|Mason^Salina|20131203|M||2131-1^Other Race^HL70005|110 Letcher Ln^^Northeast^MI^48506^USA^P||^PRN^PH^^^810^6956316|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Brazoria^Salina^^^^^L|MTH^Mother^HL70063|110 Letcher Ln^^Northeast^MI^48506^USA^P|^PRN^PH^^^810^6956316|ORC|RE||O43Y7285.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.72.1V6|P|2.5.1|PID|||2UeC-B.25.72^^^AIRA-TEST^MR~358064187^^^OIS^SS||Boise^Latrice^^^^^L|Imperial^Cambria|20131128|F||2028-9^Asian^HL70005|345 Adair St^^South Branch^MI^48761^USA^P||^PRN^PH^^^989^9329452|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Imperial^Cambria^^^^^L|MTH^Mother^HL70063|345 Adair St^^South Branch^MI^48761^USA^P|^PRN^PH^^^989^9329452|ORC|RE||T72W7286.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.73.1V6|P|2.5.1|PID|||2UeC-B.25.73^^^AIRA-TEST^MR~V32F7287^^^OIS^SPM||Johnson^Amiri^Kipling^^^^L|Jackson^Holda|20131208|M||2054-5^Black or African-American^HL70005|267 Cochran St^^Lake Leelanau^MI^49653^USA^P||^PRN^PH^^^231^8167141|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Johnson^Holda^^^^^L|MTH^Mother^HL70063|267 Cochran St^^Lake Leelanau^MI^49653^USA^P|^PRN^PH^^^231^8167141|ORC|RE||V32F7287.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.74.1Vm|P|2.5.1|PID|||2UeC-B.25.74^^^AIRA-TEST^MR~S46C7288^^^OIS^SID||Nez Perce^Sofia^Kalare^^^^L|Nilsen^Mavis|20131205|F||2106-3^White^HL70005|205 Nevada St^^Cannonsburg^MI^49317^USA^P||^PRN^PH^^^616^6536366|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Nez Perce^Mavis^^^^^L|MTH^Mother^HL70063|205 Nevada St^^Cannonsburg^MI^49317^USA^P|^PRN^PH^^^616^6536366|ORC|RE||S46C7288.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.75.1Vm|P|2.5.1|PID|||2UeC-B.25.75^^^AIRA-TEST^MR~D15V7289^^^OIS^SL||Gunnerson^Moss^^^^^L|Adams^Findabhair|20131205|M||2054-5^Black or African-American^HL70005|322 Bolgen Ln^^Frankenmuth Mutual Ins Co^MI^48787^USA^P||^PRN^PH^^^989^9113726|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Gunnerson^Findabhair^^^^^L|MTH^Mother^HL70063|322 Bolgen Ln^^Frankenmuth Mutual Ins Co^MI^48787^USA^P|^PRN^PH^^^989^9113726|ORC|RE||D15V7289.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.76.1VC|P|2.5.1|PID|||2UeC-B.25.76^^^AIRA-TEST^MR~Z93O7290^^^OIS^SR||Dawson^Nigel^Orpheus^^^^L|Muskogee^Charlotte|20131211|M||2028-9^Asian^HL70005|202 Henry Ave^^Jerome^MI^49249^USA^P||^PRN^PH^^^517^7108502|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Dawson^Charlotte^^^^^L|MTH^Mother^HL70063|202 Henry Ave^^Jerome^MI^49249^USA^P|^PRN^PH^^^517^7108502|ORC|RE||Z93O7290.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.77.1VC|P|2.5.1|PID|||2UeC-B.25.77^^^AIRA-TEST^MR~I72U7291^^^OIS^SN||Lake^Lori^Tatya^^^^L|Paso^Arnisha|20131208|F||2054-5^Black or African-American^HL70005|289 Los Angeles St^^Rochester Hills^MI^48308^USA^P||^PRN^PH^^^248^3331070|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Lake^Arnisha^^^^^L|MTH^Mother^HL70063|289 Los Angeles St^^Rochester Hills^MI^48308^USA^P|^PRN^PH^^^248^3331070|ORC|RE||I72U7291.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.78.1VR|P|2.5.1|PID|||2UeC-B.25.78^^^AIRA-TEST^MR~G43V7292^^^OIS^TAX||Hoey^Alala^R^^^^L|Hoey^Kelda|20131218|F||2106-3^White^HL70005|182 Wagoner Cir^^Sebewaing^MI^48759^USA^P||^PRN^PH^^^989^4907689|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Oak^Kelda^^^^^L|MTH^Mother^HL70063|182 Wagoner Cir^^Sebewaing^MI^48759^USA^P|^PRN^PH^^^989^4907689|ORC|RE||G43V7292.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.79.1VR|P|2.5.1|PID|||2UeC-B.25.79^^^AIRA-TEST^MR~R71F7293^^^OIS^ANT||Belmont^Wells^Bersh^^^^L|Yavapai^Giada|20131202|M||2106-3^White^HL70005|223 Baker Ln^^Coldwater^MI^49036^USA^P||^PRN^PH^^^517^6015669|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Belmont^Giada^^^^^L|MTH^Mother^HL70063|223 Baker Ln^^Coldwater^MI^49036^USA^P|^PRN^PH^^^517^6015669|ORC|RE||R71F7293.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.80.1VR|P|2.5.1|PID|||2UeC-B.25.80^^^AIRA-TEST^MR~E90Y7294^^^OIS^PNT||Pike^Durriken^L^^^^L|Keweenaw^Kaya|20131212|M||2106-3^White^HL70005|64 San Diego Ave^^Willow Run^MI^48198^USA^P||^PRN^PH^^^734^9803915|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Keweenaw^Kaya^^^^^L|MTH^Mother^HL70063|64 San Diego Ave^^Willow Run^MI^48198^USA^P|^PRN^PH^^^734^9803915|ORC|RE||E90Y7294.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.81.1W7|P|2.5.1|PID|||2UeC-B.25.81^^^AIRA-TEST^MR~P14Q7295^^^OIS^MRT||Turvo^Benedick^Shalom^^^^L|Jefferson^Mariana|20131125|M||2106-3^White^HL70005|267 Robinson Pl^^Carleton^MI^48117^USA^P||^PRN^PH^^^734^5510001|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Turvo^Mariana^^^^^L|MTH^Mother^HL70063|267 Robinson Pl^^Carleton^MI^48117^USA^P|^PRN^PH^^^734^5510001|ORC|RE||P14Q7295.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.82.1W7|P|2.5.1|PID|||2UeC-B.25.82^^^AIRA-TEST^MR~F27U7296^^^OIS^TN||Laen^Amdis^Jolan^^^^L|Thorsen^Banan|20131210|F||2054-5^Black or African-American^HL70005|75 Walsh Pl^^Palms^MI^48465^USA^P||^PRN^PH^^^989^3943325|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Thorsen^Banan^^^^^L|MTH^Mother^HL70063|75 Walsh Pl^^Palms^MI^48465^USA^P|^PRN^PH^^^989^3943325|ORC|RE||F27U7296.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.83.1W7|P|2.5.1|PID|||2UeC-B.25.83^^^AIRA-TEST^MR~V80K7297^^^OIS^U||Houghton^Tonia^Esther^^^^L|Waters^Diana|20131205|F||2106-3^White^HL70005|104 Howarth St^^Buick Oldsmobile Cadillac^MI^48550^USA^P||^PRN^PH^^^810^7316150|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Iowa^Diana^^^^^L|MTH^Mother^HL70063|104 Howarth St^^Buick Oldsmobile Cadillac^MI^48550^USA^P|^PRN^PH^^^810^7316150|ORC|RE||V80K7297.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.84.1Wn|P|2.5.1|PID|||2UeC-B.25.84^^^AIRA-TEST^MR~B05N7298^^^OIS^VS||Gorman^Kanak^Ahmed^^^^L|Westmoreland^Cardinia|20131129|M||2106-3^White^HL70005|215 Wardle Ln^^Goetzville^MI^49736^USA^P||^PRN^PH^^^906^5692042|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Gorman^Cardinia^^^^^L|MTH^Mother^HL70063|215 Wardle Ln^^Goetzville^MI^49736^USA^P|^PRN^PH^^^906^5692042|ORC|RE||B05N7298.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.85.1Wn|P|2.5.1|PID|||2UeC-B.25.85^^^AIRA-TEST^MR~A32N7299^^^OIS^VN||Roger Mills^Anata^Trusha^^^^L|Rusk^Mihoko|20131207|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|185 Monroe Ave^^Drayton Plns^MI^48330^USA^P||^PRN^PH^^^248^4306802|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Roger Mills^Mihoko^^^^^L|MTH^Mother^HL70063|185 Monroe Ave^^Drayton Plns^MI^48330^USA^P|^PRN^PH^^^248^4306802|ORC|RE||A32N7299.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.86.1Wn|P|2.5.1|PID|||2UeC-B.25.86^^^AIRA-TEST^MR~P08U7300^^^OIS^WC||Susquehanna^Egeria^Tawny^^^^L|Lincoln^Bailee|20131128|F||2106-3^White^HL70005|207 Daviess Ave^^Anchorville^MI^48004^USA^P||^PRN^PH^^^810^3110612|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Isdal^Bailee^^^^^L|MTH^Mother^HL70063|207 Daviess Ave^^Anchorville^MI^48004^USA^P|^PRN^PH^^^810^3110612|ORC|RE||P08U7300.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.25.87.1WC|P|2.5.1|PID|||2UeC-B.25.87^^^AIRA-TEST^MR~E58O7301^^^OIS^WCN||Tarrant^Jamesina^Heidy^^^^L|Osage^Zippora|20131205|F||2106-3^White^HL70005|30 Richardson Cir^^Eau Claire^MI^49111^USA^P||^PRN^PH^^^269^7977318|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Tarrant^Zippora^^^^^L|MTH^Mother^HL70063|30 Richardson Cir^^Eau Claire^MI^49111^USA^P|^PRN^PH^^^269^7977318|ORC|RE||E58O7301.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.26.01.1WC|P|2.5.1|PID|||2UeC-B.26.01^^^AIRA-TEST^MR||York^Dominic^Chad^^^^L|Atwell^Ambar|20131201|M||2054-5^Black or African-American^HL70005|344 Ryan Cir^^Redford Township^MI^48240^USA^P||^PRN^PH^^^313^9099711|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||01^No reminder/recall^HL70215|||||A|20171204|20171204|NK1|1|Atwell^Ambar^^^^^L|MTH^Mother^HL70063|344 Ryan Cir^^Redford Township^MI^48240^USA^P|^PRN^PH^^^313^9099711|ORC|RE||J93F7302.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.26.02.1WC|P|2.5.1|PID|||2UeC-B.26.02^^^AIRA-TEST^MR||Medina^Janet^^^^^L|Shoshone^Cherlin|20131122|F||2054-5^Black or African-American^HL70005|66 Logan St^^Naubinway^MI^49762^USA^P||^PRN^PH^^^906^9084076|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Medina^Cherlin^^^^^L|MTH^Mother^HL70063|66 Logan St^^Naubinway^MI^49762^USA^P|^PRN^PH^^^906^9084076|ORC|RE||J75P7303.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.26.03.1WC|P|2.5.1|PID|||2UeC-B.26.03^^^AIRA-TEST^MR||Madison^Than^Quincy^^^^L|Malone^Amelia|20131211|M||2054-5^Black or African-American^HL70005|230 Omssund St^^Superior Township^MI^48198^USA^P||^PRN^PH^^^734^7776567|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||03^Reminder/recall - no calls^HL70215|||||A|20171204|20171204|NK1|1|Chambers^Amelia^^^^^L|MTH^Mother^HL70063|230 Omssund St^^Superior Township^MI^48198^USA^P|^PRN^PH^^^734^7776567|ORC|RE||S76O7304.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.26.04.1WS|P|2.5.1|PID|||2UeC-B.26.04^^^AIRA-TEST^MR||Aurum^Jeremias^Yobachi^^^^L|Hougen^Renuka|20131123|M||2106-3^White^HL70005|134 Bergen Pl^^Grand Rapids^MI^49512^USA^P||^PRN^PH^^^616^8976272|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||04^Reminder only - any method^HL70215|||||A|20171204|20171204|NK1|1|Aurum^Renuka^^^^^L|MTH^Mother^HL70063|134 Bergen Pl^^Grand Rapids^MI^49512^USA^P|^PRN^PH^^^616^8976272|ORC|RE||F14Y7305.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.26.05.1WS|P|2.5.1|PID|||2UeC-B.26.05^^^AIRA-TEST^MR||Kitsap^Penney^Hathor^^^^L|Ferry^Mellie|20131215|F||2106-3^White^HL70005|270 Hunt St^^Farmington Hls^MI^48332^USA^P||^PRN^PH^^^248^7077049|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||05^Reminder only - no calls^HL70215|||||A|20171204|20171204|NK1|1|Kitsap^Mellie^^^^^L|MTH^Mother^HL70063|270 Hunt St^^Farmington Hls^MI^48332^USA^P|^PRN^PH^^^248^7077049|ORC|RE||B40S7306.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.26.06.1WS|P|2.5.1|PID|||2UeC-B.26.06^^^AIRA-TEST^MR||Werstad^Trudy^Cypriana^^^^L|Werstad^Caitlyn|20131210|F||2028-9^Asian^HL70005|380 Siskiyou Cir^^Grayling^MI^49738^USA^P||^PRN^PH^^^989^7641451|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||06^Recall only - any method^HL70215|||||A|20171204|20171204|NK1|1|Logan^Caitlyn^^^^^L|MTH^Mother^HL70063|380 Siskiyou Cir^^Grayling^MI^49738^USA^P|^PRN^PH^^^989^7641451|ORC|RE||M97H7307.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.26.07.1X7|P|2.5.1|PID|||2UeC-B.26.07^^^AIRA-TEST^MR||Howarth^Rolf^Harlow^^^^L|King^Shanata|20131130|M||2106-3^White^HL70005|164 Brown Ave^^Harbert^MI^49115^USA^P||^PRN^PH^^^269^2367690|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||07^Recall only - no calls^HL70215|||||A|20171204|20171204|NK1|1|Clallam^Shanata^^^^^L|MTH^Mother^HL70063|164 Brown Ave^^Harbert^MI^49115^USA^P|^PRN^PH^^^269^2367690|ORC|RE||M89S7308.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.26.08.1X7|P|2.5.1|PID|||2UeC-B.26.08^^^AIRA-TEST^MR||Dakota^Lia^Bijal^^^^L|San Mateo^Thyrrni|20131206|F||1002-5^American Indian or Alaska Native^HL70005|347 Gillespie Ave^^Rochester^MI^48308^USA^P||^PRN^PH^^^248^3466785|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||08^Reminder/recall - to provider^HL70215|||||A|20171204|20171204|NK1|1|Dakota^Thyrrni^^^^^L|MTH^Mother^HL70063|347 Gillespie Ave^^Rochester^MI^48308^USA^P|^PRN^PH^^^248^3466785|ORC|RE||E19A7309.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.26.09.1X7|P|2.5.1|PID|||2UeC-B.26.09^^^AIRA-TEST^MR||Custer^Ulf^M^^^^L|Johnston^Shahnaz|20131205|M||2106-3^White^HL70005|303 Jackson Cir^^Kenockee Township^MI^48006^USA^P||^PRN^PH^^^810^4043318|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||09^Reminder to provider^HL70215|||||A|20171204|20171204|NK1|1|Tama^Shahnaz^^^^^L|MTH^Mother^HL70063|303 Jackson Cir^^Kenockee Township^MI^48006^USA^P|^PRN^PH^^^810^4043318|ORC|RE||O60F7310.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.26.10.1Xn|P|2.5.1|PID|||2UeC-B.26.10^^^AIRA-TEST^MR||Red Willow^Lionel^Jarek^^^^L|Jefferson^Alameda|20131207|M||2054-5^Black or African-American^HL70005|398 Hubbard Ln^^Detroit^MI^48209^USA^P||^PRN^PH^^^313^6249697|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||10^Only reminder to provider, no recall^HL70215|||||A|20171204|20171204|NK1|1|Red Willow^Alameda^^^^^L|MTH^Mother^HL70063|398 Hubbard Ln^^Detroit^MI^48209^USA^P|^PRN^PH^^^313^6249697|ORC|RE||A81X7311.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.26.11.1Xn|P|2.5.1|PID|||2UeC-B.26.11^^^AIRA-TEST^MR||Nordstrom^Juliet^C^^^^L|Jefferson^Lata|20131206|F||2106-3^White^HL70005|354 Butte St^^Kalamazoo^MI^49024^USA^P||^PRN^PH^^^269^8730858|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||11^Recall to provider^HL70215|||||A|20171204|20171204|NK1|1|Nordstrom^Lata^^^^^L|MTH^Mother^HL70063|354 Butte St^^Kalamazoo^MI^49024^USA^P|^PRN^PH^^^269^8730858|ORC|RE||A03N7312.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.26.12.1Xn|P|2.5.1|PID|||2UeC-B.26.12^^^AIRA-TEST^MR||Coshocton^Galen^^^^^L|Ada^Eglantine|20131128|F||2028-9^Asian^HL70005|203 Cowlitz Pl^^Sterling Heights^MI^48314^USA^P||^PRN^PH^^^586^6053971|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||12^Only recall to provider, no reminder^HL70215|||||A|20171204|20171204|NK1|1|Pike^Eglantine^^^^^L|MTH^Mother^HL70063|203 Cowlitz Pl^^Sterling Heights^MI^48314^USA^P|^PRN^PH^^^586^6053971|ORC|RE||E03K7313.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.01.1XD|P|2.5.1|PID|||2UeC-B.27.01^^^AIRA-TEST^MR||Eigum^Kaushal^^^^^L|McGann^Rowan|20131129|M||2054-5^Black or African-American^HL70005|188 Chippewa Cir^^Boyne Falls^SC^49713^USA^P^^45001||^PRN^PH^^^231^9929199|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Eigum^Rowan^^^^^L|MTH^Mother^HL70063|188 Chippewa Cir^^Boyne Falls^MI^49713^USA^P|^PRN^PH^^^231^9929199|ORC|RE||E48C7314.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.02.1XD|P|2.5.1|PID|||2UeC-B.27.02^^^AIRA-TEST^MR||Court^Mohana^N^^^^L|Lake^Brandee|20131221|F||1002-5^American Indian or Alaska Native^HL70005|60 Placer St^^Waterford^LA^48328^USA^P^^22001||^PRN^PH^^^248^5571649|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Kjerulf^Brandee^^^^^L|MTH^Mother^HL70063|60 Placer St^^Waterford^MI^48328^USA^P|^PRN^PH^^^248^5571649|ORC|RE||B99V7315.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.03.1XD|P|2.5.1|PID|||2UeC-B.27.03^^^AIRA-TEST^MR||Whitaker^Anais^Vesna^^^^L|Plumas^Ginette|20131212|F||2054-5^Black or African-American^HL70005|70 Allegheny St^^Climax^VA^49034^USA^P^^51001||^PRN^PH^^^269^8394627|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Phelps^Ginette^^^^^L|MTH^Mother^HL70063|70 Allegheny St^^Climax^MI^49034^USA^P|^PRN^PH^^^269^8394627|ORC|RE||P56O7316.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.04.1XD|P|2.5.1|PID|||2UeC-B.27.04^^^AIRA-TEST^MR||Psconen^Yumiko^Carmela^^^^L|Tuscola^Daralis|20131209|F||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|262 Montgomery St^^Carson City^ID^48811^USA^P^^16001||^PRN^PH^^^989^4460257|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Psconen^Daralis^^^^^L|MTH^Mother^HL70063|262 Montgomery St^^Carson City^MI^48811^USA^P|^PRN^PH^^^989^4460257|ORC|RE||P03H7317.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.05.1XS|P|2.5.1|PID|||2UeC-B.27.05^^^AIRA-TEST^MR||Sullivan^Dionyza^I^^^^L|Donley^Lyndel|20131125|F||2106-3^White^HL70005|210 Lawrence Pl^^Fountain^KY^49410^USA^P^^21001||^PRN^PH^^^231^5636114|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Sullivan^Lyndel^^^^^L|MTH^Mother^HL70063|210 Lawrence Pl^^Fountain^MI^49410^USA^P|^PRN^PH^^^231^5636114|ORC|RE||T52H7318.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.06.1XS|P|2.5.1|PID|||2UeC-B.27.06^^^AIRA-TEST^MR||Mickel^Sivan^O^^^^L|Lake^Bedelia|20131215|M||2028-9^Asian^HL70005|44 Pierce Cir^^Lansing^IA^48901^USA^P^^19001||^PRN^PH^^^517^7908566|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Marion^Bedelia^^^^^L|MTH^Mother^HL70063|44 Pierce Cir^^Lansing^MI^48901^USA^P|^PRN^PH^^^517^7908566|ORC|RE||P42S7319.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.07.1XS|P|2.5.1|PID|||2UeC-B.27.07^^^AIRA-TEST^MR||Sullivan^Frayne^P^^^^L|Rogers^Lillian|20131122|M||2106-3^White^HL70005|8 Pecos Pl^^Detroit^MO^48217^USA^P^^29001||^PRN^PH^^^313^9618648|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Sullivan^Lillian^^^^^L|MTH^Mother^HL70063|8 Pecos Pl^^Detroit^MI^48217^USA^P|^PRN^PH^^^313^9618648|ORC|RE||G75D7320.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.08.1Y8|P|2.5.1|PID|||2UeC-B.27.08^^^AIRA-TEST^MR||Glenn^Connor^Deniz^^^^L|Swindells^Jaime|20131123|M||2106-3^White^HL70005|340 Schleicher Ave^^Okemos^OK^48864^USA^P^^40001||^PRN^PH^^^517^2629666|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Swindells^Jaime^^^^^L|MTH^Mother^HL70063|340 Schleicher Ave^^Okemos^MI^48864^USA^P|^PRN^PH^^^517^2629666|ORC|RE||W33S7321.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.09.1Y8|P|2.5.1|PID|||2UeC-B.27.09^^^AIRA-TEST^MR||Wells^Terrie^^^^^L|Pike^Farida|20131206|M||2106-3^White^HL70005|236 Swisher Ave^^Sylvan Township^ND^48118^USA^P^^38001||^PRN^PH^^^734^2760928|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Pike^Farida^^^^^L|MTH^Mother^HL70063|236 Swisher Ave^^Sylvan Township^MI^48118^USA^P|^PRN^PH^^^734^2760928|ORC|RE||W22K7322.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.10.1Yo|P|2.5.1|PID|||2UeC-B.27.10^^^AIRA-TEST^MR||Franklin^Edwin^Pedr^^^^L|Hood River^Jayne|20131126|M||2106-3^White^HL70005|229 Bracey Pl^^Howell^OH^48855^USA^P^^39001||^PRN^PH^^^517^7222664|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Hood River^Jayne^^^^^L|MTH^Mother^HL70063|229 Bracey Pl^^Howell^MI^48855^USA^P|^PRN^PH^^^517^7222664|ORC|RE||X15K7323.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.11.1Yo|P|2.5.1|PID|||2UeC-B.27.11^^^AIRA-TEST^MR||Willacy^Frith^A^^^^L|Hougen^Kaliyah|20131208|M||2106-3^White^HL70005|199 Westmoreland St^^Covert^NE^49043^USA^P^^31001||^PRN^PH^^^269^7059598|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Willacy^Kaliyah^^^^^L|MTH^Mother^HL70063|199 Westmoreland St^^Covert^MI^49043^USA^P|^PRN^PH^^^269^7059598|ORC|RE||W89C7324.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.12.1Yo|P|2.5.1|PID|||2UeC-B.27.12^^^AIRA-TEST^MR||Pike^Santiago^D^^^^L|Howath^Dervla|20131203|M||2106-3^White^HL70005|145 Cochise Cir^^Bridgman^PA^49106^USA^P^^42001||^PRN^PH^^^269^9389448|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Pike^Dervla^^^^^L|MTH^Mother^HL70063|145 Cochise Cir^^Bridgman^MI^49106^USA^P|^PRN^PH^^^269^9389448|ORC|RE||R63G7325.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.13.1Yo|P|2.5.1|PID|||2UeC-B.27.13^^^AIRA-TEST^MR||Buena Vista^Lilah^Marylou^^^^L|Johnson^Anar|20131211|F||2106-3^White^HL70005|157 Pushmataha Ln^^Dexter Township^IA^48169^USA^P^^19003||^PRN^PH^^^734^3596168|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Buena Vista^Anar^^^^^L|MTH^Mother^HL70063|157 Pushmataha Ln^^Dexter Township^MI^48169^USA^P|^PRN^PH^^^734^3596168|ORC|RE||T93D7326.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.14.1YD|P|2.5.1|PID|||2UeC-B.27.14^^^AIRA-TEST^MR||Palo Alto^Mallee^Cornelius^^^^L|Cumberland^Paola|20131202|M||2106-3^White^HL70005|97 Kenedy Cir^^Burr Oak^MS^49030^USA^P^^28001||^PRN^PH^^^269^9300962|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Palo Alto^Paola^^^^^L|MTH^Mother^HL70063|97 Kenedy Cir^^Burr Oak^MI^49030^USA^P|^PRN^PH^^^269^9300962|ORC|RE||K29Q7327.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.27.15.1YD|P|2.5.1|PID|||2UeC-B.27.15^^^AIRA-TEST^MR||Vance^Gunnhild^^^^^L|Harrison^Dobrila|20131205|F||2054-5^Black or African-American^HL70005|77 Werstad Cir^^Trenton^ID^48183^USA^P^^16003||^PRN^PH^^^734^6795492|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Vance^Dobrila^^^^^L|MTH^Mother^HL70063|77 Werstad Cir^^Trenton^MI^48183^USA^P|^PRN^PH^^^734^6795492|ORC|RE||O78H7328.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.01.1YD|P|2.5.1|PID|||2UeC-B.28.01^^^AIRA-TEST^MR||Carlisle^Kylan^Trey^^^^L|Navajo^Haifa|20131203|M||1002-5^American Indian or Alaska Native^HL70005|337 Wyandot Pl^^Gilford^MI^48736^USA^P||^PRN^PH^^^989^4382247||ara^Arabic^HL70396|||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Navajo^Haifa^^^^^L|MTH^Mother^HL70063|337 Wyandot Pl^^Gilford^MI^48736^USA^P|^PRN^PH^^^989^4382247|ORC|RE||P37J7329.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.02.1YT|P|2.5.1|PID|||2UeC-B.28.02^^^AIRA-TEST^MR||Hickman^Tyrus^^^^^L|Lindstrom^Kristabel|20131203|M||1002-5^American Indian or Alaska Native^HL70005|173 Napa Ln^^Independence^MI^48348^USA^P||^PRN^PH^^^248^7672591||arm^Armenian^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Lindstrom^Kristabel^^^^^L|MTH^Mother^HL70063|173 Napa Ln^^Independence^MI^48348^USA^P|^PRN^PH^^^248^7672591|ORC|RE||M97E7330.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.03.1YT|P|2.5.1|PID|||2UeC-B.28.03^^^AIRA-TEST^MR||Teton^Elisa^J^^^^L|Nowata^Alannah|20131207|F||2106-3^White^HL70005|340 Sheridan Ave^^Meskegon^MI^49444^USA^P||^PRN^PH^^^231^9103204||cat^Catalan; Valencian^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Teton^Alannah^^^^^L|MTH^Mother^HL70063|340 Sheridan Ave^^Meskegon^MI^49444^USA^P|^PRN^PH^^^231^9103204|ORC|RE||S50S7331.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.04.1YT|P|2.5.1|PID|||2UeC-B.28.04^^^AIRA-TEST^MR||Knox^Shiva^Synclair^^^^L|Cherry^Alodie|20131122|M||2054-5^Black or African-American^HL70005|21 San Mateo Pl^^Shelby Township^MI^48318^USA^P||^PRN^PH^^^586^2057346||chi^Chinese^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Knox^Alodie^^^^^L|MTH^Mother^HL70063|21 San Mateo Pl^^Shelby Township^MI^48318^USA^P|^PRN^PH^^^586^2057346|ORC|RE||H18Z7332.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.05.1Z8|P|2.5.1|PID|||2UeC-B.28.05^^^AIRA-TEST^MR||Lewis^Francesca^H^^^^L|Cummings^Victoria|20131202|F||2106-3^White^HL70005|325 Brewster Pl^^Felch^MI^49877^USA^P||^PRN^PH^^^906^9678724||dan^Danish^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Lewis^Victoria^^^^^L|MTH^Mother^HL70063|325 Brewster Pl^^Felch^MI^49877^USA^P|^PRN^PH^^^906^9678724|ORC|RE||V12B7333.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.06.1Z8|P|2.5.1|PID|||2UeC-B.28.06^^^AIRA-TEST^MR||Nuckolls^Pansy^P^^^^L|San Bernardino^Madhul|20131210|F||2054-5^Black or African-American^HL70005|117 Colon Cir^^Vassar^MI^48769^USA^P||^PRN^PH^^^989^3083637||eng^English^HL70396|||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Columbia^Madhul^^^^^L|MTH^Mother^HL70063|117 Colon Cir^^Vassar^MI^48769^USA^P|^PRN^PH^^^989^3083637|ORC|RE||F45D7334.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.07.1Z8|P|2.5.1|PID|||2UeC-B.28.07^^^AIRA-TEST^MR||Canyon^Destinee^Therese^^^^L|Smith^Lynnea|20131116|F||2131-1^Other Race^HL70005|379 Ochiltree Ln^^New Hudson^MI^48165^USA^P||^PRN^PH^^^248^7996903||fre^Armenian^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Hutchinson^Lynnea^^^^^L|MTH^Mother^HL70063|379 Ochiltree Ln^^New Hudson^MI^48165^USA^P|^PRN^PH^^^248^7996903|ORC|RE||F78C7335.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.08.1Zo|P|2.5.1|PID|||2UeC-B.28.08^^^AIRA-TEST^MR||Madison^Arland^Fedele^^^^L|Douglas^Rufina|20131207|M||2106-3^White^HL70005|224 Atascosa Pl^^Detroit^MI^48225^USA^P||^PRN^PH^^^313^4271657||ger^German^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Douglas^Rufina^^^^^L|MTH^Mother^HL70063|224 Atascosa Pl^^Detroit^MI^48225^USA^P|^PRN^PH^^^313^4271657|ORC|RE||X27W7336.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.09.1Zo|P|2.5.1|PID|||2UeC-B.28.09^^^AIRA-TEST^MR||Lancaster^Adrastos^S^^^^L|Lancaster^Zelinda|20131211|M||2028-9^Asian^HL70005|169 Morrell Cir^^Walker^MI^49544^USA^P||^PRN^PH^^^616^8089554||hat^Haitian; Haitian Creole^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Janson^Zelinda^^^^^L|MTH^Mother^HL70063|169 Morrell Cir^^Walker^MI^49544^USA^P|^PRN^PH^^^616^8089554|ORC|RE||Y48J7337.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.10.1Zo|P|2.5.1|PID|||2UeC-B.28.10^^^AIRA-TEST^MR||Monterey^Phoenix^^^^^L|Sykes^Jazmine|20131208|M||2106-3^White^HL70005|391 Pushmataha Pl^^Oden^MI^49764^USA^P||^PRN^PH^^^616^8301738||heb^Hebrew^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Monterey^Jazmine^^^^^L|MTH^Mother^HL70063|391 Pushmataha Pl^^Oden^MI^49764^USA^P|^PRN^PH^^^616^8301738|ORC|RE||Y33F7338.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.11.1Zo|P|2.5.1|PID|||2UeC-B.28.11^^^AIRA-TEST^MR||Jacinto^Eirene^Vasanti^^^^L|Madison^Cari|20131216|F||2131-1^Other Race^HL70005|26 Delta Cir^^Comstock Park^MI^49321^USA^P||^PRN^PH^^^616^7870842||hin^Hindi^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Jacinto^Cari^^^^^L|MTH^Mother^HL70063|26 Delta Cir^^Comstock Park^MI^49321^USA^P|^PRN^PH^^^616^7870842|ORC|RE||B76K7339.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.12.1ZE|P|2.5.1|PID|||2UeC-B.28.12^^^AIRA-TEST^MR||Frio^Vigilia^Carlotta^^^^L|Wrigley^Danielle|20131124|F||1002-5^American Indian or Alaska Native^HL70005|54 Sulit St^^Farmington Hls^MI^48335^USA^P||^PRN^PH^^^248^5507198||hmn^Armenian^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Frio^Danielle^^^^^L|MTH^Mother^HL70063|54 Sulit St^^Farmington Hls^MI^48335^USA^P|^PRN^PH^^^248^5507198|ORC|RE||W60S7340.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.13.1ZE|P|2.5.1|PID|||2UeC-B.28.13^^^AIRA-TEST^MR||Letcher^Hans^Randell^^^^L|Wells^Sacha|20131128|M||1002-5^American Indian or Alaska Native^HL70005|320 Miami Cir^^Fort Gratiot Township^MI^48059^USA^P||^PRN^PH^^^810^9005680||jpn^Japanese^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Garfield^Sacha^^^^^L|MTH^Mother^HL70063|320 Miami Cir^^Fort Gratiot Township^MI^48059^USA^P|^PRN^PH^^^810^9005680|ORC|RE||A34S7341.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.14.1ZE|P|2.5.1|PID|||2UeC-B.28.14^^^AIRA-TEST^MR||Eriksson^Santon^Sarasvan^^^^L|Genesee^Oonagh|20131203|M||2106-3^White^HL70005|49 Keokuk Cir^^Grand Rapids^MI^49505^USA^P||^PRN^PH^^^616^8030997||kor^Korean^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Eriksson^Oonagh^^^^^L|MTH^Mother^HL70063|49 Keokuk Cir^^Grand Rapids^MI^49505^USA^P|^PRN^PH^^^616^8030997|ORC|RE||Y21Q7342.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.15.1ZT|P|2.5.1|PID|||2UeC-B.28.15^^^AIRA-TEST^MR||Van Zandt^Milli^Rane^^^^L|Lee^Keilana|20131128|F||2054-5^Black or African-American^HL70005|176 Bracey Ave^^Bancroft^MI^48414^USA^P||^PRN^PH^^^989^3953614||rus^Russian^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Lee^Keilana^^^^^L|MTH^Mother^HL70063|176 Bracey Ave^^Bancroft^MI^48414^USA^P|^PRN^PH^^^989^3953614|ORC|RE||P09S7343.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.16.1ZT|P|2.5.1|PID|||2UeC-B.28.16^^^AIRA-TEST^MR||Brennan^Gotzone^Larissa^^^^L|Hardin^Amadis|20131218|F||2106-3^White^HL70005|150 Wasco Ln^^Rochester^MI^48307^USA^P||^PRN^PH^^^248^6233996||som^Somali^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Hardin^Amadis^^^^^L|MTH^Mother^HL70063|150 Wasco Ln^^Rochester^MI^48307^USA^P|^PRN^PH^^^248^6233996|ORC|RE||P41I7344.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.17.1ZT|P|2.5.1|PID|||2UeC-B.28.17^^^AIRA-TEST^MR||Nordholm^Richman^N^^^^L|Louisa^Abbey|20131209|M||2106-3^White^HL70005|383 Apache Ave^^Lynn Township^MI^48097^USA^P||^PRN^PH^^^810^7757386||spa^Armenian^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Nordholm^Abbey^^^^^L|MTH^Mother^HL70063|383 Apache Ave^^Lynn Township^MI^48097^USA^P|^PRN^PH^^^810^7757386|ORC|RE||S06F7345.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.28.18.209|P|2.5.1|PID|||2UeC-B.28.18^^^AIRA-TEST^MR||Livingston^Suellen^Irina^^^^L|Livingston^Nozomi|20131201|F||2106-3^White^HL70005|274 Bexar Cir^^Flint^MI^48519^USA^P||^PRN^PH^^^810^3919515||vie^Vietnamese^HL70396|||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Ganes^Nozomi^^^^^L|MTH^Mother^HL70063|274 Bexar Cir^^Flint^MI^48519^USA^P|^PRN^PH^^^810^3919515|ORC|RE||C96M7346.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.30.01.209|P|2.5.1|PID|||2UeC-B.30.01^^^AIRA-TEST^MR||Swift^Clare^K^^^^L|Lewis^Serilda|20131130|F||2106-3^White^HL70005|19 Cumberland Ave^^Kentwood^MI^49528^USA^P||^PRN^PH^^^616^2751930|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Lewis^Serilda^^^^^L|MTH^Mother^HL70063|19 Cumberland Ave^^Kentwood^MI^49528^USA^P|^PRN^PH^^^616^2751930|ORC|RE||A32U7347.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.30.02.209|P|2.5.1|PID|||2UeC-B.30.02^^^AIRA-TEST^MR||Mee^Picerious^M^^^^L|Nordstrom^Iolanthe|20131212|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|289 Payne St^^Dowling^MI^49050^USA^P||^PRN^PH^^^269^5684037|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Mee^Iolanthe^^^^^L|MTH^Mother^HL70063|289 Payne St^^Dowling^MI^49050^USA^P|^PRN^PH^^^269^5684037|ORC|RE||W75C7348.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||U|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.30.03.209|P|2.5.1|PID|||2UeC-B.30.03^^^AIRA-TEST^MR||Fagen^Valentino^Flavius^^^^L|Allen^Ailish|20131203|M||2106-3^White^HL70005|111 Marlin Ln^^Saint Clr Shores^MI^48081^USA^P||^PRN^PH^^^586^6067948|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Allen^Ailish^^^^^L|MTH^Mother^HL70063|111 Marlin Ln^^Saint Clr Shores^MI^48081^USA^P|^PRN^PH^^^586^6067948|ORC|RE||Y67S7349.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||D|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.31.01.20p|P|2.5.1|PID|||2UeC-B.31.01^^^AIRA-TEST^MR||Power^Galen^Hemlata^^^^L|Bergen^Netta|20131130|F||2054-5^Black or African-American^HL70005|3 Grant Ln^^Sheridan^MI^48884^USA^P||^PRN^PH^^^989^3219860|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Power^Netta^^^^^L|MTH^Mother^HL70063|3 Grant Ln^^Sheridan^MI^48884^USA^P|^PRN^PH^^^989^3219860|ORC|RE||U52T7350.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.31.02.20p|P|2.5.1|PID|||2UeC-B.31.02^^^AIRA-TEST^MR||Hampson^Fear^Vikram^^^^L|Hampson^Gai|20131204|M||2106-3^White^HL70005|320 Bakey Cir^^Eau Claire^MI^49111^USA^P||^PRN^PH^^^269^3141343|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Kearney^Gai^^^^^L|MTH^Mother^HL70063|320 Bakey Cir^^Eau Claire^MI^49111^USA^P|^PRN^PH^^^269^3141343|ORC|RE||R82J7351.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||N3783EO||MSD^Merck and Co^MVX||||U|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.31.03.20p|P|2.5.1|PID|||2UeC-B.31.03^^^AIRA-TEST^MR||Pike^Rene^Mog^^^^L|Burt^Elaine|20131205|M||2106-3^White^HL70005|280 Ottawa Ln^^Vehicle License Plates^MI^48980^USA^P||^PRN^PH^^^517^3706125|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Greene^Elaine^^^^^L|MTH^Mother^HL70063|280 Ottawa Ln^^Vehicle License Plates^MI^48980^USA^P|^PRN^PH^^^517^3706125|ORC|RE||D77A7352.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||S4121RG||MSD^Merck and Co^MVX||||D|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.01.20E|P|2.5.1|PID|||2UeC-B.32.01^^^AIRA-TEST^MR||Floyd^Aryan^Dayton^^^^L|Idaho^Kelly|20131208|M||2106-3^White^HL70005|94 Pawnee Ln^^Grand Rapids^MI^49515^USA^P||^PRN^PH^^^616^2749244|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Floyd^Kelly^^^^^L|MTH^Mother^HL70063|94 Pawnee Ln^^Grand Rapids^MI^49515^USA^P|^PRN^PH^^^616^2749244|ORC|RE||X62N7353.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Emmet^Vittore^^^^^^^^^^^^^^^^^^PN|||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.02.20E|P|2.5.1|PID|||2UeC-B.32.02^^^AIRA-TEST^MR||Clark^Eric^S^^^^L|Madison^Shayna|20131122|M||2028-9^Asian^HL70005|308 Cowle St^^Gould City^MI^49838^USA^P||^PRN^PH^^^906^8582835|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Clark^Shayna^^^^^L|MTH^Mother^HL70063|308 Cowle St^^Gould City^MI^49838^USA^P|^PRN^PH^^^906^8582835|ORC|RE||O93P7354.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Madison^Essien^^^^^^^^^^^^^^^^^^AA|||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.03.20E|P|2.5.1|PID|||2UeC-B.32.03^^^AIRA-TEST^MR||Franklin^Hont^Trey^^^^L|Kent^Udaya|20131206|M||1002-5^American Indian or Alaska Native^HL70005|45 Kalkaska Ave^^Reese^MI^48757^USA^P||^PRN^PH^^^989^8065654|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Franklin^Udaya^^^^^L|MTH^Mother^HL70063|45 Kalkaska Ave^^Reese^MI^48757^USA^P|^PRN^PH^^^989^8065654|ORC|RE||P85W7355.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Kent^Rasmus^^^^^^^^^^^^^^^^^^AS|||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.04.20U|P|2.5.1|PID|||2UeC-B.32.04^^^AIRA-TEST^MR||Perry^Kalista^^^^^L|Trigg^Eliza|20131201|F||2106-3^White^HL70005|259 Santiago St^^Whittaker^MI^48190^USA^P||^PRN^PH^^^734^9276956|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Amador^Eliza^^^^^L|MTH^Mother^HL70063|259 Santiago St^^Whittaker^MI^48190^USA^P|^PRN^PH^^^734^9276956|ORC|RE||F12H7356.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Amador^Gavrie^^^^^^^^^^^^^^^^^^BA|||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.05.20U|P|2.5.1|PID|||2UeC-B.32.05^^^AIRA-TEST^MR||Brot^Ernest^Cal^^^^L|Hart^Camille|20131130|M||2106-3^White^HL70005|325 Cass Cir^^Raco^MI^49715^USA^P||^PRN^PH^^^906^4657350|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Brot^Camille^^^^^L|MTH^Mother^HL70063|325 Cass Cir^^Raco^MI^49715^USA^P|^PRN^PH^^^906^4657350|ORC|RE||D36Q7357.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Hart^Sigmund^^^^^^^^^^^^^^^^^^BN|||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.06.219|P|2.5.1|PID|||2UeC-B.32.06^^^AIRA-TEST^MR||Calhoun^Laraine^Dulcie^^^^L|Edwards^Farley|20131202|F||2106-3^White^HL70005|390 Cotton Pl^^Clare^MI^48617^USA^P||^PRN^PH^^^989^3095462|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Ross^Farley^^^^^L|MTH^Mother^HL70063|390 Cotton Pl^^Clare^MI^48617^USA^P|^PRN^PH^^^989^3095462|ORC|RE||I41U7358.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Ross^Abbas^^^^^^^^^^^^^^^^^^BS|||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.07.219|P|2.5.1|PID|||2UeC-B.32.07^^^AIRA-TEST^MR||King^Echo^Dyani^^^^L|Malone^Hope|20131203|F||2106-3^White^HL70005|239 Greenland Pl^^Climax^MI^49034^USA^P||^PRN^PH^^^269^6439505|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|King^Hope^^^^^L|MTH^Mother^HL70063|239 Greenland Pl^^Climax^MI^49034^USA^P|^PRN^PH^^^269^6439505|ORC|RE||K98T7359.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Atwell^Otway^^^^^^^^^^^^^^^^^^BSN|||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.08.21p|P|2.5.1|PID|||2UeC-B.32.08^^^AIRA-TEST^MR||Newton^Natalee^Delilah^^^^L|Hughes^Aimee|20131201|F||2106-3^White^HL70005|28 Caldwell Pl^^Grand Rapids^MI^49544^USA^P||^PRN^PH^^^616^9565164|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Newton^Aimee^^^^^L|MTH^Mother^HL70063|28 Caldwell Pl^^Grand Rapids^MI^49544^USA^P|^PRN^PH^^^616^9565164|ORC|RE||A43J7360.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Umatilla^Patony^^^^^^^^^^^^^^^^^^CER|||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.09.21p|P|2.5.1|PID|||2UeC-B.32.09^^^AIRA-TEST^MR||Norman^Yasuo^^^^^L|Garfield^Joanna|20131125|M||2131-1^Other Race^HL70005|241 Morrow St^^Duck Lake^MI^49284^USA^P||^PRN^PH^^^517^8353365|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Garfield^Joanna^^^^^L|MTH^Mother^HL70063|241 Morrow St^^Duck Lake^MI^49284^USA^P|^PRN^PH^^^517^8353365|ORC|RE||V87C7361.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Garfield^Yashodhar^^^^^^^^^^^^^^^^^^CANP|||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.10.21F|P|2.5.1|PID|||2UeC-B.32.10^^^AIRA-TEST^MR||Berntsen^Malati^Rizpah^^^^L|Mackinac^Honey|20131204|F||2106-3^White^HL70005|179 Carroll Cir^^Clarkston^MI^48348^USA^P||^PRN^PH^^^248^2167604|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Creek^Honey^^^^^L|MTH^Mother^HL70063|179 Carroll Cir^^Clarkston^MI^48348^USA^P|^PRN^PH^^^248^2167604|ORC|RE||G10V7362.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Creek^Octavius^^^^^^^^^^^^^^^^^^CMA|||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.11.21U|P|2.5.1|PID|||2UeC-B.32.11^^^AIRA-TEST^MR||Navarro^Penn^Vance^^^^L|Lewis^Tanaka|20131201|M||2054-5^Black or African-American^HL70005|333 Morrin Cir^^Fowlerville^MI^48836^USA^P||^PRN^PH^^^517^6732069|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Smith^Tanaka^^^^^L|MTH^Mother^HL70063|333 Morrin Cir^^Fowlerville^MI^48836^USA^P|^PRN^PH^^^517^6732069|ORC|RE||D31X7363.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Lewis^Ogilvy^^^^^^^^^^^^^^^^^^CNM|||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.12.21U|P|2.5.1|PID|||2UeC-B.32.12^^^AIRA-TEST^MR||Knox^Orianna^O^^^^L|Lake^Walida|20131215|F||2106-3^White^HL70005|14 Monon Cir^^Idlewild^MI^49642^USA^P||^PRN^PH^^^231^4687359|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Dawes^Walida^^^^^L|MTH^Mother^HL70063|14 Monon Cir^^Idlewild^MI^49642^USA^P|^PRN^PH^^^231^4687359|ORC|RE||E20R7364.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Dawes^Ashton^^^^^^^^^^^^^^^^^^CNP|||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.13.21U|P|2.5.1|PID|||2UeC-B.32.13^^^AIRA-TEST^MR||Russell^Alena^C^^^^L|Eigum^Berdine|20131204|F||2106-3^White^HL70005|158 Alcona Pl^^Grand Blanc^MI^48480^USA^P||^PRN^PH^^^810^7547196|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Eigum^Berdine^^^^^L|MTH^Mother^HL70063|158 Alcona Pl^^Grand Blanc^MI^48480^USA^P|^PRN^PH^^^810^7547196|ORC|RE||D62M7365.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Eigum^Cranley^^^^^^^^^^^^^^^^^^CNS|||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.14.22a|P|2.5.1|PID|||2UeC-B.32.14^^^AIRA-TEST^MR||Cheyenne^Matteo^^^^^L|Sheridan^Isaura|20131129|M||2054-5^Black or African-American^HL70005|50 Forest St^^Battle Creek^MI^49015^USA^P||^PRN^PH^^^269^5323385|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Cheyenne^Isaura^^^^^L|MTH^Mother^HL70063|50 Forest St^^Battle Creek^MI^49015^USA^P|^PRN^PH^^^269^5323385|ORC|RE||F15H7366.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Sheridan^Hamilton^^^^^^^^^^^^^^^^^^CNA|||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.15.22a|P|2.5.1|PID|||2UeC-B.32.15^^^AIRA-TEST^MR||Carton^Ginger^Leona^^^^L|Marshall^Iman|20131208|F||2106-3^White^HL70005|132 Bolotad Ln^^Detroit^MI^48212^USA^P||^PRN^PH^^^313^5243919|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Carton^Iman^^^^^L|MTH^Mother^HL70063|132 Bolotad Ln^^Detroit^MI^48212^USA^P|^PRN^PH^^^313^5243919|ORC|RE||U80U7367.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Farstan^Hemendra^^^^^^^^^^^^^^^^^^CPNP|||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.16.22a|P|2.5.1|PID|||2UeC-B.32.16^^^AIRA-TEST^MR||Wright^Irvette^Sexburth^^^^L|Bear Lake^Jenna|20131203|F||2106-3^White^HL70005|390 Holmes Ave^^Detroit^MI^48222^USA^P||^PRN^PH^^^313^3970475|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Wright^Jenna^^^^^L|MTH^Mother^HL70063|390 Holmes Ave^^Detroit^MI^48222^USA^P|^PRN^PH^^^313^3970475|ORC|RE||U96D7368.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Bear Lake^Evzen^^^^^^^^^^^^^^^^^^CRN|||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.17.22q|P|2.5.1|PID|||2UeC-B.32.17^^^AIRA-TEST^MR||Gunnerson^Yogesh^Este^^^^L|Gonzales^Kalea|20131124|M||2106-3^White^HL70005|31 Murphy Pl^^Alma^MI^48801^USA^P||^PRN^PH^^^989^5399710|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Gunnerson^Kalea^^^^^L|MTH^Mother^HL70063|31 Murphy Pl^^Alma^MI^48801^USA^P|^PRN^PH^^^989^5399710|ORC|RE||V85S7369.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Gonzales^Clarke^^^^^^^^^^^^^^^^^^DIP|||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.18.22q|P|2.5.1|PID|||2UeC-B.32.18^^^AIRA-TEST^MR||Van Buren^Kenwyn^Stig^^^^L|King^Luisa|20131125|M||2106-3^White^HL70005|368 Mono Cir^^MI Metro^MI^48340^USA^P||^PRN^PH^^^248^7182336|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Van Buren^Luisa^^^^^L|MTH^Mother^HL70063|368 Mono Cir^^MI Metro^MI^48340^USA^P|^PRN^PH^^^248^7182336|ORC|RE||B47U7370.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^King^Cohn^^^^^^^^^^^^^^^^^^MD|||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.19.22q|P|2.5.1|PID|||2UeC-B.32.19^^^AIRA-TEST^MR||Knox^Chinmay^Daxton^^^^L|Mackey^Susanne|20131127|M||2106-3^White^HL70005|239 Jauppi Cir^^Harrisville^MI^48740^USA^P||^PRN^PH^^^989^9464487|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Mackey^Susanne^^^^^L|MTH^Mother^HL70063|239 Jauppi Cir^^Harrisville^MI^48740^USA^P|^PRN^PH^^^989^9464487|ORC|RE||M77C7371.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Mackey^Cseke^^^^^^^^^^^^^^^^^^DO|||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.20.22F|P|2.5.1|PID|||2UeC-B.32.20^^^AIRA-TEST^MR||Audubon^Tallis^Winston^^^^L|Creghan^Zahara|20131130|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|22 Amador Pl^^Silver Lake^MI^49436^USA^P||^PRN^PH^^^231^9340066|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Audubon^Zahara^^^^^L|MTH^Mother^HL70063|22 Amador Pl^^Silver Lake^MI^49436^USA^P|^PRN^PH^^^231^9340066|ORC|RE||I89Z7372.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Okfuskee^Digby^^^^^^^^^^^^^^^^^^PharmD|||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.21.22F|P|2.5.1|PID|||2UeC-B.32.21^^^AIRA-TEST^MR||Greenlee^Rufford^J^^^^L|Sulit^Sigrun|20131207|M||2106-3^White^HL70005|59 Chase St^^Minden City^MI^48456^USA^P||^PRN^PH^^^989^8761317|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Newport^Sigrun^^^^^L|MTH^Mother^HL70063|59 Chase St^^Minden City^MI^48456^USA^P|^PRN^PH^^^989^8761317|ORC|RE||B49Y7373.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Newport^Selim^^^^^^^^^^^^^^^^^^PHD|||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.22.22F|P|2.5.1|PID|||2UeC-B.32.22^^^AIRA-TEST^MR||Rose^Gary^^^^^L|Kananen^Kanti|20131203|M||2106-3^White^HL70005|263 Skag Pl^^Farmington Hills^MI^48332^USA^P||^PRN^PH^^^248^3964666|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Guernsey^Kanti^^^^^L|MTH^Mother^HL70063|263 Skag Pl^^Farmington Hills^MI^48332^USA^P|^PRN^PH^^^248^3964666|ORC|RE||X15S7374.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Guernsey^Morice^^^^^^^^^^^^^^^^^^EMT|||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.23.22V|P|2.5.1|PID|||2UeC-B.32.23^^^AIRA-TEST^MR||Boyd^Ruchira^Ute^^^^L|Phelps^Sumitra|20131201|F||2054-5^Black or African-American^HL70005|60 Richardson Cir^^Bloomfield Village^MI^48301^USA^P||^PRN^PH^^^248^5516674|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Phelps^Sumitra^^^^^L|MTH^Mother^HL70063|60 Richardson Cir^^Bloomfield Village^MI^48301^USA^P|^PRN^PH^^^248^5516674|ORC|RE||D31A7375.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Phelps^Makhi^^^^^^^^^^^^^^^^^^EMT-P|||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.24.22V|P|2.5.1|PID|||2UeC-B.32.24^^^AIRA-TEST^MR||Edmonson^Philida^K^^^^L|Cass^Kendal|20131212|F||2106-3^White^HL70005|58 Benton Pl^^Whitehall^MI^49463^USA^P||^PRN^PH^^^231^9406336|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Edmonson^Kendal^^^^^L|MTH^Mother^HL70063|58 Benton Pl^^Whitehall^MI^49463^USA^P|^PRN^PH^^^231^9406336|ORC|RE||F29Q7376.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Buckshorn^Dorian^^^^^^^^^^^^^^^^^^FPNP|||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.25.22V|P|2.5.1|PID|||2UeC-B.32.25^^^AIRA-TEST^MR||Julin^Amato^C^^^^L|Clay^Hine|20131216|M||2106-3^White^HL70005|74 Pacific St^^Dimondale^MI^48821^USA^P||^PRN^PH^^^517^7072687|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Julin^Hine^^^^^L|MTH^Mother^HL70063|74 Pacific St^^Dimondale^MI^48821^USA^P|^PRN^PH^^^517^7072687|ORC|RE||G09E7377.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Greeley^Jackson^^^^^^^^^^^^^^^^^^HS|||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.26.22V|P|2.5.1|PID|||2UeC-B.32.26^^^AIRA-TEST^MR||Harrison^Hunter^Kinsey^^^^L|Garvin^Suchi|20131219|M||2106-3^White^HL70005|248 Leonard Cir^^Rochester Hills^MI^48306^USA^P||^PRN^PH^^^248^6654912|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Harrison^Suchi^^^^^L|MTH^Mother^HL70063|248 Leonard Cir^^Rochester Hills^MI^48306^USA^P|^PRN^PH^^^248^6654912|ORC|RE||X19D7378.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Garvin^Clayton^^^^^^^^^^^^^^^^^^JD|||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.27.23a|P|2.5.1|PID|||2UeC-B.32.27^^^AIRA-TEST^MR||Stark^Joo-Chan^Jarrad^^^^L|Bernstrain^Edmonda|20131216|M||1002-5^American Indian or Alaska Native^HL70005|245 Goss Ln^^Detroit^MI^48268^USA^P||^PRN^PH^^^313^6710815|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Clinton^Edmonda^^^^^L|MTH^Mother^HL70063|245 Goss Ln^^Detroit^MI^48268^USA^P|^PRN^PH^^^313^6710815|ORC|RE||L70K7379.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Clinton^Hemal^^^^^^^^^^^^^^^^^^LPN|||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.28.23a|P|2.5.1|PID|||2UeC-B.32.28^^^AIRA-TEST^MR||Montgomery^Yani^Clare^^^^L|Glorinn^Alexus|20131130|F||2131-1^Other Race^HL70005|358 Legresley Ave^^Gaines^MI^48436^USA^P||^PRN^PH^^^989^8104713|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Montgomery^Alexus^^^^^L|MTH^Mother^HL70063|358 Legresley Ave^^Gaines^MI^48436^USA^P|^PRN^PH^^^989^8104713|ORC|RE||H65D7380.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Ulseth^Tate^^^^^^^^^^^^^^^^^^MA|||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.29.23a|P|2.5.1|PID|||2UeC-B.32.29^^^AIRA-TEST^MR||Isabella^Elli^^^^^L|Choctaw^Eranthe|20131203|F||2106-3^White^HL70005|101 Yakima Cir^^Litchfield^MI^49252^USA^P||^PRN^PH^^^517^6218079|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Hofflund^Eranthe^^^^^L|MTH^Mother^HL70063|101 Yakima Cir^^Litchfield^MI^49252^USA^P|^PRN^PH^^^517^6218079|ORC|RE||W20G7381.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Hofflund^Wynn^^^^^^^^^^^^^^^^^^MBA|||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.30.23q|P|2.5.1|PID|||2UeC-B.32.30^^^AIRA-TEST^MR||Jefferson^Orelia^Ofrah^^^^L|Olsen^Derryth|20131128|F||2106-3^White^HL70005|135 Sullivan Cir^^Clawson^MI^48017^USA^P||^PRN^PH^^^248^4698742|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Jefferson^Derryth^^^^^L|MTH^Mother^HL70063|135 Sullivan Cir^^Clawson^MI^48017^USA^P|^PRN^PH^^^248^4698742|ORC|RE||H25R7382.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Merwik^Packard^^^^^^^^^^^^^^^^^^MPH|||||S4121RG||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.31.23q|P|2.5.1|PID|||2UeC-B.32.31^^^AIRA-TEST^MR||Anderson^Arely^E^^^^L|Karlsson^Astra|20131204|F||2028-9^Asian^HL70005|188 Canyon St^^Eagle Harbor^MI^49950^USA^P||^PRN^PH^^^906^5688296|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Anderson^Astra^^^^^L|MTH^Mother^HL70063|188 Canyon St^^Eagle Harbor^MI^49950^USA^P|^PRN^PH^^^906^5688296|ORC|RE||I60T7383.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Karlsson^Marmaduke^^^^^^^^^^^^^^^^^^MS|||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.32.23q|P|2.5.1|PID|||2UeC-B.32.32^^^AIRA-TEST^MR||Washington^Kelly^T^^^^L|Nilsen^Guan-yin|20131124|F||2054-5^Black or African-American^HL70005|306 Nelson Ave^^Oshtemo^MI^49077^USA^P||^PRN^PH^^^269^3671083|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Nilsen^Guan-yin^^^^^L|MTH^Mother^HL70063|306 Nelson Ave^^Oshtemo^MI^49077^USA^P|^PRN^PH^^^269^3671083|ORC|RE||Q12T7384.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Nilsen^Saunders^^^^^^^^^^^^^^^^^^MSN|||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.33.23G|P|2.5.1|PID|||2UeC-B.32.33^^^AIRA-TEST^MR||Floyd^Dorcas^Rane^^^^L|Haughton^Dayla|20131202|F||2106-3^White^HL70005|30 Spencer Pl^^Barlow Branch^MI^49686^USA^P||^PRN^PH^^^231^7000140|||||||||2135-2^Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Floyd^Dayla^^^^^L|MTH^Mother^HL70063|30 Spencer Pl^^Barlow Branch^MI^49686^USA^P|^PRN^PH^^^231^7000140|ORC|RE||X89P7385.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Haughton^Cort^^^^^^^^^^^^^^^^^^MDA|||||L6696AE||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.34.23G|P|2.5.1|PID|||2UeC-B.32.34^^^AIRA-TEST^MR||Crittenden^Chizu^T^^^^L|Erath^Anani|20131203|F||1002-5^American Indian or Alaska Native^HL70005|262 Pesken Ln^^Beulah^MI^49617^USA^P||^PRN^PH^^^231^8751143|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Crittenden^Anani^^^^^L|MTH^Mother^HL70063|262 Pesken Ln^^Beulah^MI^49617^USA^P|^PRN^PH^^^231^8751143|ORC|RE||B27V7386.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Brown^Zachary^^^^^^^^^^^^^^^^^^MT|||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.35.23G|P|2.5.1|PID|||2UeC-B.32.35^^^AIRA-TEST^MR||Alpine^Sorrel^Kendall^^^^L|Clinton^Greta|20131211|F||2028-9^Asian^HL70005|267 Placer Cir^^Willis^MI^48191^USA^P||^PRN^PH^^^734^9885051|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Alpine^Greta^^^^^L|MTH^Mother^HL70063|267 Placer Cir^^Willis^MI^48191^USA^P|^PRN^PH^^^734^9885051|ORC|RE||S29U7387.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Anderson^Sriram^^^^^^^^^^^^^^^^^^NG|||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.36.23G|P|2.5.1|PID|||2UeC-B.32.36^^^AIRA-TEST^MR||Calaveras^Brencis^Gino^^^^L|Sonoma^Desiree|20131207|M||2106-3^White^HL70005|10 Crittenden Ave^^Utica^MI^48316^USA^P||^PRN^PH^^^586^3155989|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Brewster^Desiree^^^^^L|MTH^Mother^HL70063|10 Crittenden Ave^^Utica^MI^48316^USA^P|^PRN^PH^^^586^3155989|ORC|RE||U00B7388.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Sonoma^Jaxton^^^^^^^^^^^^^^^^^^NP|||||Y5841RR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.37.23V|P|2.5.1|PID|||2UeC-B.32.37^^^AIRA-TEST^MR||Elk^Niley^T^^^^L|Archer^Nilini|20131212|F||2106-3^White^HL70005|326 DeWitt Pl^^Bessemer^MI^49911^USA^P||^PRN^PH^^^906^9994116|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Archer^Nilini^^^^^L|MTH^Mother^HL70063|326 DeWitt Pl^^Bessemer^MI^49911^USA^P|^PRN^PH^^^906^9994116|ORC|RE||N22J7389.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Archer^Kerrin^^^^^^^^^^^^^^^^^^PA|||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.38.23V|P|2.5.1|PID|||2UeC-B.32.38^^^AIRA-TEST^MR||Hawke^Zalia^A^^^^L|Deuel^Filomena|20131214|F||2106-3^White^HL70005|121 Hillsdale Ave^^Luna Pier^MI^48157^USA^P||^PRN^PH^^^734^5524542|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Hawke^Filomena^^^^^L|MTH^Mother^HL70063|121 Hillsdale Ave^^Luna Pier^MI^48157^USA^P|^PRN^PH^^^734^5524542|ORC|RE||P57A7390.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Deuel^Jabez^^^^^^^^^^^^^^^^^^PHN|||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.39.23V|P|2.5.1|PID|||2UeC-B.32.39^^^AIRA-TEST^MR||Court^Austin^B^^^^L|Connor^Eir|20131211|M||2106-3^White^HL70005|225 Simmingsen Ave^^Escanaba^MI^49829^USA^P||^PRN^PH^^^906^8104319|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Court^Eir^^^^^L|MTH^Mother^HL70063|225 Simmingsen Ave^^Escanaba^MI^49829^USA^P|^PRN^PH^^^906^8104319|ORC|RE||G71C7391.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Connor^Brycen^^^^^^^^^^^^^^^^^^RMA|||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.40.24b|P|2.5.1|PID|||2UeC-B.32.40^^^AIRA-TEST^MR||Custer^Isaac^Kateb^^^^L|Perry^Reagan|20131121|M||2054-5^Black or African-American^HL70005|166 Liberty Ln^^Southfield^MI^48075^USA^P||^PRN^PH^^^248^9279852|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Custer^Reagan^^^^^L|MTH^Mother^HL70063|166 Liberty Ln^^Southfield^MI^48075^USA^P|^PRN^PH^^^248^9279852|ORC|RE||S96F7392.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Perry^Vishnu^^^^^^^^^^^^^^^^^^RN|||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.41.24b|P|2.5.1|PID|||2UeC-B.32.41^^^AIRA-TEST^MR||Cerro Gordo^Vaughan^Vasudeva^^^^L|Alcona^Dahlia|20131122|M||2054-5^Black or African-American^HL70005|207 Hancock Cir^^Hillman^MI^49746^USA^P||^PRN^PH^^^989^3522854|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Alcona^Dahlia^^^^^L|MTH^Mother^HL70063|207 Hancock Cir^^Hillman^MI^49746^USA^P|^PRN^PH^^^989^3522854|ORC|RE||I08L7393.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Alcona^Hyam^^^^^^^^^^^^^^^^^^RPH|||||Q3110HZ||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.42.24b|P|2.5.1|PID|||2UeC-B.32.42^^^AIRA-TEST^MR||Denton^Signild^D^^^^L|Jessamine^Cleopatra|20131212|F||2131-1^Other Race^HL70005|172 Cottle Ave^^Belmont^MI^49306^USA^P||^PRN^PH^^^616^2331598|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|McClain^Cleopatra^^^^^L|MTH^Mother^HL70063|172 Cottle Ave^^Belmont^MI^49306^USA^P|^PRN^PH^^^616^2331598|ORC|RE||I68N7394.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Jessamine^Gara^^^^^^^^^^^^^^^^^^SEC|||||N3783EO||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.32.43.24r|P|2.5.1|PID|||2UeC-B.32.43^^^AIRA-TEST^MR||Cowley^Aren^Omari^^^^L|Santa Cruz^Maryam|20131202|M||2076-8^Native Hawaiian or Other Pacific Islander^HL70005|201 Paulding Cir^^Tawas City^MI^48763^USA^P||^PRN^PH^^^989^7123386|||||||||2186-5^not Hispanic or Latino^HL70005|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Santa Cruz^Maryam^^^^^L|MTH^Mother^HL70063|201 Paulding Cir^^Tawas City^MI^48763^USA^P|^PRN^PH^^^989^7123386|ORC|RE||H87D7395.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001|^Santa Cruz^Rene^^^^^^^^^^^^^^^^^^TS|||||V7634SH||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.33.01.24r|P|2.5.1|PID|||2UeC-B.33.01^^^AIRA-TEST^MR||Richardson^Troilus^Sandy^^^^L|Mackinac^Dulcina|20131203|M||2054-5^Black or African-American^HL70005|193 Peniston Ave^^Highland^MI^48357^USA^P||^PRN^PH^^^248^2858078|||||||||2186-5^not Hispanic or Latino^HL70005||N||PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Richardson^Dulcina^^^^^L|MTH^Mother^HL70063|193 Peniston Ave^^Highland^MI^48357^USA^P|^PRN^PH^^^248^2858078|ORC|RE||B42G7396.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U6329BP||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.33.02.24r|P|2.5.1|PID|||2UeC-B.33.02^^^AIRA-TEST^MR||Kirkland^Lucius^Yazid^^^^L|Marin^Theone|20131201|M||2106-3^White^HL70005|29 Fremont St^^Dearborn^MI^48123^USA^P||^PRN^PH^^^313^4778513|||||||||2186-5^not Hispanic or Latino^HL70005||Y|1|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Kay^Theone^^^^^L|MTH^Mother^HL70063|29 Fremont St^^Dearborn^MI^48123^USA^P|^PRN^PH^^^313^4778513|ORC|RE||A50O7397.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||Z7029FR||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.33.03.24r|P|2.5.1|PID|||2UeC-B.33.03^^^AIRA-TEST^MR||Clearfield^Corliss^Mayrah^^^^L|Johnsson^Marabel|20131128|F||2106-3^White^HL70005|167 Lake Cir^^Beaverton^MI^48612^USA^P||^PRN^PH^^^989^4257487|||||||||2186-5^not Hispanic or Latino^HL70005||Y|1|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Clearfield^Marabel^^^^^L|MTH^Mother^HL70063|167 Lake Cir^^Beaverton^MI^48612^USA^P|^PRN^PH^^^989^4257487|ORC|RE||G02V7398.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||P3400YX||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V05^VFC eligible - Federally Qualified Health Center Patient (under-insured)^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.33.04.24G|P|2.5.1|PID|||2UeC-B.33.04^^^AIRA-TEST^MR||Cummings^Keegan^Elias^^^^L|Spooner^Shri|20131126|M||2054-5^Black or African-American^HL70005|44 Wheeler Pl^^Flint^MI^48554^USA^P||^PRN^PH^^^810^6466218|||||||||2186-5^not Hispanic or Latino^HL70005||Y|1|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Spooner^Shri^^^^^L|MTH^Mother^HL70063|44 Wheeler Pl^^Flint^MI^48554^USA^P|^PRN^PH^^^810^6466218|ORC|RE||K77X7399.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.34.01.24G|P|2.5.1|PID|||2UeC-B.34.01^^^AIRA-TEST^MR||Knox^Hafiz^Sidney^^^^L|Vargas^Isaura|20131201|M||2106-3^White^HL70005|186 Darke Cir^^Kalamazoo^MI^49024^USA^P||^PRN^PH^^^269^5922304|||||||||2135-2^Hispanic or Latino^HL70005||Y|2|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Knox^Isaura^^^^^L|MTH^Mother^HL70063|186 Darke Cir^^Kalamazoo^MI^49024^USA^P|^PRN^PH^^^269^5922304|ORC|RE||Z31S7400.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||21^Varicella^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||G3407KC||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V02^VFC eligible - Medicaid/Medicaid Managed Care^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|21^Varicella^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20080313||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.34.02.24W|P|2.5.1|PID|||2UeC-B.34.02^^^AIRA-TEST^MR||Crane^Elise^Afric^^^^L|Bolgen^Wahida|20131205|F||2054-5^Black or African-American^HL70005|154 Lindblom Ln^^Lowell^MI^49331^USA^P||^PRN^PH^^^616^8857708|||||||||2186-5^not Hispanic or Latino^HL70005||Y|3|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Crane^Wahida^^^^^L|MTH^Mother^HL70063|154 Lindblom Ln^^Lowell^MI^49331^USA^P|^PRN^PH^^^616^8857708|ORC|RE||J65C7401.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||94^MMRV^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||V7737HT||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|RA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V03^VFC eligible - Uninsured^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|94^MMRV^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20100521||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|MSH|^~\&||DMC53427|||20171204140817-0700||VXU^V04^VXU_V04|2UeC-B.34.03.24W|P|2.5.1|PID|||2UeC-B.34.03^^^AIRA-TEST^MR||Lenawee^Vincentia^^^^^L|Morros^Cleta|20131214|F||2106-3^White^HL70005|13 Delaware Ave^^Clarkston^MI^48346^USA^P||^PRN^PH^^^248^7040442|||||||||2135-2^Hispanic or Latino^HL70005||Y|4|PD1|||||||||||02^Reminder/Recall - any method^HL70215|||||A|20171204|20171204|NK1|1|Morros^Cleta^^^^^L|MTH^Mother^HL70063|13 Delaware Ave^^Clarkston^MI^48346^USA^P|^PRN^PH^^^248^7040442|ORC|RE||W15Z7402.3^AIRA|||||||I-23432^Burden^Donna^A^^^^^NIST-AA-1||57422^RADON^NICHOLAS^^^^^^NIST-AA-1^L|RXA|0|1|20171204||03^MMR^CVX|0.5|mL^milliliters^UCUM||00^Administered^NIP001||||||U1747GW||MSD^Merck and Co^MVX||||A|RXR|SC^^HL70162|LA^^HL70163|OBX|1|CE|64994-7^Vaccine funding program eligibility category^LN|1|V04^VFC eligible - American Indian/Alaskan Native^HL70064||||||F|||20171204|||VXC40^Eligibility captured at the immunization level^CDCPHINVS|OBX|2|CE|30956-7^Vaccine Type^LN|2|03^MMR^CVX||||||F|OBX|3|TS|29768-9^Date vaccine information statement published^LN|2|20120420||||||F|OBX|4|TS|29769-7^Date vaccine information statement presented^LN|2|20171204||||||F|